
<html lang="en"     class="pb-page"  data-request-id="0884b4eb-b5cd-44b8-932b-b8a4163fb92b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.5b00760;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-12;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer" /></meta><meta name="dc.Creator" content="Donald P.  McDonnell" /></meta><meta name="dc.Creator" content="Suzanne E.  Wardell" /></meta><meta name="dc.Creator" content="John D.  Norris" /></meta><meta name="dc.Description" content="Drugs that inhibit estrogen receptor alpha (ERα) or that block the production of estrogens remain frontline interventions in the treatment and management of breast cancer at all stages. However, re..." /></meta><meta name="Description" content="Drugs that inhibit estrogen receptor alpha (ERα) or that block the production of estrogens remain frontline interventions in the treatment and management of breast cancer at all stages. However, re..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 3, 2015" /></meta><meta name="dc.Type" content="editorial" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00760" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00760" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00760" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00760" /></link>
        
    
    

<title>Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00760" /></meta><meta property="og:title" content="Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="Drugs that inhibit estrogen receptor alpha (ERα) or that block the production of estrogens remain frontline interventions in the treatment and management of breast cancer at all stages. However, resistance to endocrine therapies, especially in the setting of advanced disease, remains an impediment to durable clinical responses. Although the mechanisms underlying resistance to existing agents are complex, preclinical studies suggest that selective estrogen receptor downregulators (SERDs), molecules which eliminate ERα expression, may have particular utility in the treatment of breast cancers that have progressed on tamoxifen and/or aromatase inhibitors. The discovery and development of orally bioavailable SERDs provide the opportunity to evaluate the utility of eliminating ERα expression in advanced metastatic breast cancers." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00760"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00760">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00760&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00760&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00760&amp;href=/doi/10.1021/acs.jmedchem.5b00760" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4883-4887</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501881c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Viewpoint</span><a href="/doi/10.1021/acs.jmedchem.5b00054" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+P.++McDonnell">Donald P. McDonnell</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+E.++Wardell">Suzanne E. Wardell</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++Norris">John D. Norris</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 919-684-6035. Fax: 919-681-7139. E-mail: <a href="/cdn-cgi/l/email-protection#482c272629242c66252b2c2726262d2424082c3d232d662d2c3d"><span class="__cf_email__" data-cfemail="dabeb5b4bbb6bef4b7b9beb5b4b4bfb6b69abeafb1bff4bfbeaf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00760&amp;href=/doi/10.1021%2Facs.jmedchem.5b00760" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4883–4887</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 3, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 May 2015</li><li><span class="item_label"><b>Published</b> online</span>3 June 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 June 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00760</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4883%26pageCount%3D5%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDonald%2BP.%2BMcDonnell%252C%2BSuzanne%2BE.%2BWardell%252C%2BJohn%2BD.%2BNorris%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D12%26contentID%3Dacs.jmedchem.5b00760%26title%3DOral%2BSelective%2BEstrogen%2BReceptor%2BDownregulators%2B%2528SERDs%2529%252C%2Ba%2BBreakthrough%2BEndocrine%2BTherapy%2Bfor%2BBreast%2BCancer%26numPages%3D5%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4887%26publicationDate%3DJune%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00760"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5534</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">95</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00760" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;P. McDonnell&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;E. Wardell&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. Norris&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;4883-4887&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00760&quot;},&quot;abstract&quot;:&quot;Drugs that inhibit estrogen receptor alpha (ERα) or that block the production of estrogens remain frontline interventions in the treatment and management of breast cancer at all stages. However, resistance to endocrine therapies, especially in the setting of advanced disease, remains an impediment to durable clinical responses. Although the mechanisms underlying resistance to existing agents are complex, preclinical studies suggest that selective estrogen receptor downregulators (SERDs), molecules which eliminate ERα expression, may have particular utility in the treatment of breast cancers that have progressed on tamoxifen and/or aromatase inhibitors. The discovery and development of orally bioavailable SERDs provide the opportunity to evaluate the utility of eliminating ERα expression in advanced metastatic breast cancers.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00760&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00760" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00760&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00760" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00760&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00760" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00760&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00760&amp;href=/doi/10.1021/acs.jmedchem.5b00760" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00760" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00760" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (581 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00760%26sid%3Dliteratum%253Aachs%26pmid%3D26039356%26genre%3Darticle%26aulast%3DMcDonnell%26date%3D2015%26atitle%3DOral%2BSelective%2BEstrogen%2BReceptor%2BDownregulators%2B%2528SERDs%2529%252C%2Ba%2BBreakthrough%2BEndocrine%2BTherapy%2Bfor%2BBreast%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D12%26spage%3D4883%26epage%3D4887%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/jmcmar.2015.58.issue-12/20150625/jmcmar.2015.58.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><p class="articleBody_abstractText">Drugs that inhibit estrogen receptor alpha (ERα) or that block the production of estrogens remain frontline interventions in the treatment and management of breast cancer at all stages. However, resistance to endocrine therapies, especially in the setting of advanced disease, remains an impediment to durable clinical responses. Although the mechanisms underlying resistance to existing agents are complex, preclinical studies suggest that selective estrogen receptor downregulators (SERDs), molecules which eliminate ERα expression, may have particular utility in the treatment of breast cancers that have progressed on tamoxifen and/or aromatase inhibitors. The discovery and development of orally bioavailable SERDs provide the opportunity to evaluate the utility of eliminating ERα expression in advanced metastatic breast cancers.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div id="ac_i1" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i1"> </h2><div class="NLM_p">There are numerous reports describing the pharmacological and therapeutic activity of small molecules that target key regulatory nodes in signaling pathways of pathological importance in breast cancer. Among the most promising of these new drugs are those that inhibit mTOR or cdk4/6.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Notwithstanding the recent clinical success of these newer targeted therapies, it is unlikely that they will have as significant an impact on the pharmacotherapy of estrogen receptor (ER) positive breast cancer as drugs that interfere with the estrogen signaling axis. Of these, tamoxifen, a selective estrogen receptor modulator (SERM), and the aromatase inhibitors (i.e., letrozole), drugs developed over 25 years ago, remain frontline interventions in the management of ER positive disease. However, de novo and acquired resistance remains an impediment to durable responses in patients on these established endocrine therapies.</div><div class="NLM_p">Until recently, treatment failure in patients taking tamoxifen or an aromatase inhibitor was considered to herald the end of the utility of targeting the ERα signaling axis in breast cancer. This contention was supported by the lack of clinical activity of a wide range of structurally diverse SERMs in endocrine resistant disease.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> However, in recent years, the field has made considerable progress toward understanding the molecular pharmacology of ERα and how changes in key pathways that impact ER action contribute to endocrine resistance. It is now well established that ERα remains engaged in advanced disease, contributes to disease pathogenesis, and remains a viable therapeutic target. This contemporary view of ERα action in breast cancer led to the development of ICI182,780 (fulvestrant) a high affinity competitive antagonist of ER that also targets the receptor for proteasome-dependent degradation (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Reflecting its distinct pharmacological profile, fulvestrant is now considered to be a first-in-class selective estrogen receptor downregulator (SERD). Unfortunately, fulvestrant has significant pharmaceutical liabilities (requiring intramuscular injection) that have negatively impacted its widespread use.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Regardless, the positive clinical activity of fulvestrant and studies of its mechanism of action have informed approaches to develop second (and third) generation SERDs, some of which are now undergoing clinical evaluation. The orally bioavailable drug described by Lai et al. in this issue, GDC-0810 (ARN-810), is the most advanced of the next generation SERDs and is currently being evaluated in clinical trials in breast cancer patients who have progressed on standard endocrine therapy.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> A brief discussion of the science underlying the discovery of GDC-0810 will help to explain the considerable optimism for the clinical success of this drug, and others in the same class, in patients with breast cancer.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures of ERα Modulators That Display SERD Activity in Cellular and Animal Models of Breast Cancer</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/medium/jm-2015-00760e_0002.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">Early models describing the pharmacology of ER were quite simple. In brief, it was held that in the absence of hormone the receptor was maintained in an inactive state through its association with a large heat-shock protein complex within the cytoplasm. Agonist binding induced a conformational change in the receptor resulting in its dimerization, nuclear translocation, and subsequent interaction with specific DNA sequences within the regulatory regions of target genes. It was inferred from this simple “on/off” model that all agonists, when corrected for affinity, were equivalent and that antagonists functioned simply by competitively inhibiting agonist binding freezing the receptor in an inactive (apo) conformation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Within the confines of this model, it was initially considered that tamoxifen was an ER antagonist. However, in studies first performed in rodents and subsequently in humans, it became apparent that depending on the target organ, tamoxifen could function either as an antagonist or as an agonist.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> This observation led to the reclassification of tamoxifen, and most other “ER antagonists”, as selective estrogen receptor modulators (SERMs), reflecting their tissue selective agonist/antagonist properties. The subsequent dissection of the mechanisms underlying the selective agonist/antagonist activity of SERMs resulted in a significant revision of the established model of ER pharmacology. The three most important tenets of the updated model are the following: (1) the overall shape of ER is influenced by the nature of the ligand to which it is bound; (2) receptor conformation influences the presentation of protein–protein interaction surfaces that allow it to interact with either positive or negative acting “coregulators”; (3) the functional activity of coregulators differs between cells. Thus, the same receptor–ligand complex can have completely different activities in different cells.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> These findings were also informative with respect to our understanding of tamoxifen resistance in breast cancer. Initially attributed to ERα loss, increased drug metabolism, or MDR1-mediated drug efflux, it is now believed that resistance to tamoxifen results from changes in the expression (or activity) of coregulators that enable tamoxifen to manifest agonist activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Evidence in support of this model came from structural studies that revealed that upon binding tamoxifen, ERα adopted a unique conformation that resulted in the presentation of protein–protein interaction surfaces required for its partial agonist activity.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Surprisingly, these surfaces were distinct from those presented upon binding 17β-estradiol, suggesting that the tamoxifen–ERα complex either was interacting in an ectopic manner with coregulator(s) that enabled agonist activity or was interacting in a unique way with coregulators with which ERα would normally engage. It was implied therefore that tamoxifen resistant cancers should be sensitive to ERα ligands that induced a conformational change in the receptor that did not enable the presentation of coregulator binding surfaces required for 17β-estradiol or tamoxifen agonist activity (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Conformation-based compound profiling led to the identification of GW5638 and its 4-OH metabolite, GW7604, compounds that had distinct effects on ER structure.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Significantly, these drugs inhibited 17β-estradiol-dependent growth of ERα-positive breast tumor xenografts and more importantly were shown to be extremely effective in tumor models of tamoxifen resistance. Crystallographic analysis of the ERα-GW7604 complex revealed that the carboxylic acid group in this compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was the key “warhead” and that its direct interaction with the peptide backbone of the receptor induced a conformational change that exposed a hydrophobic surface on the receptor that targeted it for degradation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> This molecule was brought forward for clinical development in 2001 by Dupont Pharmaceuticals and showed promise in a phase I trial of heavily pretreated, unselected breast cancer patients. Unfortunately, development of this drug was discontinued, a casualty of the portfolio review that accompanied the takeover of Dupont by Bristol-Myers Squibb. While disappointing, the strong functional data and the clear understanding of its mechanism of action provided a platform upon which to base screens for new chemical entities with similar SERD activity. GDC-0810 is the first of these new SERDs to emerge; however, additional compounds with structural similarity to GW5638 (e.g., AZD9496) are also currently making their way through clinical development.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/medium/jm-2015-00760e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/large/jm-2015-00760e_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular pharmacology of SERDs in the setting of tamoxifen resistance. Upon binding tamoxifen, ERα undergoes a specific conformational change that enables the presentation of protein–protein interaction surfaces for which in tamoxifen sensitive cells there are no compatible coregulators. Thus, tamoxifen binding commits ER down a “nonproductive” pathway, an activity that manifests as antagonism. It is proposed that chronic administration of tamoxifen, however, results in the selection of a subpopulation of cells that express a compatible coactivator (CoA). In this manner the pharmacology of tamoxifen “switches” from that of an antagonist to an agonist. SERDs, like GDC-0810, have activity in the setting of tamoxifen resistance because they (a) function as high affinity competitive antagonists, (b) induce a conformational change that is incompatible with coregulator interactions, and (c) target the receptor for proteasomal degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/large/jm-2015-00760e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00760&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As noted by Lai et al., GW5638 is a prodrug that is converted following oral delivery to its more potent metabolite GW7604.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The extent to which this conversion is required for clinical activity is unknown, but it is likely to be important given the higher affinity of the hydroxylated metabolite. Using cross-species microsome profiling, it was determined that the conversion of GW5638 to GW7604 was variable with only ∼16% conversion observed in human liver microsomes. This potential liability was mitigated in a new chemical series by modifications in the GW5638 parent molecule that led to increased potency and removed the primary site for glucuronidation while maintaining SERD activity. The molecule selected for development, GDC-0810, has significantly improved exposure over benchmark compounds in animals, was equivalent to GW5638 in its ability to degrade ER, and maintained the ability to inhibit the growth of tumors in a clinically relevant xenograft model of tamoxifen resistance. It seems intuitive that elimination of the need for metabolic activation would increase efficacy, although the extent to which this contributes to clinical activity remains to be determined.</div><div class="NLM_p">The results of the ongoing clinical trials with GDC-0810 are eagerly awaited, as they will provide a definitive test of the utility of targeting ERα in advanced metastatic breast cancer. In the meantime the studies presented by Lai et al., and others like it, provide the framework for discussion of a variety of issues related to targeting ERα in advanced disease. One of the most hotly debated issues in the field is whether or not SERDs will have any therapeutic advantage over high affinity competitive antagonists of ER without SERD activity. A cursory review of the clinical studies performed with several structurally different high affinity antagonists would seem to suggest that high affinity antagonists are not the answer.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, the results of only a few of the clinical trials of these drugs were ever published, and thus, it is not clear by what criteria (efficacy, safety, or economics) they were considered unsuccessful. It would be very useful in this regard to have available the results of the clinical studies that evaluated pipendoxifene (ERA924) and acolbifene (EM652), two high affinity ERα antagonists that were discontinued for unstated reasons. The disappointing studies with the raloxifene derivative, arzoxifene, were initially considered to indicate that high affinity antagonists would be ineffective in advanced disease.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, the structure of the ERα–raloxifene complex (and by inference the arzoxifene complex) is very similar to that of the ERα–tamoxifen complex, a result that would predict cross resistance. Indeed arzoxifene was ineffective in the MCF-7 xenograft model of tamoxifen resistance, the gold standard in the field.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Clearly, the question of whether or not high affinity antagonists/SERMs have a place in the treatment of advanced ER positive breast cancer remains to be determined. There is a significant body of work that would support the particular utility of a SERD. Notably, it has been demonstrated in the past in a variety of models that increased expression of coregulators or hyperactivation of signaling pathways that impact the ER–coregulator complex enables the receptor to activate target gene transcription in a ligand-independent manner. These mechanisms are also thought to underlie resistance both to SERMs and to aromatase inhibitors.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Ligand-independent activation of ERα reduces the antagonist efficacy of SERMs, while the sensitivity to SERDs is unaffected. Further, it now appears that up to 20% of tumors in metastatic, endocrine resistant breast cancer contain activating mutations in the receptor and the preclinical studies presented thus far support the idea that SERDs are a viable approach to treat patients whose tumors harbor these mutations.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Missing from the studies of Lai et al. are data describing the activity of GDC-0810 on ERα where its activity is rendered constitutively active.</div><div class="NLM_p">A second area in breast cancer that is emerging as a priority for pharmacotherapy is breast cancer brain metastasis (BCBM). Whereas the treatment (and management) of peripheral disease has improved substantially with the advent of tamoxifen and aromatase inhibitors, there has been a dramatic increase in the incidence of BCBM.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Initially, it was considered that BCBM was only a significant morbidity in ERα-negative breast cancer. However, more recent studies have indicated that the prevalence of ERα-positive BCBM is considerably higher than expected.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This is of concern as the aromatase enzyme (cyp19) is expressed in brain and considering that the ERα-partial agonist 27-hydroxycholesterol is the most abundant oxysterol in brain.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> There is little data on the ability of existing ER modulators and aromatase inhibitors to cross the blood–brain barrier (BBB), and thus, there is considerable interest in evaluating brain penetrant SERDs or SERMs in patients with BCBM. The ongoing clinical studies with GDC-0810 should be informative with respect to its ability to cross the BBB.</div><div class="NLM_p">In addition to GDC-0810, there are several new ER modulators at various stages of development, and it is reasonable to expect, given the underlying science, that several of these will be effective enough to warrant their registration as monotherapies. However, it is likely that the true potential of GDC-0810, and like compounds, will be observed in the context of drug combinations that target ERα and other signaling pathways. It has been shown for instance that resistance to HER2/EGFR inhibitors and to PI3K inhibitors is associated with increased intratumoral expression of ER, and in relevant models it has been shown that such resistance can be reversed by the SERD fulvestrant.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> Likewise in human tumor explants it has been shown that inhibition of MAPK or Src results in an increase in ERα protein.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Thus, dual or multiple pathway inhibition may be required to realize the full potential of SERDs or SERMs. Indeed, the recent results of the PALOMA 3 clinical trial were very encouraging, as it was reported that regimens in which the cdk4/6 inhibitor (palbociclib) and fulvestrant were combined demonstrated an impressive improvement in progression free survival (10 months) when compared to fulvestrant plus placebo in women with ER positive metastatic breast cancer. Similar studies of cdk4/6 inhibitors in combination with the newer SERDs (GDC-0810) are expected. The results of a recently opened clinical trial of palbociclib with bazedoxifene (a SERM that significantly downregulates ERα expression) will also be important to the field (NCT02448771).</div><div class="NLM_p">Finally, it remains to be determined if all SERDs are the same. Currently, there are at least three chemical classes of SERDs either approved or in development: (a) steroids (fulvestrant), (b) acrylic acids (GW5638/GDC0810), and (c) others (OP-1094) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). From what is known thus far, it appears as if the mechanisms underlying the SERD activity of these different classes of compounds are not the same.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Identification of the specific E2/E3 ubiquitin ligases responsible for the activity of these drugs and a determination of the relationship between the expression of these particular enzymes and efficacy may enable approaches to personalize SERD usage.</div><div class="NLM_p last">In conclusion, as evidenced by the studies presented by Lai et al., there has been considerable progress of late in developing orally bioavailable SERDs and it is likely that these will have a significant impact on the pharmacotherapy of breast cancer. Given that GDC-0810 and AZD9694 are already in clinical trials, it is likely that the answers to some of the questions raised above will be answered in the relatively near future.</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald P. McDonnell</span>, 
    <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Cancer Biology, Duke University School
of Medicine, Durham, North Carolina 27710, United States</span>, 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ff9b90919e939bd1929c9b9091919a9393bf9b8a949ad19a9b8a"><span class="__cf_email__" data-cfemail="84e0ebeae5e8e0aae9e7e0ebeaeae1e8e8c4e0f1efe1aae1e0f1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne E. Wardell</span>, 
    <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Cancer Biology, Duke University School
of Medicine, Durham, North Carolina 27710, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. Norris</span>, 
    <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Cancer Biology, Duke University School
of Medicine, Durham, North Carolina 27710, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00760" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Supporting funding for all authors was provided by the NIH (Grant DK048807).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Mayer, E. L.</span><span> </span><span class="NLM_article-title">Targeting breast cancer with CDK inhibitors</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1007%2Fs11912-015-0443-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=25716100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A280%3ADC%252BC2MrptVantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=443&author=E.+L.+Mayer&title=Targeting+breast+cancer+with+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting breast cancer with CDK inhibitors</span></div><div class="casAuthors">Mayer Erica L</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dysregulation of the cell cycle is a classic hallmark of cancer growth and metastatic potential.  Re-establishing cell cycle control through CDK inhibition has emerged as an attractive option in the development of targeted cancer therapy.  Three oral agents selectively targeting CDK4/6 have been developed: palbociclib, abemaciclib, and LEE011.  Preclinical models show optimal activity in hormone receptor positive breast cancer, which may display biologic features suggesting particular dependence on the CDK4/cyclin D1/Rb interaction.  Palbociclib has been studied in a randomized phase 2 clinical trial in metastatic hormone receptor positive breast cancer in which the combination of palbociclib and endocrine therapy significantly prolonged progression-free survival over endocrine therapy alone.  The toxicity profile of palbociclib and the other CDK 4/6 inhibitors in early phase I and II trials has been predominantly hematologic, characterized by limited neutropenia, as well as variable gastrointestinal toxicity.  Multiple phase II and III studies are ongoing with all three agents, and are designed to explore the role of CDK 4/6 inhibition in metastatic hormone receptor positive breast cancer.  The next wave of studies will examine further clinical and scientific topics, including the role of CDK 4/6 inhibition in the neo/adjuvant setting, the combination of CDK 4/6 inhibitors with other targeted therapies, and the activity of CDK 4/6 inhibitors in the HER2 positive subset of breast cancer, as well as in other cancer subtypes.  Should ongoing study confirm benefits and tolerability of CDK 4/6 inhibition, combination therapy with endocrine agents may become a new standard of care for hormone receptor positive breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBpxScH0UYfUh5eUSa2oe_fW6udTcc2ea-3gzXkx_ekLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrptVantw%253D%253D&md5=01eda5d08847dab9cc5386e44daa00a9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11912-015-0443-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-015-0443-3%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DE.%2BL.%26atitle%3DTargeting%2520breast%2520cancer%2520with%2520CDK%2520inhibitors%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2015%26volume%3D17%26spage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahmoud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span> </span><span class="NLM_article-title">Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1056%2FNEJMoa1109653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=22149876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=520-529&author=J.+Baselgaauthor=M.+Camponeauthor=M.+Piccartauthor=H.+A.+Burrisauthor=H.+S.+Rugoauthor=T.+Sahmoudauthor=S.+Noguchiauthor=M.+Gnantauthor=K.+I.+Pritchardauthor=F.+Lebrunauthor=J.+T.+Beckauthor=Y.+Itoauthor=D.+Yardleyauthor=I.+Deleuauthor=A.+Perezauthor=T.+Bachelotauthor=L.+Vittoriauthor=Z.+Xuauthor=P.+Mukhopadhyayauthor=D.+Lebwohlauthor=G.+N.+Hortobagyi&title=Everolimus+in+postmenopausal+hormone-receptor-positive+advanced+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer</span></div><div class="casAuthors">Baselga, Jose; Campone, Mario; Piccart, Martine; Burris, Howard A., III; Rugo, Hope S.; Sahmoud, Tarek; Noguchi, Shinzaburo; Gnant, Michael; Pritchard, Kathleen I.; Lebrun, Fabienne; Beck, Thaddeus; Ito, Yoshinori; Yardley, Denise; Deleu, Ines; Perez, Alejandra; Bachelot, Thomas; Vittori, Luc; Xu, Zhiying; Mukhopadhyay, Pabak; Lebwohl, David; Hortobagyi, Gabriel N.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-529</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Resistance to endocrine therapy in breast cancer is assocd. with activation of the mammalian target of rapamycin (mTOR) intracellular signaling pathway.  In early studies, the mTOR inhibitor everolimus added to endocrine therapy showed antitumor activity.  METHODS In this phase 3, randomized trial, we compared everolimus and exemestane vs. exemestane and placebo (randomly assigned in a 2:1 ratio) in 724 patients with hormone-receptor-pos. advanced breast cancer who had recurrence or progression while receiving previous therapy with a nonsteroidal aromatase inhibitor in. the adjuvant setting or to treat advanced disease (or both).  The primary end point was progression-free survival.  Secondary end points included survival, response rate, and safety.  A preplanned interim anal. was performed by an independent data and safety monitoring committee after 359 progression-free survival events were obsd.  RESULTS Baseline characteristics were well balanced between the two study groups.  The median age was 62 years, 56% had visceral involvement, and 84% had hormone-sensitive disease.  Previous therapy included letrozole or anastrozole (1000/%), tamoxifen (48%), fulvestrant (16%), and chemotherapy (68%).  The most common grade 3 or 4 adverse events were stomatitis (8% in the everolimus-plus-exemestane group vs. 1% in the placebo-plus-exemestane group), anemia (6% vs. <1%), dyspnea (4% vs. 1%), hyperglycemia (4% vs. <1%), fatigue (4% vs. 1%), and pneumonitis (3% vs. 0%).  At the interim anal., median progression-free survival was 6.9 mo with everolimus plus exemestane and 2.8 mo with placebo plus exemestane, according to assessments by local investigators (hazard ratio for progression or death, 0.43; 95% confidence interval [CI], 0.35 to 0.54; P < 0.001).  Median progression-free survival was 10.6 mo and 4.1 mo, resp., according to central assessment (hazard ratio, 0.36; 95% CI, 0.27 to 0.47; P < 0.001).  CONCLUSIONS Everolimus combined with an aromatase inhibitor improved progression-free survival in patients with hormone-receptor-pos. advanced breast cancer previously treated with nonsteroidal aromatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW3J0igrmzy7Vg90H21EOLACvtfcHk0lgOfJ8oAkBz2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKqsrs%253D&md5=30e70c0893b458334ec553f43737e4f2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1109653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1109653%26sid%3Dliteratum%253Aachs%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DCampone%26aufirst%3DM.%26aulast%3DPiccart%26aufirst%3DM.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DSahmoud%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DS.%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLebrun%26aufirst%3DF.%26aulast%3DBeck%26aufirst%3DJ.%2BT.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DYardley%26aufirst%3DD.%26aulast%3DDeleu%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DBachelot%26aufirst%3DT.%26aulast%3DVittori%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26atitle%3DEverolimus%2520in%2520postmenopausal%2520hormone-receptor-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D520%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Johnston, S. R.</span><span> </span><span class="NLM_article-title">Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">4376s</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387s</span><div class="note"><p class="first last">(discussion 4411s–4412s)</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=11916228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD38Xltlyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=4376s-4387s&author=S.+R.+Johnston&title=Endocrine+manipulation+in+advanced+breast+cancer%3A+recent+advances+with+SERM+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrine manipulation in advanced breast cancer: Recent advances with SERM therapies</span></div><div class="casAuthors">Johnston, Stephen R. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12, Suppl.</span>),
    <span class="NLM_cas:pages">4376S-4387S</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Tamoxifen is one of the most effective treatments for breast cancer through its ability to antagonize estrogen-dependent growth by binding estrogen receptors (ERs) and inhibiting breast epithelial cell proliferation.  However, tamoxifen has estrogenic agonist effects in other tissues such as bone and endometrium because of liganded ER-activating target genes in these different cell types.  Several novel antiestrogen compds. have been developed that are also selective ER modulators (SERMs) but that have a reduced agonist profile on breast and gynecol. tissues.  These SERMs offer the potential for enhanced efficacy and reduced toxicity compared with tamoxifen.  In advanced breast cancer clin. data exist for three first-generation SERMs (toremifene, droloxifene, idoxifene), which are related to the triphenylethylene structure of tamoxifen.  In Phase II trials in a total of 263 patients resistant to tamoxifen, the median objective response rate to these SERMs way only 5% (range, 0-15%), with stable disease for 6 mo in an addnl. 18% (range, 9-23%).  As first-line therapy for advanced breast cancer, the median response rate was 31% (range, 20-68%) with a median time to progression of 7 mo.  Randomized Phase III trials for toremifene and idoxifene in more than 1500 patients showed no significant difference compared with tamoxifen.  Fewer clin. data exist for the structurally distinct second- and third-generation SERMs (raloxifene, arzoxifene, EM-800, and ERA-923), although a similarly low median response rate of 6% (range, 0-14%) was seen in Phase II trials in tamoxifen-resistant patients.  It remains unclear whether any clin. advantage exists for second- and third-generation SERMs over tamoxifen as first-line therapy.  With the emergence of potent aromatase inhibitors (AIs) that are superior to tamoxifen, the clin. questions in advanced disease have shifted to which antiestrogen (including SERMs) may be effective following failure of AIs, and whether any merit exists for combined AI/SERM therapy.  The main advantage for SERM therapy probably remains in early stage-disease (adjuvant therapy or prevention), in which the estrogenic effects on bone and reduced gynecol. side effects may prove more beneficial than either tamoxifen or AI.  The issue is whether the current clin. data for SERMs in advanced breast cancer are sufficiently strong to encourage that further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpF6hXEfwfYLVg90H21EOLACvtfcHk0lhBY6ENv3GyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xltlyjug%253D%253D&md5=e8213625c91f3c25c9fbdcccab013aa2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DS.%2BR.%26atitle%3DEndocrine%2520manipulation%2520in%2520advanced%2520breast%2520cancer%253A%2520recent%2520advances%2520with%2520SERM%2520therapies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D4376s%26epage%3D4387s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Deshmane, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melemed, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzdar, A. U.</span><span> </span><span class="NLM_article-title">Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4967</span><span class="NLM_x">–</span> <span class="NLM_lpage">4973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1200%2FJCO.2006.09.5992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=17971595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOhtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=4967-4973&author=V.+Deshmaneauthor=S.+Krishnamurthyauthor=A.+S.+Melemedauthor=P.+Petersonauthor=A.+U.+Buzdar&title=Phase+III+double-blind+trial+of+arzoxifene+compared+with+tamoxifen+for+locally+advanced+or+metastatic+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer</span></div><div class="casAuthors">Deshmane, VijayaLaxmi; Krishnamurthy, S.; Melemed, Allen S.; Peterson, Patrick; Buzdar, Aman U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">4967-4973</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To compare the efficacy of arzoxifene with tamoxifen for the treatment of locally advanced or metastatic breast cancer.  Patients and Methods: Women with estrogen- or progesterone-receptor-pos. breast cancer who had not received prior systemic therapy, or who had relapsed more than 12 mo after stopping adjuvant hormonal therapy, were randomly assigned to receive 20 mg arzoxifene or 20 mg tamoxifen daily.  Each treatment arm was to have 240 patients enrolled.  The primary end point was progression-free survival.  Secondary end points included other measures of tumor response, overall survival, and safety.  Results: Enrollment was stopped when a planned interim anal. of the first 200 patients suggested arzoxifene to be significantly inferior to tamoxifen.  The median progression-free survival for the 352 patients who had been randomly assigned when enrollment was stopped was 4.0 mo (95% CI, 3.4 to 5.6 mo) for the arzoxifene group and 7.5 mo (95% CI, 5.9 to 8.8 mo) for the tamoxifen group.  On-study progression-free survival (P = .011) and time to treatment failure (P = .029) also favored tamoxifen.  Overall tumor response rate and median response duration were comparable between the groups.  Adverse events were similar between the treatments, except for nausea (more frequent with arzoxifene) and vaginal discharge (more frequent with tamoxifen).  Conclusion: Tamoxifen produced significantly longer progression-free survival and time to treatment failure compared with arzoxifene in the treatment of locally advanced and metastatic breast cancer.  There were no significant differences between tumor response rate, clin. benefit rate, or median response duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TBBdzHZWMbVg90H21EOLACvtfcHk0lhBY6ENv3GyGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOhtbfK&md5=464ad5ce1273cc4210417b6e85f763e7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.09.5992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.09.5992%26sid%3Dliteratum%253Aachs%26aulast%3DDeshmane%26aufirst%3DV.%26aulast%3DKrishnamurthy%26aufirst%3DS.%26aulast%3DMelemed%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DP.%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26atitle%3DPhase%2520III%2520double-blind%2520trial%2520of%2520arzoxifene%2520compared%2520with%2520tamoxifen%2520for%2520locally%2520advanced%2520or%2520metastatic%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D4967%26epage%3D4973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">DeFriend, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blamey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundred, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeling, A. E.</span><span> </span><span class="NLM_article-title">Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=408-414&author=D.+J.+DeFriendauthor=A.+Howellauthor=R.+I.+Nicholsonauthor=E.+Andersonauthor=M.+Dowsettauthor=R.+E.+Manselauthor=R.+W.+Blameyauthor=N.+J.+Bundredauthor=J.+F.+Robertsonauthor=C.+Saundersauthor=M.+Baumauthor=P.+Waltonauthor=F.+Sutcliffeauthor=A.+E.+Wakeling&title=Investigation+of+a+new+pure+antiestrogen+%28ICI+182780%29+in+women+with+primary+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeFriend%26aufirst%3DD.%2BJ.%26aulast%3DHowell%26aufirst%3DA.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3DBlamey%26aufirst%3DR.%2BW.%26aulast%3DBundred%26aufirst%3DN.%2BJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BF.%26aulast%3DSaunders%26aufirst%3DC.%26aulast%3DBaum%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DP.%26aulast%3DSutcliffe%26aufirst%3DF.%26aulast%3DWakeling%26aufirst%3DA.%2BE.%26atitle%3DInvestigation%2520of%2520a%2520new%2520pure%2520antiestrogen%2520%2528ICI%2520182780%2529%2520in%2520women%2520with%2520primary%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D408%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Robertson, J. F. R.</span><span> </span><span class="NLM_article-title">Fulvestrant (Faslodex)—how to make a good drug better</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=774-784&author=J.+F.+R.+Robertson&title=Fulvestrant+%28Faslodex%29%E2%80%94how+to+make+a+good+drug+better"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BF.%2BR.%26atitle%3DFulvestrant%2520%2528Faslodex%2529%25E2%2580%2594how%2520to%2520make%2520a%2520good%2520drug%2520better%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D774%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahraman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-j.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudente, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darimont, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span> </span><span class="NLM_article-title">Identification of GDC-0810 (ARN-810), an orally bioavailable selective estrogen receptor degrader (SERD) that demonstrates robust activity in tamoxifen-resistant breast cancer xenografts</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Laiauthor=M.+Kahramanauthor=S.+Govekauthor=J.+Nagasawaauthor=C.+Bonnefousauthor=J.+Julienauthor=K.+Douglasauthor=J.+Sensintaffarauthor=N.+Luauthor=K.-j.+Leeauthor=A.+Aparicioauthor=J.+Kaufmanauthor=J.+Qianauthor=G.+Shaoauthor=R.+Prudenteauthor=M.+J.+Moonauthor=J.+D.+Josephauthor=B.+Darimontauthor=D.+Brighamauthor=K.+Grillotauthor=R.+Heymanauthor=P.+J.+Rixauthor=J.+H.+Hagerauthor=N.+D.+Smith&title=Identification+of+GDC-0810+%28ARN-810%29%2C+an+orally+bioavailable+selective+estrogen+receptor+degrader+%28SERD%29+that+demonstrates+robust+activity+in+tamoxifen-resistant+breast+cancer+xenografts&doi=10.1021%2Facs.jmedchem.5b00054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00054%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%26aulast%3DKahraman%26aufirst%3DM.%26aulast%3DGovek%26aufirst%3DS.%26aulast%3DNagasawa%26aufirst%3DJ.%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DJulien%26aufirst%3DJ.%26aulast%3DDouglas%26aufirst%3DK.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DK.-j.%26aulast%3DAparicio%26aufirst%3DA.%26aulast%3DKaufman%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DG.%26aulast%3DPrudente%26aufirst%3DR.%26aulast%3DMoon%26aufirst%3DM.%2BJ.%26aulast%3DJoseph%26aufirst%3DJ.%2BD.%26aulast%3DDarimont%26aufirst%3DB.%26aulast%3DBrigham%26aufirst%3DD.%26aulast%3DGrillot%26aufirst%3DK.%26aulast%3DHeyman%26aufirst%3DR.%26aulast%3DRix%26aufirst%3DP.%2BJ.%26aulast%3DHager%26aufirst%3DJ.%2BH.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26atitle%3DIdentification%2520of%2520GDC-0810%2520%2528ARN-810%2529%252C%2520an%2520orally%2520bioavailable%2520selective%2520estrogen%2520receptor%2520degrader%2520%2528SERD%2529%2520that%2520demonstrates%2520robust%2520activity%2520in%2520tamoxifen-resistant%2520breast%2520cancer%2520xenografts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">McDonnell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardell, S. E.</span><span> </span><span class="NLM_article-title">The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1016%2Fj.coph.2010.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=20926342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVals73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=620-628&author=D.+P.+McDonnellauthor=S.+E.+Wardell&title=The+molecular+mechanisms+underlying+the+pharmacological+actions+of+ER+modulators%3A+implications+for+new+drug+discovery+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer</span></div><div class="casAuthors">McDonnell, Donald P.; Wardell, Suzanne E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-628</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Our understanding of the mol. mechanisms underlying the pharmacol. actions of estrogen receptor (ER) ligands has evolved considerably in recent years.  Much of this knowledge has come from a detailed dissection of the mechanism(s) of action of the Selective Estrogen Receptor Modulators (SERMs) tamoxifen and raloxifene, so called for their ability to function as ER agonists or antagonists depending on the tissue in which they operate.  These mechanistic insights have had a significant impact on the discovery of second generation SERMs, some of which are in late stage clin. development for the treatment/prevention of breast cancer as well as other estrogenopathies.  In addn. to the SERMs, however, have emerged the Selective Estrogen Degraders (SERDs), which as their name suggests, interact with and facilitate ER turnover in cells.  One drug of this class, fulvestrant, has been approved as a third line treatment for ER-pos. metastatic breast cancer.  Whereas the first generation SERMs/SERDs were discovered in a serendipitous manner, this review will highlight how our understanding of the mol. pharmacol. of ER ligands has been utilized in the development of the next generation of SERMs/SERDs, some of which are likely to have a major impact on the pharmacotherapy of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b2l5p-n0bbVg90H21EOLACvtfcHk0lgZZwDPcJKVEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVals73P&md5=24d1490ca0b0570c21e9768c9de134d6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DWardell%26aufirst%3DS.%2BE.%26atitle%3DThe%2520molecular%2520mechanisms%2520underlying%2520the%2520pharmacological%2520actions%2520of%2520ER%2520modulators%253A%2520implications%2520for%2520new%2520drug%2520discovery%2520in%2520breast%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D620%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gottardis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyaswaroop, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1988&pages=812-815&author=M.+M.+Gottardisauthor=S.+P.+Robinsonauthor=P.+G.+Satyaswaroopauthor=V.+C.+Jordan&title=Contrasting+actions+of+tamoxifen+on+endometrial+and+breast+tumor+growth+in+the+athymic+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGottardis%26aufirst%3DM.%2BM.%26aulast%3DRobinson%26aufirst%3DS.%2BP.%26aulast%3DSatyaswaroop%26aufirst%3DP.%2BG.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DContrasting%2520actions%2520of%2520tamoxifen%2520on%2520endometrial%2520and%2520breast%2520tumor%2520growth%2520in%2520the%2520athymic%2520mouse%26jtitle%3DCancer%2520Res.%26date%3D1988%26volume%3D48%26spage%3D812%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Love, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazess, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMets, D. L.</span><span> </span><span class="NLM_article-title">Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1056%2FNEJM199203263261302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1542321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A280%3ADyaK387nvVaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1992&pages=852-856&author=R.+R.+Loveauthor=R.+B.+Mazessauthor=H.+S.+Bardenauthor=S.+Epsteinauthor=P.+A.+Newcombauthor=V.+C.+Jordanauthor=P.+P.+Carboneauthor=D.+L.+DeMets&title=Effects+of+tamoxifen+on+bone+mineral+density+in+postmenopausal+women+with+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer</span></div><div class="casAuthors">Love R R; Mazess R B; Barden H S; Epstein S; Newcomb P A; Jordan V C; Carbone P P; DeMets D L</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">852-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  Tamoxifen, a synthetic antiestrogen, increases disease-free and overall survival when used as adjuvant therapy for primary breast cancer.  Because it is given for long periods, it is important to know whether tamoxifen affects the skeleton, particularly since it is used extensively in postmenopausal women who are at risk for osteoporosis.  Using photon absorptiometry, we studied the effects of tamoxifen on the bone mineral density of the lumbar spine and radius and on biochemical measures of bone metabolism in 140 postmenopausal women with axillary-node-negative breast cancer, in a two-year randomized, double-blind, placebo-controlled trial.  RESULTS:  In the women given tamoxifen, the mean bone mineral density of the lumbar spine increased by 0.61 percent per year, whereas in those given placebo it decreased by 1.00 percent per year (P less than 0.001).  Radial bone mineral density decreased to the same extent in both groups.  In a subgroup randomly selected from each group, serum osteocalcin and alkaline phosphatase concentrations decreased significantly in women given tamoxifen (P less than 0.001 for each variable), whereas serum parathyroid hormone and 1,25-dihydroxyvitamin D concentrations did not change significantly in either group.  CONCLUSIONS:  In postmenopausal women, treatment with tamoxifen is associated with preservation of the bone mineral density of the lumbar spine.  Whether this favorable effect on bone mineral density is accompanied by a decrease in the risk of fractures remains to be determined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSY_qsjc-vTAUcLvDNbOD4DfW6udTcc2eZoi4E_bTiZnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387nvVaqtA%253D%253D&md5=a39f73f6913dd02f208ae65e5c520dc4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJM199203263261302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199203263261302%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DR.%2BR.%26aulast%3DMazess%26aufirst%3DR.%2BB.%26aulast%3DBarden%26aufirst%3DH.%2BS.%26aulast%3DEpstein%26aufirst%3DS.%26aulast%3DNewcomb%26aufirst%3DP.%2BA.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26aulast%3DCarbone%26aufirst%3DP.%2BP.%26aulast%3DDeMets%26aufirst%3DD.%2BL.%26atitle%3DEffects%2520of%2520tamoxifen%2520on%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520women%2520with%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1992%26volume%3D326%26spage%3D852%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Musgrove, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span> </span><span class="NLM_article-title">Biological determinants of endocrine resistance in breast cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1038%2Fnrc2713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=19701242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVegtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=631-643&author=E.+A.+Musgroveauthor=R.+L.+Sutherland&title=Biological+determinants+of+endocrine+resistance+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Biological determinants of endocrine resistance in breast cancer</span></div><div class="casAuthors">Musgrove, Elizabeth A.; Sutherland, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">631-643</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Endocrine therapies targeting estrogen action (anti-estrogens, such as tamoxifen, and aromatase inhibitors) decrease mortality from breast cancer, but their efficacy is limited by intrinsic and acquired therapeutic resistance.  Candidate mol. biomarkers and gene expression signatures of tamoxifen response emphasize the importance of deregulation of proliferation and survival signaling in endocrine resistance.  However, definition of the specific genetic lesions and mol. processes that det. clin. endocrine resistance is incomplete.  The development of large-scale computational and genetic approaches offers the promise of identifying the mediators of endocrine resistance that may be exploited as potential therapeutic targets and biomarkers of response in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbi_1MVsJjz7Vg90H21EOLACvtfcHk0lhtwMMTXPBeLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVegtrzL&md5=e57a6a082e0f41d26422350657201de5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc2713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2713%26sid%3Dliteratum%253Aachs%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26atitle%3DBiological%2520determinants%2520of%2520endocrine%2520resistance%2520in%2520breast%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D631%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huacani, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowlkes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Peptide antagonists of the human estrogen receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=744-746&author=J.+D.+Norrisauthor=L.+A.+Paigeauthor=D.+J.+Christensenauthor=C.-Y.+Changauthor=M.+R.+Huacaniauthor=D.+Fanauthor=P.+T.+Hamiltonauthor=D.+M.+Fowlkesauthor=D.+P.+McDonnell&title=Peptide+antagonists+of+the+human+estrogen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DPaige%26aufirst%3DL.%2BA.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DChang%26aufirst%3DC.-Y.%26aulast%3DHuacani%26aufirst%3DM.%2BR.%26aulast%3DFan%26aufirst%3DD.%26aulast%3DHamilton%26aufirst%3DP.%2BT.%26aulast%3DFowlkes%26aufirst%3DD.%2BM.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DPeptide%2520antagonists%2520of%2520the%2520human%2520estrogen%2520receptor%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D744%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barstad, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushner, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, G. L.</span><span> </span><span class="NLM_article-title">The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1016%2FS0092-8674%2800%2981717-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=9875847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADyaK1MXjslyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=927-937&author=A.+K.+Shiauauthor=D.+Barstadauthor=P.+M.+Loriaauthor=L.+Chengauthor=P.+J.+Kushnerauthor=D.+A.+Agardauthor=G.+L.+Greene&title=The+structural+basis+of+estrogen+receptor%2Fcoactivator+recognition+and+the+antagonism+of+this+interaction+by+tamoxifen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen</span></div><div class="casAuthors">Shiau, Andrew K.; Barstad, Danielle; Loria, Paula M.; Cheng, Lin; Kushner, Peter J.; Agard, David A.; Greene, Geoffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">927-937</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ligand-dependent activation of transcription by nuclear receptors (NRs) is mediated by interactions with coactivators.  Receptor agonists promote coactivator binding, and antagonists block coactivator binding.  Here we report the crystal structure of the human estrogen receptor α (hERα) ligand-binding domain (LBD) bound to both the agonist diethylstilbestrol (DES) and a peptide derived from the NR box II region of the coactivator GRIP1 and the crystal structure of the hERα LBD bound to the selective antagonist 4-hydroxytamoxifen (OHT).  In the DES-LBD-peptide complex, the peptide binds as a short α helix to a hydrophobic groove on the surface of the LBD.  In the OHT-LBD complex, helix 12 occludes the coactivator recognition groove by mimicking the interactions of the NR box peptide with the LBD.  These structures reveal the two distinct mechanisms by which structural features of OHT promote this "autoinhibitory" helix 12 conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjqf40oHhE7Vg90H21EOLACvtfcHk0lhUMWmA0YcQSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslyltQ%253D%253D&md5=074d616cf353f0d98cea5b26c4595c10</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981717-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981717-1%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DBarstad%26aufirst%3DD.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DKushner%26aufirst%3DP.%2BJ.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26atitle%3DThe%2520structural%2520basis%2520of%2520estrogen%2520receptor%252Fcoactivator%2520recognition%2520and%2520the%2520antagonism%2520of%2520this%2520interaction%2520by%2520tamoxifen%26jtitle%3DCell%26date%3D1998%26volume%3D95%26spage%3D927%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Connor, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadwater, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhirst, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2917</span><span class="NLM_x">–</span> <span class="NLM_lpage">2922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=11306468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2917-2922&author=C.+E.+Connorauthor=J.+D.+Norrisauthor=G.+Broadwaterauthor=T.+M.+Willsonauthor=M.+M.+Gottardisauthor=M.+W.+Dewhirstauthor=D.+P.+McDonnell&title=Circumventing+tamoxifen+resistance+in+breast+cancers+using+antiestrogens+that+induce+unique+conformational+changes+in+the+estrogen+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor</span></div><div class="casAuthors">Connor, Caroline E.; Norris, John D.; Broadwater, Gloria; Willson, Timothy M.; Gottardis, Marco M.; Dewhirst, Mark W.; McDonnell, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2917-2922</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tamoxifen inhibits estrogen receptor (ER) transcriptional activity by competitively inhibiting estradiol binding and inducing conformational changes in the receptor that may prevent its interaction with coactivators.  In bone, the cardiovascular system, and some breast tumors, however, tamoxifen exhibits agonist activity, suggesting that the tamoxifen-ER complex is not recognized identically in all cells.  We used phage display to demonstrate that the antiestrogen GW5638 induces a unique structural change in the ER.  The biol. significance of this conformational change was revealed in studies that demonstrated that tamoxifen-resistant breast tumor explants are not cross-resistant to GW5638.  Because of these properties, this drug is currently being developed as a potential therapeutic for tamoxifen-resistant breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2YSN94iysMbVg90H21EOLACvtfcHk0lhUMWmA0YcQSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGqsrw%253D&md5=d7ecae7d445901e2f2c4f133ebbacdc5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConnor%26aufirst%3DC.%2BE.%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DBroadwater%26aufirst%3DG.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DGottardis%26aufirst%3DM.%2BM.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DCircumventing%2520tamoxifen%2520resistance%2520in%2520breast%2520cancers%2520using%2520antiestrogens%2520that%2520induce%2520unique%2520conformational%2520changes%2520in%2520the%2520estrogen%2520receptor%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2917%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momtahen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubahn, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauls, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triantafillou, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, P. G.</span><span> </span><span class="NLM_article-title">3-[4-(1,2-Diphenylbut-1- enyl)phenyl]acrylic acid: A non-steroidal estrogen with functional selectivity for bone over uterus in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00037a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1550-1552&author=T.+M.+Willsonauthor=B.+R.+Henkeauthor=T.+M.+Momtahenauthor=P.+S.+Charifsonauthor=K.+W.+Batchelorauthor=D.+B.+Lubahnauthor=L.+B.+Mooreauthor=B.+B.+Oliverauthor=H.+R.+Saulsauthor=J.+A.+Triantafillouauthor=S.+G.+Wolfeauthor=P.+G.+Baer&title=3-%5B4-%281%2C2-Diphenylbut-1-+enyl%29phenyl%5Dacrylic+acid%3A+A+non-steroidal+estrogen+with+functional+selectivity+for+bone+over+uterus+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00037a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00037a002%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26aulast%3DMomtahen%26aufirst%3DT.%2BM.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DBatchelor%26aufirst%3DK.%2BW.%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DOliver%26aufirst%3DB.%2BB.%26aulast%3DSauls%26aufirst%3DH.%2BR.%26aulast%3DTriantafillou%26aufirst%3DJ.%2BA.%26aulast%3DWolfe%26aufirst%3DS.%2BG.%26aulast%3DBaer%26aufirst%3DP.%2BG.%26atitle%3D3-%255B4-%25281%252C2-Diphenylbut-1-%2520enyl%2529phenyl%255Dacrylic%2520acid%253A%2520A%2520non-steroidal%2520estrogen%2520with%2520functional%2520selectivity%2520for%2520bone%2520over%2520uterus%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1550%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wu, Y. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, G. L.</span><span> </span><span class="NLM_article-title">Structural basis for an unexpected mode of SERM-mediated ER antagonism</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=413-424&author=Y.+V.+L.+Wuauthor=X.+Yangauthor=Z.+Renauthor=D.+P.+McDonnellauthor=J.+D.+Norrisauthor=T.+M.+Willsonauthor=G.+L.+Greene&title=Structural+basis+for+an+unexpected+mode+of+SERM-mediated+ER+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BV.%2BL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26atitle%3DStructural%2520basis%2520for%2520an%2520unexpected%2520mode%2520of%2520SERM-mediated%2520ER%2520antagonism%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D413%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Schafer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentrem, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Regan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Los Reyes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2505</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=11489833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVOmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=2505-2512&author=J.+M.+Schaferauthor=E.+S.+Leeauthor=R.+C.+Dardesauthor=D.+Bentremauthor=R.+M.+O%E2%80%99Reganauthor=A.+De+Los+Reyesauthor=V.+C.+Jordan&title=Analysis+of+cross-resistance+of+the+selective+estrogen+receptor+modulators+arzoxifene+%28LY353381%29+and+LY117018+in+tamoxifen-stimulated+breast+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts</span></div><div class="casAuthors">Schafer, Jennifer MacGregor; Lee, Eun-Sook; Dardes, Rita C.; Bentrem, David; O'Regan, Ruth M.; De Los Reyes, Alexander; Jordan, V. Craig</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2505-2512</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cross-resistance is the primary issue facing the evaluation of new antiestrogens to treat metastatic breast cancer because they may be tested, initially, in populations of patients that have failed long-term adjuvant tamoxifen (Tam) therapy.  We have tested the benzothiophene derivs., arzoxifene (Arzox; LY353381) and LY117018 in two models of Tam-stimulated tumor growth derived from either MCF-7 or T47D breast cancer cells.  Using the MCF-7:Tam model, we found that both Arzox and LY117018 (1.5 mg/day) resulted in tumor growth and, therefore, were partially cross-resistant with Tam.  Next, using the T47D:17β-estradiol (E2) model, we compared the antiestrogenic/antitumor properties of Arzox and LY117018 and detd. that neither Arzox nor LY117018 caused T47D:E2 tumor growth after 21 wk.  In addn., we detd. that long-term treatment does not result in failure and subsequent development of transplantable Arzox- or LY117018-stimulated tumors.  To establish whether Arzox and LY117018 are cross-resistant in T47D:Tam tumors, mice were treated with Arzox or LY117018 (1.5 mg/day), and, again, we found that neither resulted in the growth of transplantable tumors.  Lastly, we showed that Arzox and LY117018 were only partially able to compete with postmenopausal E2 (0.3 cm silastic capsule) in T47D:Tam tumors.  However, when T47D:E2 tumors were treated for 7 days instead of 5 days, both Arzox and LY117018 were more effective.  Arzox is not cross-resistant with Tam in the T47D athymic mouse model but does exhibit cross-resistance in the MCF-7 model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWskSi8cKWLbVg90H21EOLACvtfcHk0liBlTwtBvIZQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVOmtbs%253D&md5=3158525d66e8988ad2e969995537dede</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchafer%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DDardes%26aufirst%3DR.%2BC.%26aulast%3DBentrem%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Regan%26aufirst%3DR.%2BM.%26aulast%3DDe%2BLos%2BReyes%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DAnalysis%2520of%2520cross-resistance%2520of%2520the%2520selective%2520estrogen%2520receptor%2520modulators%2520arzoxifene%2520%2528LY353381%2529%2520and%2520LY117018%2520in%2520tamoxifen-stimulated%2520breast%2520cancer%2520xenografts%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D2505%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Masamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitjan, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2918</span><span class="NLM_x">–</span> <span class="NLM_lpage">2925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1210%2Fjc.80.10.2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=7559875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADyaK2MXoslCns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=2918-2925&author=S.+Masamuraauthor=S.+J.+Santnerauthor=D.+F.+Heitjanauthor=R.+J.+Santen&title=Estrogen+deprivation+causes+estradiol+hypersensitivity+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells</span></div><div class="casAuthors">Masamura, Shigeru; Santner, Steven J.; Heitjan, Daniel F.; Santen, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2918-25</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Genetic and environmental factors can modulate the level of sensitivity to various hormones, including estrogens.  Enhanced sensitivity to estradiol (E2) has been demonstrated in several biol. conditions, such as in sheep during the nonbreeding season, in untreated patients with Turner's syndrome, and in the prepubertal state in normal girls.  The authors postulated that secondary responses to hormonal therapy in patients with breast cancer could also result from enhanced E2 sensitivity, developing as an adaptive mechanism to E2 deprivation.  The present study used the MCF-7 human breast cancer cell line as a model system to test the concept that enhanced sensitivity to E2 may occur as a result of adaptation to low E2 levels.  After depriving MCF-7 cells of estrogens in tissue culture medium for periods of 1-6 mo, the authors established conditions under which replication could be stimulated maximally by 10-14-10-15M E2.  In contrast, wild-type cells not exposed to estrogen deprivation required 10-10M E2 to grow at the same rate.  Further, the concn. of the antiestrogen, ICI 164384, needed to inhibit growth by 50% in estrogen-deprived cells was much lower than that required in wild-type cells (i.e. 10-15 vs. 10-9M).  Nude mice implanted with these estrogen-deprived cells demonstrated an earlier appearance of palpable tumors in response to E2 than animals bearing wild-type cells.  Reexposure to 10-10-10-9M E2, either in vivo or in vitro, returned these cells to the level of estrogen sensitivity obsd. in wild-type cells.  Apparently, breast cancer cells can adapt to low levels of estrogens by enhancing their sensitivity to E2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcOoAZDaWphbVg90H21EOLACvtfcHk0liBlTwtBvIZQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslCns7Y%253D&md5=e61b1298d67a65bc5854b1afc3376af3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fjc.80.10.2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.80.10.2918%26sid%3Dliteratum%253Aachs%26aulast%3DMasamura%26aufirst%3DS.%26aulast%3DSantner%26aufirst%3DS.%2BJ.%26aulast%3DHeitjan%26aufirst%3DD.%2BF.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DEstrogen%2520deprivation%2520causes%2520estradiol%2520hypersensitivity%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1995%26volume%3D80%26spage%3D2918%26epage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Jeselsohn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yelensky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwalter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frampton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meric-Bernstam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Angulo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer-Lozano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Fidalgo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristofanilli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giltnane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balko, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soussan-Gutman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Come, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusztai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span> </span><span class="NLM_article-title">Emergence of constitutively active estrogen receptor-alpha mutations in pretreated advanced estrogen receptor-positive breast cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1158%2F1078-0432.CCR-13-2332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=24398047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1eiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1757-1767&author=R.+Jeselsohnauthor=R.+Yelenskyauthor=G.+Buchwalterauthor=G.+Framptonauthor=F.+Meric-Bernstamauthor=A.+M.+Gonzalez-Anguloauthor=J.+Ferrer-Lozanoauthor=J.+A.+Perez-Fidalgoauthor=M.+Cristofanilliauthor=H.+Gomezauthor=C.+L.+Arteagaauthor=J.+Giltnaneauthor=J.+M.+Balkoauthor=M.+T.+Croninauthor=M.+Jaroszauthor=J.+Sunauthor=M.+Hawrylukauthor=D.+Lipsonauthor=G.+Ottoauthor=J.+S.+Rossauthor=A.+Dvirauthor=L.+Soussan-Gutmanauthor=I.+Wolfauthor=T.+Rubinekauthor=L.+Gilmoreauthor=S.+Schnittauthor=S.+E.+Comeauthor=L.+Pusztaiauthor=P.+Stephensauthor=M.+Brownauthor=V.+A.+Miller&title=Emergence+of+constitutively+active+estrogen+receptor-alpha+mutations+in+pretreated+advanced+estrogen+receptor-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer</span></div><div class="casAuthors">Jeselsohn, Rinath; Yelensky, Roman; Buchwalter, Gilles; Frampton, Garrett; Meric-Bernstam, Funda; Gonzalez-Angulo, Ana Maria; Ferrer-Lozano, Jaime; Perez-Fidalgo, Jose A.; Cristofanilli, Massimo; Gomez, Henry; Arteaga, Carlos L.; Giltnane, Jennifer; Balko, Justin M.; Cronin, Maureen T.; Jarosz, Mirna; Sun, James; Hawryluk, Matthew; Lipson, Doron; Otto, Geoff; Ross, Jeffrey S.; Dvir, Addie; Soussan-Gutman, Lior; Wolf, Ido; Rubinek, Tamar; Gilmore, Lauren; Schnitt, Stuart; Come, Steven E.; Pusztai, Lajos; Stephens, Philip; Brown, Myles; Miller, Vincent A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1757-1767</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We undertook this study to det. the prevalence of estrogen receptor (ER) α (ESR1) mutations throughout the natural history of hormone-dependent breast cancer and to delineate the functional roles of the most commonly detected alterations.  Exptl. Design: We studied a total of 249 tumor specimens from 208 patients.  The specimens include 134 ER-pos. (ER+/HER2-) and, as controls, 115 ER-neg. (ER-) tumors.  The ER+ samples consist of 58 primary breast cancers and 76 metastatic samples.  All tumors were sequenced to high unique coverage using next-generation sequencing targeting the coding sequence of the estrogen receptor and an addnl. 182 cancer-related genes.  Results: Recurring somatic mutations in codons 537 and 538 within the ligand-binding domain of ER were detected in ER+ metastatic disease.  Overall, the frequency of these mutations was 12% [9/76; 95% confidence interval (CI), 6%-21%] in metastatic tumors and in a subgroup of patients who received an av. of 7 lines of treatment the frequency was 20% (5/25; 95% CI, 7%-41%).  These mutations were not detected in primary or treatment-naive ER+ cancer or in any stage of ER- disease.  Functional studies in cell line models demonstrate that these mutations render estrogen receptor constitutive activity and confer partial resistance to currently available endocrine treatments.  Conclusions: In this study, we show evidence for the temporal selection of functional ESR1 mutations as potential drivers of endocrine resistance during the progression of ER+ breast cancer.  Clin Cancer Res; 20(7); 1757-67. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdteKI6rKn7Vg90H21EOLACvtfcHk0liBlTwtBvIZQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1eiu74%253D&md5=245ddc458d449b0fd6b1804285fb4ed1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2332%26sid%3Dliteratum%253Aachs%26aulast%3DJeselsohn%26aufirst%3DR.%26aulast%3DYelensky%26aufirst%3DR.%26aulast%3DBuchwalter%26aufirst%3DG.%26aulast%3DFrampton%26aufirst%3DG.%26aulast%3DMeric-Bernstam%26aufirst%3DF.%26aulast%3DGonzalez-Angulo%26aufirst%3DA.%2BM.%26aulast%3DFerrer-Lozano%26aufirst%3DJ.%26aulast%3DPerez-Fidalgo%26aufirst%3DJ.%2BA.%26aulast%3DCristofanilli%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DH.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DGiltnane%26aufirst%3DJ.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DCronin%26aufirst%3DM.%2BT.%26aulast%3DJarosz%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DHawryluk%26aufirst%3DM.%26aulast%3DLipson%26aufirst%3DD.%26aulast%3DOtto%26aufirst%3DG.%26aulast%3DRoss%26aufirst%3DJ.%2BS.%26aulast%3DDvir%26aufirst%3DA.%26aulast%3DSoussan-Gutman%26aufirst%3DL.%26aulast%3DWolf%26aufirst%3DI.%26aulast%3DRubinek%26aufirst%3DT.%26aulast%3DGilmore%26aufirst%3DL.%26aulast%3DSchnitt%26aufirst%3DS.%26aulast%3DCome%26aufirst%3DS.%2BE.%26aulast%3DPusztai%26aufirst%3DL.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26atitle%3DEmergence%2520of%2520constitutively%2520active%2520estrogen%2520receptor-alpha%2520mutations%2520in%2520pretreated%2520advanced%2520estrogen%2520receptor-positive%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D1757%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Freedman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anders, C. K.</span><span> </span><span class="NLM_article-title">Treatment of breast cancer brain metastases</span> <span class="citation_source-journal">Curr. Breast Cancer Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1007%2Fs12609-011-0061-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=22754605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFaks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1-9&author=R.+A.+Freedmanauthor=C.+K.+Anders&title=Treatment+of+breast+cancer+brain+metastases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Breast Cancer Brain Metastases</span></div><div class="casAuthors">Freedman, Rachel A.; Anders, Carey K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Breast Cancer Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CBCRAO</span>;
        ISSN:<span class="NLM_cas:issn">1943-4588</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Approx. 10% to 15% of women with metastatic breast cancer will develop brain metastases.  Treatment options for these women remain limited, particularly at the time of central nervous system (CNS) relapse following completion of initial CNS-directed therapy.  Historically, prior studies have broadly examd. systemic treatments for breast cancer brain metastases with mixed, but overall disappointing, results.  More recently, studies have increasingly selected patients based on breast cancer subtype and have examd. novel, targeted agents that have preclin. suggestion of blood-brain barrier penetration.  Correlative science objectives, with both tissue-based and novel imaging endpoints, are more frequently incorporated into trials of this nature, with the goal of enhancing our understanding of possible predictors of response.  This review summarizes the current and emerging data on systemic therapy for breast cancer brain metastases and provides a framework for future directions in treating this clin.-challenging entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRjOxjP6vGbVg90H21EOLACvtfcHk0li1tw3WDYGP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFaks7g%253D&md5=ebf7717cf16d5bd53e68b945e1095413</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs12609-011-0061-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12609-011-0061-5%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DR.%2BA.%26aulast%3DAnders%26aufirst%3DC.%2BK.%26atitle%3DTreatment%2520of%2520breast%2520cancer%2520brain%2520metastases%26jtitle%3DCurr.%2520Breast%2520Cancer%2520Rep.%26date%3D2012%26volume%3D4%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Duchnowska, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dziadziuszko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Och, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czartoryska-Arlukowicz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radecka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszewski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szubstarski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polish Brain Metastasis Consortium.</span><span> </span><span class="NLM_article-title">Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">R119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R119&author=R.+Duchnowskaauthor=R.+Dziadziuszkoauthor=T.+Trojanowskiauthor=T.+Mandatauthor=W.+Ochauthor=B.+Czartoryska-Arlukowiczauthor=B.+Radeckaauthor=W.+Olszewskiauthor=F.+Szubstarskiauthor=W.+Kozlowskiauthor=B.+Jaroszauthor=W.+Rogowskiauthor=A.+Kowalczykauthor=J.+Limonauthor=W.+Biernatauthor=J.+Jassemauthor=Polish+Brain+Metastasis+Consortium.&title=Conversion+of+epidermal+growth+factor+receptor+2+and+hormone+receptor+expression+in+breast+cancer+metastases+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuchnowska%26aufirst%3DR.%26aulast%3DDziadziuszko%26aufirst%3DR.%26aulast%3DTrojanowski%26aufirst%3DT.%26aulast%3DMandat%26aufirst%3DT.%26aulast%3DOch%26aufirst%3DW.%26aulast%3DCzartoryska-Arlukowicz%26aufirst%3DB.%26aulast%3DRadecka%26aufirst%3DB.%26aulast%3DOlszewski%26aufirst%3DW.%26aulast%3DSzubstarski%26aufirst%3DF.%26aulast%3DKozlowski%26aufirst%3DW.%26aulast%3DJarosz%26aufirst%3DB.%26aulast%3DRogowski%26aufirst%3DW.%26aulast%3DKowalczyk%26aufirst%3DA.%26aulast%3DLimon%26aufirst%3DJ.%26aulast%3DBiernat%26aufirst%3DW.%26aulast%3DJassem%26aufirst%3DJ.%26aulast%3D%26atitle%3DConversion%2520of%2520epidermal%2520growth%2520factor%2520receptor%25202%2520and%2520hormone%2520receptor%2520expression%2520in%2520breast%2520cancer%2520metastases%2520to%2520the%2520brain%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2012%26volume%3D14%26spage%3DR119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Simpson, E. R.</span><span> </span><span class="NLM_article-title">Sources of estrogen and their importance</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1016%2FS0960-0760%2803%2900360-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=14623515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=225-230&author=E.+R.+Simpson&title=Sources+of+estrogen+and+their+importance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sources of estrogen and their importance</span></div><div class="casAuthors">Simpson, E. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3-5</span>),
    <span class="NLM_cas:pages">225-230</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In premenopausal women, the ovaries are the principle source of estradiol, which functions as a circulating hormone to act on distal target tissues.  However, in postmenopausal women when the ovaries cease to produce estrogen, and in men, this is no longer the case, because estradiol is no longer solely an endocrine factor.  Instead, it is produced in a no. of extra-gonadal sites and acts locally at these sites as a paracrine or even intracrine factor.  These sites include the mesenchymal cells of adipose tissue including that of the breast, osteoblasts and chondrocytes of bone, the vascular endothelium and aortic smooth muscle cells, and numerous sites in the brain.  Thus, circulating levels of estrogens in postmenopausal women and in men are not the drivers of estrogen action, they are reactive rather than proactive.  This is because in these cases circulating estrogen originates in the extra-gonadal sites where it acts locally, and if it escapes local metab. then it enters the circulation.  Therefore, circulating levels reflect rather than direct estrogen action in postmenopausal women and in men.  Tissue-specific regulation of CYP19 expression is achieved through the use of distinct promoters, each of which is regulated by different hormonal factors and second messenger signaling pathways.  Thus, in the ovary, CYP19 expression is regulated by FSH which acts through cAMP via the proximal promoter II, whereas in placenta the distal promoter I.1 regulates CYP19 expression in response to retinoids.  In adipose tissue and bone by contrast, another distal promoter-promoter I.4-drives CYP19 expression under the control of glucocorticoids, class 1 cytokines and TNFα.  The importance of this unique aspect of the tissue-specific regulation of aromatase expression lies in the fact that the low circulating levels of estrogens which are obsd. in postmenopausal women have little bearing on the concns. of estrogen in, for example, a breast tumor, which can reach levels at least one order of magnitude greater than those present in the circulation, due to local synthesis within the breast.  Thus, the estrogen which is responsible for breast cancer development, for the maintenance of bone mineralization and for the maintenance of cognitive function is not circulating estrogen but rather that which is produced locally at these specific sites within the breast, bone and brain.  In breast adipose of breast cancer patients, aromatase activity and CYP19 expression are elevated.  This occurs in response to tumor-derived factors such as prostaglandin E2 produced by breast tumor fibroblasts and epithelium as well as infiltrating macrophages.  This increased CYP19 expression is assocd. with a switch in promoter usage from the normal adipose-specific promoter I.4 to the cAMP responsive promoter, promoter II.  Since these two promoters are regulated by different cohorts of transcription factors and coactivators, it follows that the differential regulation of CYP19 expression via alternative promoters in disease-free and cancerous breast adipose tissue may permit the development of selective aromatase modulators (SAMs) that target the aberrant overexpression of aromatase in cancerous breast, while sparing estrogen synthesis in other sites such as normal adipose tissue, bone and brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkuXyHF9aebVg90H21EOLACvtfcHk0li1tw3WDYGP2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D&md5=c1624c91faeee8db6aec04c2be84b3a2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900360-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900360-1%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26atitle%3DSources%2520of%2520estrogen%2520and%2520their%2520importance%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D86%26spage%3D225%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Creighton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ashry, D.</span><span> </span><span class="NLM_article-title">Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">3903</span><span class="NLM_x">–</span> <span class="NLM_lpage">3911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=3903-3911&author=C.+J.+Creightonauthor=A.+M.+Hilgerauthor=S.+Murthyauthor=J.+M.+Raeauthor=A.+M.+Chinnaiyanauthor=D.+El-Ashry&title=Activation+of+mitogen-activated+protein+kinase+in+estrogen+receptor+alpha-positive+breast+cancer+cells+in+vitro+induces+an+in+vivo+molecular+phenotype+of+estrogen+receptor+alpha-negative+human+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCreighton%26aufirst%3DC.%2BJ.%26aulast%3DHilger%26aufirst%3DA.%2BM.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DRae%26aufirst%3DJ.%2BM.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DEl-Ashry%26aufirst%3DD.%26atitle%3DActivation%2520of%2520mitogen-activated%2520protein%2520kinase%2520in%2520estrogen%2520receptor%2520alpha-positive%2520breast%2520cancer%2520cells%2520in%2520vitro%2520induces%2520an%2520in%2520vivo%2520molecular%2520phenotype%2520of%2520estrogen%2520receptor%2520alpha-negative%2520human%2520breast%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D3903%26epage%3D3911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulazzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyass, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7795</span><span class="NLM_x">–</span> <span class="NLM_lpage">7800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7795-7800&author=W.+Xiaauthor=S.+Bacusauthor=P.+Hegdeauthor=I.+Husainauthor=J.+Strumauthor=L.+Liuauthor=G.+Paulazzoauthor=L.+Lyassauthor=P.+Truskauthor=J.+Hillauthor=J.+Harrisauthor=N.+L.+Spector&title=A+model+of+acquired+autoresistance+to+a+potent+ErbB2+tyrosine+kinase+inhibitor+and+a+therapeutic+strategy+to+prevent+its+onset+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DBacus%26aufirst%3DS.%26aulast%3DHegde%26aufirst%3DP.%26aulast%3DHusain%26aufirst%3DI.%26aulast%3DStrum%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPaulazzo%26aufirst%3DG.%26aulast%3DLyass%26aufirst%3DL.%26aulast%3DTrusk%26aufirst%3DP.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DA%2520model%2520of%2520acquired%2520autoresistance%2520to%2520a%2520potent%2520ErbB2%2520tyrosine%2520kinase%2520inhibitor%2520and%2520a%2520therapeutic%2520strategy%2520to%2520prevent%2520its%2520onset%2520in%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7795%26epage%3D7800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bosch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamaschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spratt, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola-Villegas, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minuesa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Garcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grueso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">283ra51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1126%2Fscitranslmed.aaa4442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=25877889" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=283ra51&author=A.+Boschauthor=Z.+Liauthor=A.+Bergamaschiauthor=H.+Ellisauthor=E.+Toskaauthor=A.+Pratauthor=J.+J.+Taoauthor=D.+E.+Sprattauthor=N.+T.+Viola-Villegasauthor=P.+Castelauthor=G.+Minuesaauthor=N.+Morseauthor=J.+Rodonauthor=Y.+Ibrahimauthor=J.+Cortesauthor=J.+Perez-Garciaauthor=P.+Galvanauthor=J.+Gruesoauthor=M.+Guzmanauthor=J.+A.+Katzenellenbogenauthor=M.+Kharasauthor=J.+S.+Lewisauthor=M.+Dicklerauthor=V.+Serraauthor=N.+Rosenauthor=S.+Chandarlapatyauthor=M.+Scaltritiauthor=J.+Baselga&title=PI3K+inhibition+results+in+enhanced+estrogen+receptor+function+and+dependence+in+hormone+receptor-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa4442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa4442%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBergamaschi%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DH.%26aulast%3DToska%26aufirst%3DE.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DTao%26aufirst%3DJ.%2BJ.%26aulast%3DSpratt%26aufirst%3DD.%2BE.%26aulast%3DViola-Villegas%26aufirst%3DN.%2BT.%26aulast%3DCastel%26aufirst%3DP.%26aulast%3DMinuesa%26aufirst%3DG.%26aulast%3DMorse%26aufirst%3DN.%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DY.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DPerez-Garcia%26aufirst%3DJ.%26aulast%3DGalvan%26aufirst%3DP.%26aulast%3DGrueso%26aufirst%3DJ.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DKharas%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DDickler%26aufirst%3DM.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DPI3K%2520inhibition%2520results%2520in%2520enhanced%2520estrogen%2520receptor%2520function%2520and%2520dependence%2520in%2520hormone%2520receptor-positive%2520breast%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D283ra51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Wijayaratne, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowlkes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Comparative analyses of the mechanistic differences among antiestrogens</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">5828</span><span class="NLM_x">–</span> <span class="NLM_lpage">5840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1999&pages=5828-5840&author=A.+L.+Wijayaratneauthor=S.+C.+Nagelauthor=L.+A.+Paigeauthor=D.+J.+Christensenauthor=J.+D.+Norrisauthor=D.+M.+Fowlkesauthor=D.+P.+McDonnell&title=Comparative+analyses+of+the+mechanistic+differences+among+antiestrogens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWijayaratne%26aufirst%3DA.%2BL.%26aulast%3DNagel%26aufirst%3DS.%2BC.%26aulast%3DPaige%26aufirst%3DL.%2BA.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DFowlkes%26aufirst%3DD.%2BM.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DComparative%2520analyses%2520of%2520the%2520mechanistic%2520differences%2520among%2520antiestrogens%26jtitle%3DEndocrinology%26date%3D1999%26volume%3D140%26spage%3D5828%26epage%3D5840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Wittmann, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">9549</span><span class="NLM_x">–</span> <span class="NLM_lpage">9560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9549-9560&author=B.+M.+Wittmannauthor=A.+Sherkauthor=D.+P.+McDonnell&title=Definition+of+functionally+important+mechanistic+differences+among+selective+estrogen+receptor+down-regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittmann%26aufirst%3DB.%2BM.%26aulast%3DSherk%26aufirst%3DA.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DDefinition%2520of%2520functionally%2520important%2520mechanistic%2520differences%2520among%2520selective%2520estrogen%2520receptor%2520down-regulators%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D9549%26epage%3D9560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 95 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Madhusoodanan Mottamal, Borui Kang, Xianyou Peng, <span class="NLM_string-name hlFld-ContribAuthor">Guangdi Wang</span>. </span><span class="cited-content_cbyCitation_article-title">From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (14)
                                     , 9334-9343. <a href="https://doi.org/10.1021/acsomega.0c06362" title="DOI URL">https://doi.org/10.1021/acsomega.0c06362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c06362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c06362%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DFrom%252BPure%252BAntagonists%252Bto%252BPure%252BDegraders%252Bof%252Bthe%252BEstrogen%252BReceptor%25253A%252BEvolving%252BStrategies%252Bfor%252Bthe%252BSame%252BTarget%26aulast%3DMottamal%26aufirst%3DMadhusoodanan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D31122020%26date%3D19032021%26date%3D30032021%26volume%3D6%26issue%3D14%26spage%3D9334%26epage%3D9343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard A. Ward, Stephen Fawell, Nicolas Floc’h, Vikki Flemington, Darren McKerrecher, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities in Cancer Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3297-3351. <a href="https://doi.org/10.1021/acs.chemrev.0c00383" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChallenges%252Band%252BOpportunities%252Bin%252BCancer%252BDrug%252BResistance%26aulast%3DWard%26aufirst%3DRichard%2BA.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D21072020%26volume%3D121%26issue%3D6%26spage%3D3297%26epage%3D3351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yunlong Lu, <span class="NLM_string-name hlFld-ContribAuthor">Wukun Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15094-15114. <a href="https://doi.org/10.1021/acs.jmedchem.0c00913" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00913%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BEstrogen%252BReceptor%252BDegraders%252B%252528SERDs%252529%25253A%252BA%252BPromising%252BStrategy%252Bfor%252BEstrogen%252BReceptor%252BPositive%252BEndocrine-Resistant%252BBreast%252BCancer%26aulast%3DLu%26aufirst%3DYunlong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29052020%26date%3D02112020%26volume%3D63%26issue%3D24%26spage%3D15094%26epage%3D15114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Emily J. Hanan, Jun Liang, Xiaojing Wang, Robert A. Blake, Nicole Blaquiere, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Monomeric Targeted Protein Degraders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11330-11361. <a href="https://doi.org/10.1021/acs.jmedchem.0c00093" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00093%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMonomeric%252BTargeted%252BProtein%252BDegraders%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17012020%26date%3D15062020%26date%3D30042020%26volume%3D63%26issue%3D20%26spage%3D11330%26epage%3D11361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jun Liang, Robert Blake, Jae Chang, Lori S. Friedman, Simon Goodacre, Steven Hartman, Ellen Rei Ingalla, James R. Kiefer, Tracy Kleinheinz, Sharada Labadie, Jun Li, Kwong Wah Lai, Jiangpeng Liao, Vidhi Mody, Neville McLean, Ciara Metcalfe, Michelle Nannini, Daniel Otwine, Yingqing Ran, Nick Ray, Fabien Roussel, Amy Sambrone, Deepak Sampath, Maia Vinogradova, John Wai, Tao Wang, Kuen Yeap, Amy Young, Jason Zbieg, Birong Zhang, Xiaoping Zheng, Yu Zhong, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojing Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of GNE-149 as a Full Antagonist and Efficient Degrader of Estrogen Receptor alpha for ER+ Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1342-1347. <a href="https://doi.org/10.1021/acsmedchemlett.0c00224" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00224%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BGNE-149%252Bas%252Ba%252BFull%252BAntagonist%252Band%252BEfficient%252BDegrader%252Bof%252BEstrogen%252BReceptor%252Balpha%252Bfor%252BER%25252B%252BBreast%252BCancer%26aulast%3DLiang%26aufirst%3DJun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28042020%26date%3D26052020%26date%3D29052020%26date%3D26052020%26volume%3D11%26issue%3D6%26spage%3D1342%26epage%3D1347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jessica Caciolla, Angelo Spinello, Silvia Martini, Alessandra Bisi, Nadia Zaffaroni, Silvia Gobbi, <span class="NLM_string-name hlFld-ContribAuthor">Alessandra Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 732-739. <a href="https://doi.org/10.1021/acsmedchemlett.9b00591" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00591%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTargeting%252BOrthosteric%252Band%252BAllosteric%252BPockets%252Bof%252BAromatase%252Bvia%252BDual-Mode%252BNovel%252BAzole%252BInhibitors%26aulast%3DCaciolla%26aufirst%3DJessica%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11122019%26date%3D23032020%26date%3D26032020%26date%3D23032020%26volume%3D11%26issue%3D5%26spage%3D732%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Philip P. Chamberlain, Laura A. D’Agostino, J. Michael Ellis, Joshua D. Hansen, Mary E. Matyskiela, Joseph J. McDonald, Jennifer R. Riggs, <span class="NLM_string-name hlFld-ContribAuthor">Lawrence G. Hamann</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 1592-1602. <a href="https://doi.org/10.1021/acsmedchemlett.9b00425" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00425%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvolution%252Bof%252BCereblon-Mediated%252BProtein%252BDegradation%252Bas%252Ba%252BTherapeutic%252BModality%26aulast%3DChamberlain%26aufirst%3DPhilip%2BP.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15092019%26date%3D12112019%26date%3D25112019%26date%3D12112019%26volume%3D10%26issue%3D12%26spage%3D1592%26epage%3D1602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiantao Hu, Biao Hu, Mingliang Wang, Fuming Xu, Bukeyan Miao, Chao-Yie Yang, Mi Wang, Zhaomin Liu, Daniel F. Hayes, Krishnapriya Chinnaswamy, James Delproposto, Jeanne Stuckey, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1420-1442. <a href="https://doi.org/10.1021/acs.jmedchem.8b01572" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01572%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BERD-308%252Bas%252Ba%252BHighly%252BPotent%252BProteolysis%252BTargeting%252BChimera%252B%252528PROTAC%252529%252BDegrader%252Bof%252BEstrogen%252BReceptor%252B%252528ER%252529%26aulast%3DHu%26aufirst%3DJiantao%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D09102018%26date%3D18012019%26volume%3D62%26issue%3D3%26spage%3D1420%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  Churcher</span>  . </span><span class="cited-content_cbyCitation_article-title">Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (2)
                                     , 444-452. <a href="https://doi.org/10.1021/acs.jmedchem.7b01272" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01272%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProtac-Induced%252BProtein%252BDegradation%252Bin%252BDrug%252BDiscovery%25253A%252BBreaking%252Bthe%252BRules%252Bor%252BJust%252BMaking%252BNew%252BOnes%25253F%26aulast%3DChurcher%26aufirst%3DIan%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D27082017%26date%3D19122017%26date%3D25012018%26date%3D16112017%26volume%3D61%26issue%3D2%26spage%3D444%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Min</span>, <span class="hlFld-ContribAuthor ">Valeria Sanabria  Guillen</span>, <span class="hlFld-ContribAuthor ">Abhishek  Sharma</span>, <span class="hlFld-ContribAuthor ">Yuechao  Zhao</span>, <span class="hlFld-ContribAuthor ">Yvonne  Ziegler</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Mayne</span>, <span class="hlFld-ContribAuthor ">Sathish  Srinivasan</span>, <span class="hlFld-ContribAuthor ">Sung Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Kathryn E.  Carlson</span>, <span class="hlFld-ContribAuthor ">Kendall W.  Nettles</span>, <span class="hlFld-ContribAuthor ">Benita S.  Katzenellenbogen</span>, and <span class="hlFld-ContribAuthor ">John A.  Katzenellenbogen</span>  . </span><span class="cited-content_cbyCitation_article-title">Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6321-6336. <a href="https://doi.org/10.1021/acs.jmedchem.7b00585" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00585</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00585%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdamantyl%252BAntiestrogens%252Bwith%252BNovel%252BSide%252BChains%252BReveal%252Ba%252BSpectrum%252Bof%252BActivities%252Bin%252BSuppressing%252BEstrogen%252BReceptor%252BMediated%252BActivities%252Bin%252BBreast%252BCancer%252BCells%26aulast%3DMin%26aufirst%3DJian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04052017%26date%3D14072017%26date%3D27072017%26date%3D28062017%26volume%3D60%26issue%3D14%26spage%3D6321%26epage%3D6336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather E.  Burks</span>, <span class="hlFld-ContribAuthor ">Tinya  Abrams</span>, <span class="hlFld-ContribAuthor ">Christina A.  Kirby</span>, <span class="hlFld-ContribAuthor ">Jason  Baird</span>, <span class="hlFld-ContribAuthor ">Alexander  Fekete</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Hamann</span>, <span class="hlFld-ContribAuthor ">Sunkyu  Kim</span>, <span class="hlFld-ContribAuthor ">Franco  Lombardo</span>, <span class="hlFld-ContribAuthor ">Alice  Loo</span>, <span class="hlFld-ContribAuthor ">Danuta  Lubicka</span>, <span class="hlFld-ContribAuthor ">Kaitlin  Macchi</span>, <span class="hlFld-ContribAuthor ">Donald P.  McDonnell</span>, <span class="hlFld-ContribAuthor ">Yuji  Mishina</span>, <span class="hlFld-ContribAuthor ">John D.  Norris</span>, <span class="hlFld-ContribAuthor ">Jill  Nunez</span>, <span class="hlFld-ContribAuthor ">Chitra  Saran</span>, <span class="hlFld-ContribAuthor ">Yingchuan  Sun</span>, <span class="hlFld-ContribAuthor ">Noel M.  Thomsen</span>, <span class="hlFld-ContribAuthor ">Chunrong  Wang</span>, <span class="hlFld-ContribAuthor ">Jianling  Wang</span>, and <span class="hlFld-ContribAuthor ">Stefan  Peukert</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of an Acrylic Acid Based Tetrahydroisoquinoline as an Orally Bioavailable Selective Estrogen Receptor Degrader for ERα+ Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2790-2818. <a href="https://doi.org/10.1021/acs.jmedchem.6b01468" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01468%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BAcrylic%252BAcid%252BBased%252BTetrahydroisoquinoline%252Bas%252Ban%252BOrally%252BBioavailable%252BSelective%252BEstrogen%252BReceptor%252BDegrader%252Bfor%252BER%2525CE%2525B1%25252B%252BBreast%252BCancer%26aulast%3DBurks%26aufirst%3DHeather%2BE.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D04112016%26date%3D15032017%26date%3D13042017%26volume%3D60%26issue%3D7%26spage%3D2790%26epage%3D2818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Xiong</span>, <span class="hlFld-ContribAuthor ">Jiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Lauren M.  Gutgesell</span>, <span class="hlFld-ContribAuthor ">Yueting  Wang</span>, <span class="hlFld-ContribAuthor ">Sue  Lee</span>, <span class="hlFld-ContribAuthor ">Bhargava  Karumudi</span>, <span class="hlFld-ContribAuthor ">Huiping  Zhao</span>, <span class="hlFld-ContribAuthor ">Yunlong  Lu</span>, <span class="hlFld-ContribAuthor ">Debra A.  Tonetti</span>, and <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1325-1342. <a href="https://doi.org/10.1021/acs.jmedchem.6b01355" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01355%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BSelective%252BEstrogen%252BReceptor%252BDownregulators%252B%252528SERDs%252529%252BDeveloped%252Bagainst%252BTreatment-Resistant%252BBreast%252BCancer%26aulast%3DXiong%26aufirst%3DRui%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D15092016%26date%3D10022017%26date%3D23022017%26date%3D24012017%26volume%3D60%26issue%3D4%26spage%3D1325%26epage%3D1342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiawang  Liu</span>, <span class="hlFld-ContribAuthor ">Shilong  Zheng</span>, <span class="hlFld-ContribAuthor ">Shanchun  Guo</span>, <span class="hlFld-ContribAuthor ">Changde  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiu  Zhong</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Peng  Ma</span>, <span class="hlFld-ContribAuthor ">Elena V.  Skripnikova</span>, <span class="hlFld-ContribAuthor ">Melyssa R.  Bratton</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Wiese</span>, and <span class="hlFld-ContribAuthor ">Guangdi  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 102-106. <a href="https://doi.org/10.1021/acsmedchemlett.6b00410" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00410%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRational%252BDesign%252Bof%252Ba%252BBoron-Modified%252BTriphenylethylene%252B%252528GLL398%252529%252Bas%252Ban%252BOral%252BSelective%252BEstrogen%252BReceptor%252BDownregulator%26aulast%3DLiu%26aufirst%3DJiawang%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15102016%26date%3D29112016%26date%3D02122016%26date%3D12012017%26date%3D29112016%26volume%3D8%26issue%3D1%26spage%3D102%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Foteinos-Ioannis  Dimitrakopoulos</span>, <span class="hlFld-ContribAuthor ">Anastasia  Kottorou</span>, <span class="hlFld-ContribAuthor ">Aspasia  Tzezou</span>. </span><span class="cited-content_cbyCitation_article-title">Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2021,</strong> <em>517 </em>, 55-65. <a href="https://doi.org/10.1016/j.canlet.2021.05.030" title="DOI URL">https://doi.org/10.1016/j.canlet.2021.05.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2021.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2021.05.030%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DEndocrine%252Bresistance%252Band%252Bepigenetic%252Breprogramming%252Bin%252Bestrogen%252Breceptor%252Bpositive%252Bbreast%252Bcancer%26aulast%3DDimitrakopoulos%26aufirst%3DFoteinos-Ioannis%26date%3D2021%26volume%3D517%26spage%3D55%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Hernando</span>, <span class="hlFld-ContribAuthor ">Belén  Ortega-Morillo</span>, <span class="hlFld-ContribAuthor ">Marta  Tapia</span>, <span class="hlFld-ContribAuthor ">Santiago  Moragón</span>, <span class="hlFld-ContribAuthor ">María Teresa  Martínez</span>, <span class="hlFld-ContribAuthor ">Pilar  Eroles</span>, <span class="hlFld-ContribAuthor ">Iris  Garrido-Cano</span>, <span class="hlFld-ContribAuthor ">Anna  Adam-Artigues</span>, <span class="hlFld-ContribAuthor ">Ana  Lluch</span>, <span class="hlFld-ContribAuthor ">Begoña  Bermejo</span>, <span class="hlFld-ContribAuthor ">Juan Miguel  Cejalvo</span>. </span><span class="cited-content_cbyCitation_article-title">Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (15)
                                     , 7812. <a href="https://doi.org/10.3390/ijms22157812" title="DOI URL">https://doi.org/10.3390/ijms22157812</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22157812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22157812%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DOral%252BSelective%252BEstrogen%252BReceptor%252BDegraders%252B%252528SERDs%252529%252Bas%252Ba%252BNovel%252BBreast%252BCancer%252BTherapy%25253A%252BPresent%252Band%252BFuture%252Bfrom%252Ba%252BClinical%252BPerspective%26aulast%3DHernando%26aufirst%3DCristina%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D15%26spage%3D7812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Corinne N.  Haines</span>, <span class="hlFld-ContribAuthor ">Suzanne E.  Wardell</span>, <span class="hlFld-ContribAuthor ">Donald P.  McDonnell</span>. </span><span class="cited-content_cbyCitation_article-title">Current and emerging estrogen receptor-targeted therapies for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2021,</strong> <em>71 </em><a href="https://doi.org/10.1042/EBC20200174" title="DOI URL">https://doi.org/10.1042/EBC20200174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20200174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20200174%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DCurrent%252Band%252Bemerging%252Bestrogen%252Breceptor-targeted%252Btherapies%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DHaines%26aufirst%3DCorinne%25C2%25A0N.%26date%3D2021%26date%3D2021%26volume%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fahmida  Rasha</span>, <span class="hlFld-ContribAuthor ">Monica  Sharma</span>, <span class="hlFld-ContribAuthor ">Kevin  Pruitt</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of endocrine therapy resistance in breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2021,</strong> <em>532 </em>, 111322. <a href="https://doi.org/10.1016/j.mce.2021.111322" title="DOI URL">https://doi.org/10.1016/j.mce.2021.111322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2021.111322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2021.111322%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DMechanisms%252Bof%252Bendocrine%252Btherapy%252Bresistance%252Bin%252Bbreast%252Bcancer%26aulast%3DRasha%26aufirst%3DFahmida%26date%3D2021%26volume%3D532%26spage%3D111322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlene  Kay</span>, <span class="hlFld-ContribAuthor ">Carlos  Martínez-Pérez</span>, <span class="hlFld-ContribAuthor ">James  Meehan</span>, <span class="hlFld-ContribAuthor ">Mark  Gray</span>, <span class="hlFld-ContribAuthor ">Victoria  Webber</span>, <span class="hlFld-ContribAuthor ">J Michael  Dixon</span>, <span class="hlFld-ContribAuthor ">Arran K  Turnbull</span>. </span><span class="cited-content_cbyCitation_article-title">Current trends in the treatment of HR+/HER2+ breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2021,</strong> <em>17 </em>
                                    (13)
                                     , 1665-1681. <a href="https://doi.org/10.2217/fon-2020-0504" title="DOI URL">https://doi.org/10.2217/fon-2020-0504</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon-2020-0504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon-2020-0504%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DCurrent%252Btrends%252Bin%252Bthe%252Btreatment%252Bof%252BHR%25252B%25252FHER2%25252B%252Bbreast%252Bcancer%26aulast%3DKay%26aufirst%3DCharlene%26date%3D2021%26volume%3D17%26issue%3D13%26spage%3D1665%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald P.  McDonnell</span>, <span class="hlFld-ContribAuthor ">Suzanne E.  Wardell</span>, <span class="hlFld-ContribAuthor ">Ching-Yi  Chang</span>, <span class="hlFld-ContribAuthor ">John D.  Norris</span>. </span><span class="cited-content_cbyCitation_article-title">Next-Generation Endocrine Therapies for Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Oncology</span><span> <strong>2021,</strong> <em>39 </em>
                                    (12)
                                     , 1383-1388. <a href="https://doi.org/10.1200/JCO.20.03565" title="DOI URL">https://doi.org/10.1200/JCO.20.03565</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1200/JCO.20.03565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1200%2FJCO.20.03565%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Oncology%26atitle%3DNext-Generation%252BEndocrine%252BTherapies%252Bfor%252BBreast%252BCancer%26aulast%3DMcDonnell%26aufirst%3DDonald%2BP.%26date%3D2021%26volume%3D39%26issue%3D12%26spage%3D1383%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esmael Besufikad  Belachew</span>, <span class="hlFld-ContribAuthor ">Dareskedar Tsehay  Sewasew</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fendo.2021.599586" title="DOI URL">https://doi.org/10.3389/fendo.2021.599586</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2021.599586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2021.599586%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DMolecular%252BMechanisms%252Bof%252BEndocrine%252BResistance%252Bin%252BEstrogen-Receptor-Positive%252BBreast%252BCancer%26aulast%3DBelachew%26aufirst%3DEsmael%2BBesufikad%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcus J. C.  Long</span>. </span><span class="cited-content_cbyCitation_article-title">Time to Get Turned on by Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2021,</strong> <em>22 </em>
                                    (5)
                                     , 814-817. <a href="https://doi.org/10.1002/cbic.202000497" title="DOI URL">https://doi.org/10.1002/cbic.202000497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000497%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DTime%252Bto%252BGet%252BTurned%252Bon%252Bby%252BChemical%252BBiology%26aulast%3DLong%26aufirst%3DMarcus%2BJ.%2BC.%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D5%26spage%3D814%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew B.  Benowitz</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Jones</span>, <span class="hlFld-ContribAuthor ">John D.  Harling</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic potential of PROTACs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 1-24. <a href="https://doi.org/10.1080/13543776.2021.1840553" title="DOI URL">https://doi.org/10.1080/13543776.2021.1840553</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1840553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1840553%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DThe%252Btherapeutic%252Bpotential%252Bof%252BPROTACs%26aulast%3DBenowitz%26aufirst%3DAndrew%2BB.%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D1%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesudass Joseph  Sahayarayan</span>, <span class="hlFld-ContribAuthor ">Kulanthaivel Soundar  Rajan</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Vidhyavathi</span>, <span class="hlFld-ContribAuthor ">Mutharasappan  Nachiappan</span>, <span class="hlFld-ContribAuthor ">Dhamodharan  Prabhu</span>, <span class="hlFld-ContribAuthor ">Saleh  Alfarraj</span>, <span class="hlFld-ContribAuthor ">Selvaraj  Arokiyaraj</span>, <span class="hlFld-ContribAuthor ">Amalorpavanaden Nicholas  Daniel</span>. </span><span class="cited-content_cbyCitation_article-title">In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches. </span><span class="cited-content_cbyCitation_journal-name">Saudi Journal of Biological Sciences</span><span> <strong>2021,</strong> <em>28 </em>
                                    (1)
                                     , 400-407. <a href="https://doi.org/10.1016/j.sjbs.2020.10.023" title="DOI URL">https://doi.org/10.1016/j.sjbs.2020.10.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.sjbs.2020.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.sjbs.2020.10.023%26sid%3Dliteratum%253Aachs%26jtitle%3DSaudi%2520Journal%2520of%2520Biological%2520Sciences%26atitle%3DIn-silico%252Bprotein-ligand%252Bdocking%252Bstudies%252Bagainst%252Bthe%252Bestrogen%252Bprotein%252Bof%252Bbreast%252Bcancer%252Busing%252Bpharmacophore%252Bbased%252Bvirtual%252Bscreening%252Bapproaches%26aulast%3DSahayarayan%26aufirst%3DJesudass%2BJoseph%26date%3D2021%26volume%3D28%26issue%3D1%26spage%3D400%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Besret</span>, <span class="hlFld-ContribAuthor ">Sébastien  d’Heilly</span>, <span class="hlFld-ContribAuthor ">Cathy  Aubert</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bluet</span>, <span class="hlFld-ContribAuthor ">Florence  Gruss-Leleu</span>, <span class="hlFld-ContribAuthor ">Françoise  Le-Gall</span>, <span class="hlFld-ContribAuthor ">Anne  Caron</span>, <span class="hlFld-ContribAuthor ">Laurent  Andrieu</span>, <span class="hlFld-ContribAuthor ">Sylvie  Vincent</span>, <span class="hlFld-ContribAuthor ">Maysoun  Shomali</span>, <span class="hlFld-ContribAuthor ">Monsif  Bouaboula</span>, <span class="hlFld-ContribAuthor ">Carole  Voland</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Ming</span>, <span class="hlFld-ContribAuthor ">Sébastien  Roy</span>, <span class="hlFld-ContribAuthor ">Srinivas  Rao</span>, <span class="hlFld-ContribAuthor ">Chantal  Carrez</span>, <span class="hlFld-ContribAuthor ">Erwan  Jouannot</span>. </span><span class="cited-content_cbyCitation_article-title">Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-020-00646-w" title="DOI URL">https://doi.org/10.1186/s13550-020-00646-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-020-00646-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-020-00646-w%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DTranslational%252Bstrategy%252Busing%252Bmultiple%252Bnuclear%252Bimaging%252Bbiomarkers%252Bto%252Bevaluate%252Btarget%252Bengagement%252Band%252Bearly%252Btherapeutic%252Befficacy%252Bof%252BSAR439859%25252C%252Ba%252Bnovel%252Bselective%252Bestrogen%252Breceptor%252Bdegrader%26aulast%3DBesret%26aufirst%3DLaurent%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Wang</span>, <span class="hlFld-ContribAuthor ">Abhishek  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">The Quest for Orally Available Selective Estrogen Receptor Degraders (SERDs). </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (22)
                                     , 2072-2097. <a href="https://doi.org/10.1002/cmdc.202000473" title="DOI URL">https://doi.org/10.1002/cmdc.202000473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000473%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BQuest%252Bfor%252BOrally%252BAvailable%252BSelective%252BEstrogen%252BReceptor%252BDegraders%252B%252528SERDs%252529%26aulast%3DWang%26aufirst%3DLucia%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D22%26spage%3D2072%26epage%3D2097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Lin</span>, <span class="hlFld-ContribAuthor ">Hua  Xiang</span>, <span class="hlFld-ContribAuthor ">Guoshun  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>206 </em>, 112689. <a href="https://doi.org/10.1016/j.ejmech.2020.112689" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112689%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bestrogen%252Breceptor%252B%2525CE%2525B1%252Bfor%252Bdegradation%252Bwith%252BPROTACs%25253A%252BA%252Bpromising%252Bapproach%252Bto%252Bovercome%252Bendocrine%252Bresistance%26aulast%3DLin%26aufirst%3DXin%26date%3D2020%26volume%3D206%26spage%3D112689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali  Sartaj</span>, <span class="hlFld-ContribAuthor ">Sanjula  Baboota</span>, <span class="hlFld-ContribAuthor ">Javed  Ali</span>. </span><span class="cited-content_cbyCitation_article-title">Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Drug Targets</span><span> <strong>2020,</strong> <em>20 </em>
                                    (8)
                                     , 603-615. <a href="https://doi.org/10.2174/1568009620666200331124113" title="DOI URL">https://doi.org/10.2174/1568009620666200331124113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009620666200331124113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009620666200331124113%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Drug%2520Targets%26atitle%3DNanomedicine%25253A%252BA%252BPromising%252BAvenue%252Bfor%252Bthe%252BDevelopment%252Bof%252BEffective%252BTherapy%252Bfor%252BBreast%252BCancer%26aulast%3DSartaj%26aufirst%3DAli%26date%3D2020%26volume%3D20%26issue%3D8%26spage%3D603%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaitlyn J.  Andreano</span>, <span class="hlFld-ContribAuthor ">Jennifer G.  Baker</span>, <span class="hlFld-ContribAuthor ">Sunghee  Park</span>, <span class="hlFld-ContribAuthor ">Rachid  Safi</span>, <span class="hlFld-ContribAuthor ">Sandeep  Artham</span>, <span class="hlFld-ContribAuthor ">Steffi  Oesterreich</span>, <span class="hlFld-ContribAuthor ">Rinath  Jeselsohn</span>, <span class="hlFld-ContribAuthor ">Myles  Brown</span>, <span class="hlFld-ContribAuthor ">Sarah  Sammons</span>, <span class="hlFld-ContribAuthor ">Suzanne E.  Wardell</span>, <span class="hlFld-ContribAuthor ">Ching-yi  Chang</span>, <span class="hlFld-ContribAuthor ">John D.  Norris</span>, <span class="hlFld-ContribAuthor ">Donald P.  McDonnell</span>. </span><span class="cited-content_cbyCitation_article-title">The Dysregulated Pharmacology of Clinically Relevant
              ESR1
              Mutants is Normalized by Ligand-activated WT Receptor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2020,</strong> <em>19 </em>
                                    (7)
                                     , 1395-1405. <a href="https://doi.org/10.1158/1535-7163.MCT-19-1148" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-1148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-1148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-1148%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DThe%252BDysregulated%252BPharmacology%252Bof%252BClinically%252BRelevant%252BESR1%252BMutants%252Bis%252BNormalized%252Bby%252BLigand-activated%252BWT%252BReceptor%26aulast%3DAndreano%26aufirst%3DKaitlyn%2BJ.%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D7%26spage%3D1395%26epage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  He</span>, <span class="hlFld-ContribAuthor ">Wentao  Ning</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel dual-acting modulators targeting both estrogen receptor α (ERα) and lysine-specific demethylase 1 (LSD1) for treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112281. <a href="https://doi.org/10.1016/j.ejmech.2020.112281" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112281%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bdual-acting%252Bmodulators%252Btargeting%252Bboth%252Bestrogen%252Breceptor%252B%2525CE%2525B1%252B%252528ER%2525CE%2525B1%252529%252Band%252Blysine-specific%252Bdemethylase%252B1%252B%252528LSD1%252529%252Bfor%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DHe%26aufirst%3DMing%26date%3D2020%26volume%3D195%26spage%3D112281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filippo  Acconcia</span>. </span><span class="cited-content_cbyCitation_article-title">The Network of Angiotensin Receptors in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (6)
                                     , 1336. <a href="https://doi.org/10.3390/cells9061336" title="DOI URL">https://doi.org/10.3390/cells9061336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9061336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9061336%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DThe%252BNetwork%252Bof%252BAngiotensin%252BReceptors%252Bin%252BBreast%252BCancer%26aulast%3DAcconcia%26aufirst%3DFilippo%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D6%26spage%3D1336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Divya  Bafna</span>, <span class="hlFld-ContribAuthor ">Fuqiang  Ban</span>, <span class="hlFld-ContribAuthor ">Paul S.  Rennie</span>, <span class="hlFld-ContribAuthor ">Kriti  Singh</span>, <span class="hlFld-ContribAuthor ">Artem  Cherkasov</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Ligand Discovery for Estrogen Receptor Alpha. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (12)
                                     , 4193. <a href="https://doi.org/10.3390/ijms21124193" title="DOI URL">https://doi.org/10.3390/ijms21124193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21124193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21124193%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DComputer-Aided%252BLigand%252BDiscovery%252Bfor%252BEstrogen%252BReceptor%252BAlpha%26aulast%3DBafna%26aufirst%3DDivya%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D12%26spage%3D4193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shagufta</span>, <span class="hlFld-ContribAuthor ">Irshad  Ahmad</span>, <span class="hlFld-ContribAuthor ">Shimy  Mathew</span>, <span class="hlFld-ContribAuthor ">Sofia  Rahman</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 438-454. <a href="https://doi.org/10.1039/C9MD00570F" title="DOI URL">https://doi.org/10.1039/C9MD00570F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00570F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00570F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bselective%252Bestrogen%252Breceptor%252Bdownregulators%252B%252528SERDs%252529%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DShagufta%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D4%26spage%3D438%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atefeh  Yassemi</span>, <span class="hlFld-ContribAuthor ">Soheila  Kashanian</span>, <span class="hlFld-ContribAuthor ">Hossein  Zhaleh</span>. </span><span class="cited-content_cbyCitation_article-title">Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Development and Technology</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 397-407. <a href="https://doi.org/10.1080/10837450.2019.1703739" title="DOI URL">https://doi.org/10.1080/10837450.2019.1703739</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10837450.2019.1703739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10837450.2019.1703739%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Development%2520and%2520Technology%26atitle%3DFolic%252Bacid%252Breceptor-targeted%252Bsolid%252Blipid%252Bnanoparticles%252Bto%252Benhance%252Bcytotoxicity%252Bof%252Bletrozole%252Bthrough%252Binduction%252Bof%252Bcaspase-3%252Bdependent-apoptosis%252Bfor%252Bbreast%252Bcancer%252Btreatment%26aulast%3DYassemi%26aufirst%3DAtefeh%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D397%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cuihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Qunlin  Li</span>, <span class="hlFld-ContribAuthor ">Yujie  Ren</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling studies of benzothiophene-containing derivatives as promising selective estrogen receptor downregulators: a combination of 3D-QSAR, molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em> </em>, 1-22. <a href="https://doi.org/10.1080/07391102.2020.1751717" title="DOI URL">https://doi.org/10.1080/07391102.2020.1751717</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1751717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1751717%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bmodeling%252Bstudies%252Bof%252Bbenzothiophene-containing%252Bderivatives%252Bas%252Bpromising%252Bselective%252Bestrogen%252Breceptor%252Bdownregulators%25253A%252Ba%252Bcombination%252Bof%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DZhang%26aufirst%3DCuihua%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shanchun  Guo</span>, <span class="hlFld-ContribAuthor ">Changde  Zhang</span>, <span class="hlFld-ContribAuthor ">Madhusoodanan  Mottamal</span>, <span class="hlFld-ContribAuthor ">Ahamed  Hossain</span>, <span class="hlFld-ContribAuthor ">Jiawang  Liu</span>, <span class="hlFld-ContribAuthor ">Guangdi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2020,</strong> <em>180 </em>
                                    (2)
                                     , 359-368. <a href="https://doi.org/10.1007/s10549-020-05558-w" title="DOI URL">https://doi.org/10.1007/s10549-020-05558-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-020-05558-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-020-05558-w%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DGLL398%25252C%252Ban%252Boral%252Bselective%252Bestrogen%252Breceptor%252Bdegrader%252B%252528SERD%252529%25252C%252Bblocks%252Btumor%252Bgrowth%252Bin%252Bxenograft%252Bbreast%252Bcancer%252Bmodels%26aulast%3DGuo%26aufirst%3DShanchun%26date%3D2020%26date%3D2020%26volume%3D180%26issue%3D2%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaitlyn J.  Andreano</span>, <span class="hlFld-ContribAuthor ">Suzanne E.  Wardell</span>, <span class="hlFld-ContribAuthor ">Jennifer G.  Baker</span>, <span class="hlFld-ContribAuthor ">Taylor K.  Desautels</span>, <span class="hlFld-ContribAuthor ">Robert  Baldi</span>, <span class="hlFld-ContribAuthor ">Christina A.  Chao</span>, <span class="hlFld-ContribAuthor ">Kendall A.  Heetderks</span>, <span class="hlFld-ContribAuthor ">Yeeun  Bae</span>, <span class="hlFld-ContribAuthor ">Rui  Xiong</span>, <span class="hlFld-ContribAuthor ">Debra A.  Tonetti</span>, <span class="hlFld-ContribAuthor ">Lauren M.  Gutgesell</span>, <span class="hlFld-ContribAuthor ">Jiong  Zhao</span>, <span class="hlFld-ContribAuthor ">Jessica A.  Sorrentino</span>, <span class="hlFld-ContribAuthor ">Delita A.  Thompson</span>, <span class="hlFld-ContribAuthor ">John E.  Bisi</span>, <span class="hlFld-ContribAuthor ">Jay C.  Strum</span>, <span class="hlFld-ContribAuthor ">Gregory R. J.  Thatcher</span>, <span class="hlFld-ContribAuthor ">John D.  Norris</span>. </span><span class="cited-content_cbyCitation_article-title">G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research and Treatment</span><span> <strong>2020,</strong> <em>180 </em>
                                    (3)
                                     , 635-646. <a href="https://doi.org/10.1007/s10549-020-05575-9" title="DOI URL">https://doi.org/10.1007/s10549-020-05575-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10549-020-05575-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10549-020-05575-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%2520and%2520Treatment%26atitle%3DG1T48%25252C%252Ban%252Boral%252Bselective%252Bestrogen%252Breceptor%252Bdegrader%25252C%252Band%252Bthe%252BCDK4%25252F6%252Binhibitor%252Blerociclib%252Binhibit%252Btumor%252Bgrowth%252Bin%252Banimal%252Bmodels%252Bof%252Bendocrine-resistant%252Bbreast%252Bcancer%26aulast%3DAndreano%26aufirst%3DKaitlyn%2BJ.%26date%3D2020%26date%3D2020%26volume%3D180%26issue%3D3%26spage%3D635%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Wang</span>, <span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Degradation of proteins by PROTACs and other strategies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 207-238. <a href="https://doi.org/10.1016/j.apsb.2019.08.001" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDegradation%252Bof%252Bproteins%252Bby%252BPROTACs%252Band%252Bother%252Bstrategies%26aulast%3DWang%26aufirst%3DYang%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D207%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter S.  Dragovich</span>, <span class="hlFld-ContribAuthor ">Pragya  Adhikari</span>, <span class="hlFld-ContribAuthor ">Robert A.  Blake</span>, <span class="hlFld-ContribAuthor ">Nicole  Blaquiere</span>, <span class="hlFld-ContribAuthor ">Jinhua  Chen</span>, <span class="hlFld-ContribAuthor ">Yun-Xing  Cheng</span>, <span class="hlFld-ContribAuthor ">Willem  den Besten</span>, <span class="hlFld-ContribAuthor ">Jinping  Han</span>, <span class="hlFld-ContribAuthor ">Steven J.  Hartman</span>, <span class="hlFld-ContribAuthor ">Jintang  He</span>, <span class="hlFld-ContribAuthor ">Mingtao  He</span>, <span class="hlFld-ContribAuthor ">Ellen  Rei Ingalla</span>, <span class="hlFld-ContribAuthor ">Amrita V.  Kamath</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Tommy  Lai</span>, <span class="hlFld-ContribAuthor ">Douglas D.  Leipold</span>, <span class="hlFld-ContribAuthor ">Chun Sing  Li</span>, <span class="hlFld-ContribAuthor ">Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Jiawei  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Fanwei  Meng</span>, <span class="hlFld-ContribAuthor ">Lingyao  Meng</span>, <span class="hlFld-ContribAuthor ">Carl  Ng</span>, <span class="hlFld-ContribAuthor ">Kaishan  Peng</span>, <span class="hlFld-ContribAuthor ">Gail  Lewis Phillips</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Pillow</span>, <span class="hlFld-ContribAuthor ">Rebecca K.  Rowntree</span>, <span class="hlFld-ContribAuthor ">Jack D.  Sadowsky</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Leanna  Staben</span>, <span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Kunpeng  Wan</span>, <span class="hlFld-ContribAuthor ">Xinxin  Wang</span>, <span class="hlFld-ContribAuthor ">BinQing  Wei</span>, <span class="hlFld-ContribAuthor ">Ingrid E.  Wertz</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Xin</span>, <span class="hlFld-ContribAuthor ">Keyang  Xu</span>, <span class="hlFld-ContribAuthor ">Hui  Yao</span>, <span class="hlFld-ContribAuthor ">Richard  Zang</span>, <span class="hlFld-ContribAuthor ">Donglu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yongxin  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126907. <a href="https://doi.org/10.1016/j.bmcl.2019.126907" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126907%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntibody-mediated%252Bdelivery%252Bof%252Bchimeric%252Bprotein%252Bdegraders%252Bwhich%252Btarget%252Bestrogen%252Breceptor%252Balpha%252B%252528ER%2525CE%2525B1%252529%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gizem Tugce  Ulu</span>, <span class="hlFld-ContribAuthor ">Yagmur  Kiraz</span>, <span class="hlFld-ContribAuthor ">Yusuf  Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Personalized biomedicine in cancer: from traditional therapy to sustainable healthcare. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 441-457. <a href="https://doi.org/10.1016/B978-0-12-819541-3.00022-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-819541-3.00022-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-819541-3.00022-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-819541-3.00022-0%26sid%3Dliteratum%253Aachs%26atitle%3DPersonalized%252Bbiomedicine%252Bin%252Bcancer%25253A%252Bfrom%252Btraditional%252Btherapy%252Bto%252Bsustainable%252Bhealthcare%26aulast%3DUlu%26aufirst%3DGizem%2BTugce%26date%3D2020%26spage%3D441%26epage%3D457%26pub%3DElsevier%26atitle%3DBiodiversity%252Band%252BBiomedicine%26date%3D2020%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica  Iorfida</span>, <span class="hlFld-ContribAuthor ">Manuelita  Mazza</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Munzone</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives</p>. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer: Targets and Therapy</span><span> <strong>2020,</strong> <em>Volume 12 </em>, 45-56. <a href="https://doi.org/10.2147/BCTT.S196240" title="DOI URL">https://doi.org/10.2147/BCTT.S196240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/BCTT.S196240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FBCTT.S196240%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%253A%2520Targets%2520and%2520Therapy%26atitle%3D%25253Cp%25253EFulvestrant%252Bin%252BCombination%252Bwith%252BCDK4%25252F6%252BInhibitors%252Bfor%252BHER2-%252BMetastatic%252BBreast%252BCancers%25253A%252BCurrent%252BPerspectives%25253C%25252Fp%25253E%26aulast%3DIorfida%26aufirst%3DMonica%26date%3D2020%26date%3D2020%26volume%3DVolume%252012%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">IndhujaMuthiah  Vaikundaraja</span>, <span class="hlFld-ContribAuthor ">Manikandan  Dhanushkodi</span>, <span class="hlFld-ContribAuthor ">Venkatraman  Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">JayachandranPerumal  Kalaiarasi</span>, <span class="hlFld-ContribAuthor ">Nikita  Mehra</span>, <span class="hlFld-ContribAuthor ">ArunKumar  Rajan</span>, <span class="hlFld-ContribAuthor ">Gangothri  Selvarajan</span>, <span class="hlFld-ContribAuthor ">SivaSree  Kesana</span>, <span class="hlFld-ContribAuthor ">Balasubramanian  Ananthi</span>, <span class="hlFld-ContribAuthor ">Priya  Iyer</span>, <span class="hlFld-ContribAuthor ">Geetha  Senguttuvan</span>, <span class="hlFld-ContribAuthor ">Manjula  Rao</span>, <span class="hlFld-ContribAuthor ">Arvind  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Sridevi  Velusamy</span>, <span class="hlFld-ContribAuthor ">Hemanth  Raj</span>, <span class="hlFld-ContribAuthor ">Rama  Ranganathan</span>, <span class="hlFld-ContribAuthor ">Shirley  Sundersingh</span>, <span class="hlFld-ContribAuthor ">Selvaluxmy  Ganesarajah</span>, <span class="hlFld-ContribAuthor ">TrivadiS  Ganesan</span>, <span class="hlFld-ContribAuthor ">TenaliGnana  Sagar</span>. </span><span class="cited-content_cbyCitation_article-title">Fulvestrant in hormone-positive advanced breast cancer: Real-world outcome. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research, Statistics, and Treatment</span><span> <strong>2020,</strong> <em>3 </em>
                                    (2)
                                     , 275. <a href="https://doi.org/10.4103/CRST.CRST_53_20" title="DOI URL">https://doi.org/10.4103/CRST.CRST_53_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/CRST.CRST_53_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2FCRST.CRST_53_20%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%252C%2520Statistics%252C%2520and%2520Treatment%26atitle%3DFulvestrant%252Bin%252Bhormone-positive%252Badvanced%252Bbreast%252Bcancer%25253A%252BReal-world%252Boutcome%26aulast%3DVaikundaraja%26aufirst%3DIndhujaMuthiah%26date%3D2020%26volume%3D3%26issue%3D2%26spage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jay C.  Groppe</span>. </span><span class="cited-content_cbyCitation_article-title">Induced degradation of protein kinases by bifunctional small molecules: a next-generation strategy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (12)
                                     , 1237-1253. <a href="https://doi.org/10.1080/17460441.2019.1660641" title="DOI URL">https://doi.org/10.1080/17460441.2019.1660641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1660641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1660641%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DInduced%252Bdegradation%252Bof%252Bprotein%252Bkinases%252Bby%252Bbifunctional%252Bsmall%252Bmolecules%25253A%252Ba%252Bnext-generation%252Bstrategy%26aulast%3DGroppe%26aufirst%3DJay%2BC.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D12%26spage%3D1237%26epage%3D1253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. O.  Tserfas</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">I. S.  Levina</span>, <span class="hlFld-ContribAuthor ">I. V.  Zavarzin</span>. </span><span class="cited-content_cbyCitation_article-title">Key structures for the synthesis of steroid antitumor agents. Synthesis of 16-dehydro-17-carbaldehydes of 13β- and 13α-estratriene series. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (12)
                                     , 2350-2354. <a href="https://doi.org/10.1007/s11172-019-2710-1" title="DOI URL">https://doi.org/10.1007/s11172-019-2710-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2710-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2710-1%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DKey%252Bstructures%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bsteroid%252Bantitumor%252Bagents.%252BSynthesis%252Bof%252B16-dehydro-17-carbaldehydes%252Bof%252B13%2525CE%2525B2-%252Band%252B13%2525CE%2525B1-estratriene%252Bseries%26aulast%3DTserfas%26aufirst%3DM.%2BO.%26date%3D2019%26date%3D2020%26volume%3D68%26issue%3D12%26spage%3D2350%26epage%3D2354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sayed M.  Abd El-Lateef</span>, <span class="hlFld-ContribAuthor ">El-Sayed M.  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Mansour</span>, <span class="hlFld-ContribAuthor ">Salama A.  Salama</span>. </span><span class="cited-content_cbyCitation_article-title">The protective role of estrogen and its receptors in gentamicin-induced acute kidney injury in rats. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2019,</strong> <em>239 </em>, 117082. <a href="https://doi.org/10.1016/j.lfs.2019.117082" title="DOI URL">https://doi.org/10.1016/j.lfs.2019.117082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2019.117082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2019.117082%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DThe%252Bprotective%252Brole%252Bof%252Bestrogen%252Band%252Bits%252Breceptors%252Bin%252Bgentamicin-induced%252Bacute%252Bkidney%252Binjury%252Bin%252Brats%26aulast%3DAbd%2BEl-Lateef%26aufirst%3DSayed%2BM.%26date%3D2019%26volume%3D239%26spage%3D117082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Barton</span>, <span class="hlFld-ContribAuthor ">Matthias R.  Meyer</span>, <span class="hlFld-ContribAuthor ">Eric R.  Prossnitz</span>. </span><span class="cited-content_cbyCitation_article-title">Nox1 downregulators: A new class of therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2019,</strong> <em>152 </em>, 108494. <a href="https://doi.org/10.1016/j.steroids.2019.108494" title="DOI URL">https://doi.org/10.1016/j.steroids.2019.108494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2019.108494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2019.108494%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DNox1%252Bdownregulators%25253A%252BA%252Bnew%252Bclass%252Bof%252Btherapeutics%26aulast%3DBarton%26aufirst%3DMatthias%26date%3D2019%26volume%3D152%26spage%3D108494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hitisha K.  Patel</span>, <span class="hlFld-ContribAuthor ">Nianjun  Tao</span>, <span class="hlFld-ContribAuthor ">Kyung-Min  Lee</span>, <span class="hlFld-ContribAuthor ">Mariela  Huerta</span>, <span class="hlFld-ContribAuthor ">Heike  Arlt</span>, <span class="hlFld-ContribAuthor ">Tara  Mullarkey</span>, <span class="hlFld-ContribAuthor ">Steven  Troy</span>, <span class="hlFld-ContribAuthor ">Carlos L.  Arteaga</span>, <span class="hlFld-ContribAuthor ">Teeru  Bihani</span>. </span><span class="cited-content_cbyCitation_article-title">Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Research</span><span> <strong>2019,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13058-019-1230-0" title="DOI URL">https://doi.org/10.1186/s13058-019-1230-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13058-019-1230-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13058-019-1230-0%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Research%26atitle%3DElacestrant%252B%252528RAD1901%252529%252Bexhibits%252Banti-tumor%252Bactivity%252Bin%252Bmultiple%252BER%25252B%252Bbreast%252Bcancer%252Bmodels%252Bresistant%252Bto%252BCDK4%25252F6%252Binhibitors%26aulast%3DPatel%26aufirst%3DHitisha%2BK.%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Zeng</span>, <span class="hlFld-ContribAuthor ">Liru  Xie</span>, <span class="hlFld-ContribAuthor ">Deliang  Chen</span>, <span class="hlFld-ContribAuthor ">Shanshan  Li</span>, <span class="hlFld-ContribAuthor ">Jinxia  Nong</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Tang</span>, <span class="hlFld-ContribAuthor ">Qianqian  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Li</span>, <span class="hlFld-ContribAuthor ">Zixin  Deng</span>, <span class="hlFld-ContribAuthor ">Xuechuan  Hong</span>, <span class="hlFld-ContribAuthor ">Mingfu  Wu</span>, <span class="hlFld-ContribAuthor ">Yuling  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">A bright NIR-II fluorescent probe for breast carcinoma imaging and image-guided surgery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (95)
                                     , 14287-14290. <a href="https://doi.org/10.1039/C9CC07694H" title="DOI URL">https://doi.org/10.1039/C9CC07694H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC07694H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC07694H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bbright%252BNIR-II%252Bfluorescent%252Bprobe%252Bfor%252Bbreast%252Bcarcinoma%252Bimaging%252Band%252Bimage-guided%252Bsurgery%26aulast%3DZeng%26aufirst%3DXiaodong%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D95%26spage%3D14287%26epage%3D14290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo  Spinello</span>, <span class="hlFld-ContribAuthor ">Ida  Ritacco</span>, <span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 1065-1076. <a href="https://doi.org/10.1080/17460441.2019.1646245" title="DOI URL">https://doi.org/10.1080/17460441.2019.1646245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1646245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1646245%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Badvances%252Bin%252Bcomputational%252Bdesign%252Bof%252Bpotent%252Baromatase%252Binhibitors%25253A%252Bopen-eye%252Bon%252Bendocrine-resistant%252Bbreast%252Bcancers%26aulast%3DSpinello%26aufirst%3DAngelo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D1065%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimberly J.  Cocce</span>, <span class="hlFld-ContribAuthor ">Jeff S.  Jasper</span>, <span class="hlFld-ContribAuthor ">Taylor K.  Desautels</span>, <span class="hlFld-ContribAuthor ">Logan  Everett</span>, <span class="hlFld-ContribAuthor ">Suzanne  Wardell</span>, <span class="hlFld-ContribAuthor ">Thomas  Westerling</span>, <span class="hlFld-ContribAuthor ">Robert  Baldi</span>, <span class="hlFld-ContribAuthor ">Tricia M.  Wright</span>, <span class="hlFld-ContribAuthor ">Kendall  Tavares</span>, <span class="hlFld-ContribAuthor ">Alex  Yllanes</span>, <span class="hlFld-ContribAuthor ">Yeeun  Bae</span>, <span class="hlFld-ContribAuthor ">Jeremy T.  Blitzer</span>, <span class="hlFld-ContribAuthor ">Craig  Logsdon</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Rakiec</span>, <span class="hlFld-ContribAuthor ">David A.  Ruddy</span>, <span class="hlFld-ContribAuthor ">Tiancong  Jiang</span>, <span class="hlFld-ContribAuthor ">Gloria  Broadwater</span>, <span class="hlFld-ContribAuthor ">Terry  Hyslop</span>, <span class="hlFld-ContribAuthor ">Allison  Hall</span>, <span class="hlFld-ContribAuthor ">Muriel  Laine</span>, <span class="hlFld-ContribAuthor ">Linda  Phung</span>, <span class="hlFld-ContribAuthor ">Geoffrey L.  Greene</span>, <span class="hlFld-ContribAuthor ">Lesley-Ann  Martin</span>, <span class="hlFld-ContribAuthor ">Sunil  Pancholi</span>, <span class="hlFld-ContribAuthor ">Mitch  Dowsett</span>, <span class="hlFld-ContribAuthor ">Simone  Detre</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Marks</span>, <span class="hlFld-ContribAuthor ">Gregory E.  Crawford</span>, <span class="hlFld-ContribAuthor ">Myles  Brown</span>, <span class="hlFld-ContribAuthor ">John D.  Norris</span>, <span class="hlFld-ContribAuthor ">Ching-yi  Chang</span>, <span class="hlFld-ContribAuthor ">Donald P.  McDonnell</span>. </span><span class="cited-content_cbyCitation_article-title">The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 889-903.e10. <a href="https://doi.org/10.1016/j.celrep.2019.09.032" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.09.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.09.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.09.032%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DThe%252BLineage%252BDetermining%252BFactor%252BGRHL2%252BCollaborates%252Bwith%252BFOXA1%252Bto%252BEstablish%252Ba%252BTargetable%252BPathway%252Bin%252BEndocrine%252BTherapy-Resistant%252BBreast%252BCancer%26aulast%3DCocce%26aufirst%3DKimberly%2BJ.%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D889%26epage%3D903.e10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Yun  Guo</span>, <span class="hlFld-ContribAuthor ">Shang-Ming-Zhu  Zeng</span>, <span class="hlFld-ContribAuthor ">Girdhar Singh  Deora</span>, <span class="hlFld-ContribAuthor ">Qing-Shan  Li</span>, <span class="hlFld-ContribAuthor ">Ban-Feng  Ruan</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (15)
                                     , 1318-1337. <a href="https://doi.org/10.2174/1568026619666190619142504" title="DOI URL">https://doi.org/10.2174/1568026619666190619142504</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190619142504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190619142504%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DEstrogen%252BReceptor%252B%2525CE%2525B1%252B%252528ER%2525CE%2525B1%252529-targeting%252BCompounds%252Band%252BDerivatives%25253A%252BRecent%252BAdvances%252Bin%252BStructural%252BModification%252Band%252BBioactivity%26aulast%3DGuo%26aufirst%3DWei-Yun%26date%3D2019%26volume%3D19%26issue%3D15%26spage%3D1318%26epage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiminori  Ohta</span>, <span class="hlFld-ContribAuthor ">Takumi  Ogawa</span>, <span class="hlFld-ContribAuthor ">Koichi  Kato</span>, <span class="hlFld-ContribAuthor ">Akifumi  Oda</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Endo</span>. </span><span class="cited-content_cbyCitation_article-title">ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2290-2293. <a href="https://doi.org/10.1016/j.bmcl.2019.06.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DER%252Bsubtype%252Bselectivity%252Bof%252Bm-carborane-containing%252Bphenols%25253A%252BC-alkyl%252Bgroups%252Bon%252Bthe%252Bm-carborane%252Bcage%252Benhance%252BER%2525CE%2525B1%252Bselectivity%26aulast%3DOhta%26aufirst%3DKiminori%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2290%26epage%3D2293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Alexander R.  Nödling</span>, <span class="hlFld-ContribAuthor ">Luke A.  Spear</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Williams</span>, <span class="hlFld-ContribAuthor ">Louis Y.P.  Luk</span>, <span class="hlFld-ContribAuthor ">Yu-Hsuan  Tsai</span>. </span><span class="cited-content_cbyCitation_article-title">Using genetically incorporated unnatural amino acids to control protein functions in mammalian cells. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2019,</strong> <em>63 </em>
                                    (2)
                                     , 237-266. <a href="https://doi.org/10.1042/EBC20180042" title="DOI URL">https://doi.org/10.1042/EBC20180042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20180042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20180042%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DUsing%252Bgenetically%252Bincorporated%252Bunnatural%252Bamino%252Bacids%252Bto%252Bcontrol%252Bprotein%252Bfunctions%252Bin%252Bmammalian%252Bcells%26aulast%3DSzczelkun%26aufirst%3DMark%26date%3D2019%26date%3D2019%26volume%3D63%26issue%3D2%26spage%3D237%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Li</span>, <span class="hlFld-ContribAuthor ">Silong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Yuan  Xiao</span>, <span class="hlFld-ContribAuthor ">Jian  Huang</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Shengtang  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>172 </em>, 48-61. <a href="https://doi.org/10.1016/j.ejmech.2019.03.058" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.058%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252Bthe%252BPROTAC%252Bdegron%252Bcandidates%25253A%252BOBHSA%252Bwith%252Bdifferent%252Bside%252Bchains%252Bas%252Bnovel%252Bselective%252Bestrogen%252Breceptor%252Bdegraders%252B%252528SERDs%252529%26aulast%3DLi%26aufirst%3DYuanyuan%26date%3D2019%26volume%3D172%26spage%3D48%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shun  Nanjyo</span>, <span class="hlFld-ContribAuthor ">Kenji  Ohgane</span>, <span class="hlFld-ContribAuthor ">Hiromasa  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Makoto  Makishima</span>, <span class="hlFld-ContribAuthor ">Yuichi  Hashimoto</span>, <span class="hlFld-ContribAuthor ">Tomomi  Noguchi-Yachide</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (10)
                                     , 1952-1961. <a href="https://doi.org/10.1016/j.bmc.2019.03.042" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.042%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bstudy%252Bof%252Bestrogen%252Breceptor%252Bdown-regulators%252Bwith%252Ba%252Bdiphenylmethane%252Bskeleton%26aulast%3DNanjyo%26aufirst%3DShun%26date%3D2019%26volume%3D27%26issue%3D10%26spage%3D1952%26epage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo  Spinello</span>, <span class="hlFld-ContribAuthor ">Silvia  Martini</span>, <span class="hlFld-ContribAuthor ">Federico  Berti</span>, <span class="hlFld-ContribAuthor ">Marzia  Pennati</span>, <span class="hlFld-ContribAuthor ">Matic  Pavlin</span>, <span class="hlFld-ContribAuthor ">Jacopo  Sgrignani</span>, <span class="hlFld-ContribAuthor ">Giovanni  Grazioso</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>, <span class="hlFld-ContribAuthor ">Nadia  Zaffaroni</span>, <span class="hlFld-ContribAuthor ">Alessandra  Magistrato</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>168 </em>, 253-262. <a href="https://doi.org/10.1016/j.ejmech.2019.02.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Baromatase%252Benzyme%25253A%252BAn%2525C2%2525A0unprecedented%252Btherapeutic%252Bstrategy%252Bto%252Bfight%252Bbreast%252Bcancer%26aulast%3DSpinello%26aufirst%3DAngelo%26date%3D2019%26volume%3D168%26spage%3D253%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Birong  Zhang</span>, <span class="hlFld-ContribAuthor ">James R.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Robert A.  Blake</span>, <span class="hlFld-ContribAuthor ">Jae H.  Chang</span>, <span class="hlFld-ContribAuthor ">Steven  Hartman</span>, <span class="hlFld-ContribAuthor ">Ellen Rei  Ingalla</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Vidhi  Mody</span>, <span class="hlFld-ContribAuthor ">Michelle  Nannini</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Yingqing  Ran</span>, <span class="hlFld-ContribAuthor ">Amy  Sambrone</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Maia  Vinogradova</span>, <span class="hlFld-ContribAuthor ">Yu  Zhong</span>, <span class="hlFld-ContribAuthor ">Jerome C.  Nwachukwu</span>, <span class="hlFld-ContribAuthor ">Kendall W.  Nettles</span>, <span class="hlFld-ContribAuthor ">Tommy  Lai</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zheng</span>, <span class="hlFld-ContribAuthor ">Hai  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaojing  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected equivalent potency of a constrained chromene enantiomeric pair rationalized by co-crystal structures in complex with estrogen receptor alpha. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (7)
                                     , 905-911. <a href="https://doi.org/10.1016/j.bmcl.2019.01.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.01.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.01.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.01.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DUnexpected%252Bequivalent%252Bpotency%252Bof%252Ba%252Bconstrained%252Bchromene%252Benantiomeric%252Bpair%252Brationalized%252Bby%252Bco-crystal%252Bstructures%252Bin%252Bcomplex%252Bwith%252Bestrogen%252Breceptor%252Balpha%26aulast%3DZhang%26aufirst%3DBirong%26date%3D2019%26volume%3D29%26issue%3D7%26spage%3D905%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatiana  Traboulsi</span>, <span class="hlFld-ContribAuthor ">Mohamed  El Ezzy</span>, <span class="hlFld-ContribAuthor ">Vanessa  Dumeaux</span>, <span class="hlFld-ContribAuthor ">Eric  Audemard</span>, <span class="hlFld-ContribAuthor ">Sylvie  Mader</span>. </span><span class="cited-content_cbyCitation_article-title">Role of SUMOylation in differential ERα transcriptional repression by tamoxifen and fulvestrant in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2019,</strong> <em>38 </em>
                                    (7)
                                     , 1019-1037. <a href="https://doi.org/10.1038/s41388-018-0468-9" title="DOI URL">https://doi.org/10.1038/s41388-018-0468-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-018-0468-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-018-0468-9%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DRole%252Bof%252BSUMOylation%252Bin%252Bdifferential%252BER%2525CE%2525B1%252Btranscriptional%252Brepression%252Bby%252Btamoxifen%252Band%252Bfulvestrant%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DTraboulsi%26aufirst%3DTatiana%26date%3D2019%26date%3D2018%26volume%3D38%26issue%3D7%26spage%3D1019%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian Mitchelle S.  de Vera</span>, <span class="hlFld-ContribAuthor ">Udayanga  S. Wanninayake</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Burris</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Insights into Estrogen Receptors and Antiestrogen Therapies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 241-263. <a href="https://doi.org/10.1007/978-3-319-99350-8_10" title="DOI URL">https://doi.org/10.1007/978-3-319-99350-8_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-99350-8_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-99350-8_10%26sid%3Dliteratum%253Aachs%26atitle%3DStructural%252BInsights%252Binto%252BEstrogen%252BReceptors%252Band%252BAntiestrogen%252BTherapies%26aulast%3Dde%2BVera%26aufirst%3DIan%2BMitchelle%2BS.%26date%3D2019%26date%3D2018%26spage%3D241%26epage%3D263%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEstrogen%252BReceptor%252Band%252BBreast%252BCancer%26aulast%3DZhang%26aufirst%3DXiaoting%26date%3D2019%26volume%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyong  Fu</span>, <span class="hlFld-ContribAuthor ">Carmine  De Angelis</span>, <span class="hlFld-ContribAuthor ">Jamunarani  Veeraraghavan</span>, <span class="hlFld-ContribAuthor ">C. Kent  Osborne</span>, <span class="hlFld-ContribAuthor ">Rachel  Schiff</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanisms of Endocrine Resistance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 265-307. <a href="https://doi.org/10.1007/978-3-319-99350-8_11" title="DOI URL">https://doi.org/10.1007/978-3-319-99350-8_11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-99350-8_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-99350-8_11%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BMechanisms%252Bof%252BEndocrine%252BResistance%26aulast%3DFu%26aufirst%3DXiaoyong%26date%3D2019%26date%3D2018%26spage%3D265%26epage%3D307%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEstrogen%252BReceptor%252Band%252BBreast%252BCancer%26aulast%3DZhang%26aufirst%3DXiaoting%26date%3D2019%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Busonero</span>, <span class="hlFld-ContribAuthor ">Stefano  Leone</span>, <span class="hlFld-ContribAuthor ">Stefania  Bartoloni</span>, <span class="hlFld-ContribAuthor ">Filippo  Acconcia</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to degrade estrogen receptor α in primary and ESR1 mutant-expressing metastatic breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2019,</strong> <em>480 </em>, 107-121. <a href="https://doi.org/10.1016/j.mce.2018.10.020" title="DOI URL">https://doi.org/10.1016/j.mce.2018.10.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2018.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2018.10.020%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DStrategies%252Bto%252Bdegrade%252Bestrogen%252Breceptor%252B%2525CE%2525B1%252Bin%252Bprimary%252Band%252BESR1%252Bmutant-expressing%252Bmetastatic%252Bbreast%252Bcancer%26aulast%3DBusonero%26aufirst%3DClaudia%26date%3D2019%26volume%3D480%26spage%3D107%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu. V.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">I. S.  Levina</span>, <span class="hlFld-ContribAuthor ">A. S.  Shashkov</span>, <span class="hlFld-ContribAuthor ">I. V.  Zavarzin</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 3-methoxy-19-norpregna-1,3,5(10),16-tetraen-20-one. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2018,</strong> <em>67 </em>
                                    (11)
                                     , 2112-2120. <a href="https://doi.org/10.1007/s11172-018-2337-7" title="DOI URL">https://doi.org/10.1007/s11172-018-2337-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-018-2337-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-018-2337-7%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B3-methoxy-19-norpregna-1%25252C3%25252C5%25252810%252529%25252C16-tetraen-20-one%26aulast%3DKuznetsov%26aufirst%3DYu.%2BV.%26date%3D2018%26date%3D2018%26volume%3D67%26issue%3D11%26spage%3D2112%26epage%3D2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Yang</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Meng</span>, <span class="hlFld-ContribAuthor ">Zhiye  Hu</span>, <span class="hlFld-ContribAuthor ">Wentao  Ning</span>, <span class="hlFld-ContribAuthor ">Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Chune  Dong</span>, <span class="hlFld-ContribAuthor ">Hai-Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen receptor sensing in living cells by a high affinity turn-on fluorescent probe. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2018,</strong> <em>272 </em>, 589-597. <a href="https://doi.org/10.1016/j.snb.2018.06.022" title="DOI URL">https://doi.org/10.1016/j.snb.2018.06.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2018.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2018.06.022%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DEstrogen%252Breceptor%252Bsensing%252Bin%252Bliving%252Bcells%252Bby%252Ba%252Bhigh%252Baffinity%252Bturn-on%252Bfluorescent%252Bprobe%26aulast%3DYang%26aufirst%3DLu%26date%3D2018%26volume%3D272%26spage%3D589%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elgene  Lim</span>, <span class="hlFld-ContribAuthor ">Jane  Beith</span>, <span class="hlFld-ContribAuthor ">Frances  Boyle</span>, <span class="hlFld-ContribAuthor ">Richard  de Boer</span>, <span class="hlFld-ContribAuthor ">Rina  Hui</span>, <span class="hlFld-ContribAuthor ">Nicole  McCarthy</span>, <span class="hlFld-ContribAuthor ">Andrew  Redfern</span>, <span class="hlFld-ContribAuthor ">Theresa  Wade</span>, <span class="hlFld-ContribAuthor ">Natasha  Woodward</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Asia-Pacific Journal of Clinical Oncology</span><span> <strong>2018,</strong> <em>14 </em>, 12-21. <a href="https://doi.org/10.1111/ajco.13065" title="DOI URL">https://doi.org/10.1111/ajco.13065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ajco.13065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fajco.13065%26sid%3Dliteratum%253Aachs%26jtitle%3DAsia-Pacific%2520Journal%2520of%2520Clinical%2520Oncology%26atitle%3DEmerging%252Bdata%252Band%252Bfuture%252Bdirections%252Bfor%252BCDK4%25252F6%252Binhibitor%252Btreatment%252Bof%252Bpatients%252Bwith%252Bhormone%252Breceptor%252Bpositive%252BHER2-non-amplified%252Bmetastatic%252Bbreast%252Bcancer%26aulast%3DLim%26aufirst%3DElgene%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D12%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yury V.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Inna S.  Levina</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Scherbakov</span>, <span class="hlFld-ContribAuthor ">Olga E.  Andreeva</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Dmitrenok</span>, <span class="hlFld-ContribAuthor ">Oleg R.  Malyshev</span>, <span class="hlFld-ContribAuthor ">Igor V.  Zavarzin</span>. </span><span class="cited-content_cbyCitation_article-title">3,20-Dihydroxy-13α-19-norpregna-1,3,5(10)-trienes. Synthesis, structures, and cytotoxic, estrogenic, and antiestrogenic effects. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2018,</strong> <em>137 </em>, 1-13. <a href="https://doi.org/10.1016/j.steroids.2018.07.007" title="DOI URL">https://doi.org/10.1016/j.steroids.2018.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2018.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2018.07.007%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3D3%25252C20-Dihydroxy-13%2525CE%2525B1-19-norpregna-1%25252C3%25252C5%25252810%252529-trienes.%252BSynthesis%25252C%252Bstructures%25252C%252Band%252Bcytotoxic%25252C%252Bestrogenic%25252C%252Band%252Bantiestrogenic%252Beffects%26aulast%3DKuznetsov%26aufirst%3DYury%2BV.%26date%3D2018%26volume%3D137%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony F.  Palermo</span>, <span class="hlFld-ContribAuthor ">Marine  Diennet</span>, <span class="hlFld-ContribAuthor ">Mohamed  El Ezzy</span>, <span class="hlFld-ContribAuthor ">Benjamin M.  Williams</span>, <span class="hlFld-ContribAuthor ">David  Cotnoir-White</span>, <span class="hlFld-ContribAuthor ">Sylvie  Mader</span>, <span class="hlFld-ContribAuthor ">James L.  Gleason</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporation of histone deacetylase inhibitory activity into the core of tamoxifen – A new hybrid design paradigm. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (15)
                                     , 4428-4440. <a href="https://doi.org/10.1016/j.bmc.2018.07.026" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.07.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.07.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIncorporation%252Bof%252Bhistone%252Bdeacetylase%252Binhibitory%252Bactivity%252Binto%252Bthe%252Bcore%252Bof%252Btamoxifen%252B%2525E2%252580%252593%252BA%252Bnew%252Bhybrid%252Bdesign%252Bparadigm%26aulast%3DPalermo%26aufirst%3DAnthony%2BF.%26date%3D2018%26volume%3D26%26issue%3D15%26spage%3D4428%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erika P.  Hamilton</span>, <span class="hlFld-ContribAuthor ">Manish R.  Patel</span>, <span class="hlFld-ContribAuthor ">Anne C.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Richard D.  Baird</span>, <span class="hlFld-ContribAuthor ">Komal  Jhaveri</span>, <span class="hlFld-ContribAuthor ">Matthias  Hoch</span>, <span class="hlFld-ContribAuthor ">Teresa  Klinowska</span>, <span class="hlFld-ContribAuthor ">Justin P.O.  Lindemann</span>, <span class="hlFld-ContribAuthor ">Shethah R.  Morgan</span>, <span class="hlFld-ContribAuthor ">Gaia  Schiavon</span>, <span class="hlFld-ContribAuthor ">Hazel M.  Weir</span>, <span class="hlFld-ContribAuthor ">Seock-Ah  Im</span>. </span><span class="cited-content_cbyCitation_article-title">A First-in-Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for ER
              +
              /HER2
              −
              Advanced Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2018,</strong> <em>24 </em>
                                    (15)
                                     , 3510-3518. <a href="https://doi.org/10.1158/1078-0432.CCR-17-3102" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-17-3102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-17-3102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-17-3102%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DA%252BFirst-in-Human%252BStudy%252Bof%252Bthe%252BNew%252BOral%252BSelective%252BEstrogen%252BReceptor%252BDegrader%252BAZD9496%252Bfor%252BER%252B%25252B%252B%25252FHER2%252B%2525E2%252588%252592%252BAdvanced%252BBreast%252BCancer%26aulast%3DHamilton%26aufirst%3DErika%2BP.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D15%26spage%3D3510%26epage%3D3518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guorong  Lu</span>, <span class="hlFld-ContribAuthor ">Mary R.  Tandang-Silvas</span>, <span class="hlFld-ContribAuthor ">Alyssa C.  Dawson</span>, <span class="hlFld-ContribAuthor ">Trenton J.  Dawson</span>, <span class="hlFld-ContribAuthor ">Jay C.  Groppe</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-selective allosteric destabilization of activin receptor-like kinases: A potential therapeutic avenue for prophylaxis of heterotopic ossification. </span><span class="cited-content_cbyCitation_journal-name">Bone</span><span> <strong>2018,</strong> <em>112 </em>, 71-89. <a href="https://doi.org/10.1016/j.bone.2018.03.027" title="DOI URL">https://doi.org/10.1016/j.bone.2018.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bone.2018.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bone.2018.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBone%26atitle%3DHypoxia-selective%252Ballosteric%252Bdestabilization%252Bof%252Bactivin%252Breceptor-like%252Bkinases%25253A%252BA%252Bpotential%252Btherapeutic%252Bavenue%252Bfor%252Bprophylaxis%252Bof%252Bheterotopic%252Bossification%26aulast%3DLu%26aufirst%3DGuorong%26date%3D2018%26volume%3D112%26spage%3D71%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zunyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yewei  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zheng</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenhai  Huang</span>, <span class="hlFld-ContribAuthor ">Dongmei  Yan</span>, <span class="hlFld-ContribAuthor ">Wenjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoju  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengrong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacy and Pharmacology</span><span> <strong>2018,</strong> <em>70 </em>
                                    (7)
                                     , 910-918. <a href="https://doi.org/10.1111/jphp.12908" title="DOI URL">https://doi.org/10.1111/jphp.12908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jphp.12908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjphp.12908%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacy%2520and%2520Pharmacology%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bcyclopropyl%252Bderivatives%252Bas%252Bsubtype-selective%252Bligands%252Bfor%252Bestrogen%252Breceptor%26aulast%3DWang%26aufirst%3DZunyuan%26date%3D2018%26date%3D2018%26volume%3D70%26issue%3D7%26spage%3D910%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hitisha K.  Patel</span>, <span class="hlFld-ContribAuthor ">Teeru  Bihani</span>. </span><span class="cited-content_cbyCitation_article-title">Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>186 </em>, 1-24. <a href="https://doi.org/10.1016/j.pharmthera.2017.12.012" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2017.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2017.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2017.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DSelective%252Bestrogen%252Breceptor%252Bmodulators%252B%252528SERMs%252529%252Band%252Bselective%252Bestrogen%252Breceptor%252Bdegraders%252B%252528SERDs%252529%252Bin%252Bcancer%252Btreatment%26aulast%3DPatel%26aufirst%3DHitisha%2BK.%26date%3D2018%26volume%3D186%26spage%3D1%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Zheng</span>, <span class="hlFld-ContribAuthor ">Lihua  Qiu</span>, <span class="hlFld-ContribAuthor ">Kemiao  Hong</span>, <span class="hlFld-ContribAuthor ">Shanliang  Dong</span>, <span class="hlFld-ContribAuthor ">Xinfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Copper- or Thermally Induced Divergent Outcomes: Synthesis of 4-Methyl 2
              H
              -Chromenes and Spiro-4
              H
              -Pyrazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (26)
                                     , 6705-6711. <a href="https://doi.org/10.1002/chem.201704759" title="DOI URL">https://doi.org/10.1002/chem.201704759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201704759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201704759%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DCopper-%252Bor%252BThermally%252BInduced%252BDivergent%252BOutcomes%25253A%252BSynthesis%252Bof%252B4-Methyl%252B2%252BH%252B-Chromenes%252Band%252BSpiro-4%252BH%252B-Pyrazoles%26aulast%3DZheng%26aufirst%3DYang%26date%3D2018%26date%3D2017%26volume%3D24%26issue%3D26%26spage%3D6705%26epage%3D6711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ines B.  Menjak</span>, <span class="hlFld-ContribAuthor ">Katarzyna J.  Jerzak</span>, <span class="hlFld-ContribAuthor ">Danielle N.  Desautels</span>, <span class="hlFld-ContribAuthor ">Kathleen I.  Pritchard</span>. </span><span class="cited-content_cbyCitation_article-title">An update on treatment for post-menopausal metastatic breast cancer in elderly patients. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2018,</strong> <em>19 </em>
                                    (6)
                                     , 597-609. <a href="https://doi.org/10.1080/14656566.2018.1454431" title="DOI URL">https://doi.org/10.1080/14656566.2018.1454431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2018.1454431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2018.1454431%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DAn%252Bupdate%252Bon%252Btreatment%252Bfor%252Bpost-menopausal%252Bmetastatic%252Bbreast%252Bcancer%252Bin%252Belderly%252Bpatients%26aulast%3DMenjak%26aufirst%3DInes%2BB.%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D6%26spage%3D597%26epage%3D609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Snehal S.  Ashtekar</span>, <span class="hlFld-ContribAuthor ">Neela M.  Bhatia</span>, <span class="hlFld-ContribAuthor ">Manish S.  Bhatia</span>. </span><span class="cited-content_cbyCitation_article-title">Development of leads targeting ER-α in breast cancer: An in silico exploration from natural domain. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2018,</strong> <em>131 </em>, 14-22. <a href="https://doi.org/10.1016/j.steroids.2017.12.016" title="DOI URL">https://doi.org/10.1016/j.steroids.2017.12.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2017.12.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2017.12.016%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DDevelopment%252Bof%252Bleads%252Btargeting%252BER-%2525CE%2525B1%252Bin%252Bbreast%252Bcancer%25253A%252BAn%252Bin%252Bsilico%252Bexploration%252Bfrom%252Bnatural%252Bdomain%26aulast%3DAshtekar%26aufirst%3DSnehal%2BS.%26date%3D2018%26volume%3D131%26spage%3D14%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald P.  McDonnell</span>, <span class="hlFld-ContribAuthor ">John D.  Norris</span>, <span class="hlFld-ContribAuthor ">Ching-yi  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Neomorphic ERα Mutations Drive Progression in Breast Cancer and Present a Challenge for New Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell</span><span> <strong>2018,</strong> <em>33 </em>
                                    (2)
                                     , 153-155. <a href="https://doi.org/10.1016/j.ccell.2018.01.014" title="DOI URL">https://doi.org/10.1016/j.ccell.2018.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccell.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccell.2018.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%26atitle%3DNeomorphic%252BER%2525CE%2525B1%252BMutations%252BDrive%252BProgression%252Bin%252BBreast%252BCancer%252Band%252BPresent%252Ba%252BChallenge%252Bfor%252BNew%252BDrug%252BDiscovery%26aulast%3DMcDonnell%26aufirst%3DDonald%2BP.%26date%3D2018%26volume%3D33%26issue%3D2%26spage%3D153%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Meyer</span>, <span class="hlFld-ContribAuthor ">Matthias  Barton</span>. </span><span class="cited-content_cbyCitation_article-title">GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseases. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2018,</strong> <em>176 </em>, 82-87. <a href="https://doi.org/10.1016/j.jsbmb.2017.03.019" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2017.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2017.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2017.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DGPER%252Bblockers%252Bas%252BNox%252Bdownregulators%25253A%252BA%252Bnew%252Bdrug%252Bclass%252Bto%252Btarget%252Bchronic%252Bnon-communicable%252Bdiseases%26aulast%3DMeyer%26aufirst%3DMatthias%2BR.%26date%3D2018%26volume%3D176%26spage%3D82%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shubhandra  Tripathi</span>, <span class="hlFld-ContribAuthor ">Gaurava  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ashok  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Design of Multi-Target Drugs Against Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 443-458. <a href="https://doi.org/10.1007/7653_2018_24" title="DOI URL">https://doi.org/10.1007/7653_2018_24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7653_2018_24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7653_2018_24%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BDesign%252Bof%252BMulti-Target%252BDrugs%252BAgainst%252BBreast%252BCancer%26aulast%3DTripathi%26aufirst%3DShubhandra%26date%3D2018%26date%3D2018%26spage%3D443%26epage%3D458%26pub%3DSpringer%2520New%2520York%26atitle%3DMulti-Target%252BDrug%252BDesign%252BUsing%252BChem-Bioinformatic%252BApproaches%26aulast%3DRoy%26aufirst%3DKunal%26date%3D2019%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balkees  Abderrahman</span>, <span class="hlFld-ContribAuthor ">V. Craig  Jordan</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid Receptors in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 272-281.e2. <a href="https://doi.org/10.1016/B978-0-323-35955-9.00021-0" title="DOI URL">https://doi.org/10.1016/B978-0-323-35955-9.00021-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-35955-9.00021-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-35955-9.00021-0%26sid%3Dliteratum%253Aachs%26atitle%3DSteroid%252BReceptors%252Bin%252BBreast%252BCancer%26aulast%3DAbderrahman%26aufirst%3DBalkees%26date%3D2018%26spage%3D272%26epage%3D281.e2%26pub%3DElsevier%26atitle%3DThe%252BBreast%26date%3D2018%26volume%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yury V.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Inna S.  Levina</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Scherbakov</span>, <span class="hlFld-ContribAuthor ">Olga E.  Andreeva</span>, <span class="hlFld-ContribAuthor ">Irina V.  Fedyushkina</span>, <span class="hlFld-ContribAuthor ">Andrey S.  Dmitrenok</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Shashkov</span>, <span class="hlFld-ContribAuthor ">Igor V.  Zavarzin</span>. </span><span class="cited-content_cbyCitation_article-title">New estrogen receptor antagonists. 3,20-Dihydroxy-19-norpregna-1,3,5(10)-trienes: Synthesis, molecular modeling, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 670-682. <a href="https://doi.org/10.1016/j.ejmech.2017.11.042" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.042%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bestrogen%252Breceptor%252Bantagonists.%252B3%25252C20-Dihydroxy-19-norpregna-1%25252C3%25252C5%25252810%252529-trienes%25253A%252BSynthesis%25252C%252Bmolecular%252Bmodeling%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DKuznetsov%26aufirst%3DYury%2BV.%26date%3D2018%26volume%3D143%26spage%3D670%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bianca  Wiedemann</span>, <span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical modulation of transcription factors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (8)
                                     , 1249-1272. <a href="https://doi.org/10.1039/C8MD00273H" title="DOI URL">https://doi.org/10.1039/C8MD00273H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00273H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00273H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DChemical%252Bmodulation%252Bof%252Btranscription%252Bfactors%26aulast%3DWiedemann%26aufirst%3DBianca%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D1249%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, , <span class="hlFld-ContribAuthor ">Honorine  Lebraud</span>, <span class="hlFld-ContribAuthor ">Tom D.  Heightman</span>. </span><span class="cited-content_cbyCitation_article-title">Protein degradation: a validated therapeutic strategy with exciting prospects. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2017,</strong> <em>61 </em>
                                    (5)
                                     , 517-527. <a href="https://doi.org/10.1042/EBC20170030" title="DOI URL">https://doi.org/10.1042/EBC20170030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20170030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20170030%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DProtein%252Bdegradation%25253A%252Ba%252Bvalidated%252Btherapeutic%252Bstrategy%252Bwith%252Bexciting%252Bprospects%26aulast%3Dvan%2BMontfort%26aufirst%3DRob%2BL.M.%26date%3D2017%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3D517%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett  Fleisher</span>, <span class="hlFld-ContribAuthor ">Ashley N.  Brown</span>, <span class="hlFld-ContribAuthor ">Sihem  Ait-Oudhia</span>. </span><span class="cited-content_cbyCitation_article-title">Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2017,</strong> <em>124 </em>, 20-33. <a href="https://doi.org/10.1016/j.phrs.2017.07.015" title="DOI URL">https://doi.org/10.1016/j.phrs.2017.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2017.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2017.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DApplication%252Bof%252Bpharmacometrics%252Band%252Bquantitative%252Bsystems%252Bpharmacology%252Bto%252Bcancer%252Btherapy%25253A%252BThe%252Bexample%252Bof%252Bluminal%252Ba%252Bbreast%252Bcancer%26aulast%3DFleisher%26aufirst%3DBrett%26date%3D2017%26volume%3D124%26spage%3D20%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganesh V  Raj</span>, <span class="hlFld-ContribAuthor ">Gangadhara Reddy  Sareddy</span>, <span class="hlFld-ContribAuthor ">Shihong  Ma</span>, <span class="hlFld-ContribAuthor ">Tae-Kyung  Lee</span>, <span class="hlFld-ContribAuthor ">Suryavathi  Viswanadhapalli</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>, <span class="hlFld-ContribAuthor ">Xihui  Liu</span>, <span class="hlFld-ContribAuthor ">Shino  Murakami</span>, <span class="hlFld-ContribAuthor ">Chien-Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Wan-Ru  Lee</span>, <span class="hlFld-ContribAuthor ">Monica  Mann</span>, <span class="hlFld-ContribAuthor ">Samaya Rajeshwari  Krishnan</span>, <span class="hlFld-ContribAuthor ">Bikash  Manandhar</span>, <span class="hlFld-ContribAuthor ">Vijay K  Gonugunta</span>, <span class="hlFld-ContribAuthor ">Douglas  Strand</span>, <span class="hlFld-ContribAuthor ">Rajeshwar Rao  Tekmal</span>, <span class="hlFld-ContribAuthor ">Jung-Mo  Ahn</span>, <span class="hlFld-ContribAuthor ">Ratna K  Vadlamudi</span>. </span><span class="cited-content_cbyCitation_article-title">Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2017,</strong> <em>6 </em><a href="https://doi.org/10.7554/eLife.26857" title="DOI URL">https://doi.org/10.7554/eLife.26857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.26857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.26857%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DEstrogen%252Breceptor%252Bcoregulator%252Bbinding%252Bmodulators%252B%252528ERXs%252529%252Beffectively%252Btarget%252Bestrogen%252Breceptor%252Bpositive%252Bhuman%252Bbreast%252Bcancers%26aulast%3DRaj%26aufirst%3DGanesh%2BV%26date%3D2017%26date%3D2017%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kanak  Raina</span>, <span class="hlFld-ContribAuthor ">Craig M  Crews</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted protein knockdown using small molecule degraders. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2017,</strong> <em>39 </em>, 46-53. <a href="https://doi.org/10.1016/j.cbpa.2017.05.016" title="DOI URL">https://doi.org/10.1016/j.cbpa.2017.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2017.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DTargeted%252Bprotein%252Bknockdown%252Busing%252Bsmall%252Bmolecule%252Bdegraders%26aulast%3DRaina%26aufirst%3DKanak%26date%3D2017%26volume%3D39%26spage%3D46%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia  Busonero</span>, <span class="hlFld-ContribAuthor ">Stefano  Leone</span>, <span class="hlFld-ContribAuthor ">Filippo  Acconcia</span>. </span><span class="cited-content_cbyCitation_article-title">Emetine induces estrogen receptor alpha degradation and prevents 17β-estradiol-induced breast cancer cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">Cellular Oncology</span><span> <strong>2017,</strong> <em>40 </em>
                                    (3)
                                     , 299-301. <a href="https://doi.org/10.1007/s13402-017-0322-z" title="DOI URL">https://doi.org/10.1007/s13402-017-0322-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13402-017-0322-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13402-017-0322-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Oncology%26atitle%3DEmetine%252Binduces%252Bestrogen%252Breceptor%252Balpha%252Bdegradation%252Band%252Bprevents%252B17%2525CE%2525B2-estradiol-induced%252Bbreast%252Bcancer%252Bcell%252Bproliferation%26aulast%3DBusonero%26aufirst%3DClaudia%26date%3D2017%26date%3D2017%26volume%3D40%26issue%3D3%26spage%3D299%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. L.  Maruthanila</span>, <span class="hlFld-ContribAuthor ">R.  Elancheran</span>, <span class="hlFld-ContribAuthor ">A. B.  Kunnumakkara</span>, <span class="hlFld-ContribAuthor ">S.  Kabilan</span>, <span class="hlFld-ContribAuthor ">Jibon  Kotoky</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of targeted approaches for the treatment of breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer</span><span> <strong>2017,</strong> <em>24 </em>
                                    (2)
                                     , 191-219. <a href="https://doi.org/10.1007/s12282-016-0732-1" title="DOI URL">https://doi.org/10.1007/s12282-016-0732-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12282-016-0732-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12282-016-0732-1%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%26atitle%3DRecent%252Bdevelopment%252Bof%252Btargeted%252Bapproaches%252Bfor%252Bthe%252Btreatment%252Bof%252Bbreast%252Bcancer%26aulast%3DMaruthanila%26aufirst%3DV.%2BL.%26date%3D2017%26date%3D2016%26volume%3D24%26issue%3D2%26spage%3D191%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aabha  Oza</span>, <span class="hlFld-ContribAuthor ">Cynthia X.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights in Estrogen Receptor (ER) Biology and Implications for Treatment. </span><span class="cited-content_cbyCitation_journal-name">Current Breast Cancer Reports</span><span> <strong>2017,</strong> <em>9 </em>
                                    (1)
                                     , 13-25. <a href="https://doi.org/10.1007/s12609-017-0231-1" title="DOI URL">https://doi.org/10.1007/s12609-017-0231-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12609-017-0231-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12609-017-0231-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Breast%2520Cancer%2520Reports%26atitle%3DNew%252BInsights%252Bin%252BEstrogen%252BReceptor%252B%252528ER%252529%252BBiology%252Band%252BImplications%252Bfor%252BTreatment%26aulast%3DOza%26aufirst%3DAabha%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D1%26spage%3D13%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nello  Mainolfi</span>, <span class="hlFld-ContribAuthor ">Tim  Rasmusson</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Protein Degradation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 301-334. <a href="https://doi.org/10.1016/bs.armc.2017.08.005" title="DOI URL">https://doi.org/10.1016/bs.armc.2017.08.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.armc.2017.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.armc.2017.08.005%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BProtein%252BDegradation%26aulast%3DMainolfi%26aufirst%3DNello%26date%3D2017%26spage%3D301%26epage%3D334%26pub%3DElsevier%26atitle%3DPlatform%252BTechnologies%252Bin%252BDrug%252BDiscovery%252Band%252BValidation%26date%3D2017%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kumaraguruparan  Ramasamy</span>, <span class="hlFld-ContribAuthor ">Cathy  Samayoa</span>, <span class="hlFld-ContribAuthor ">Naveen  Krishnegowda</span>, <span class="hlFld-ContribAuthor ">Rajeshwar R.  Tekmal</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Use of Estrogen Receptor β Agonists in Prevention and Treatment of Endocrine Therapy Resistant Breast Cancers: Observations From Preclinical Models. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 177-194. <a href="https://doi.org/10.1016/bs.pmbts.2017.08.002" title="DOI URL">https://doi.org/10.1016/bs.pmbts.2017.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmbts.2017.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmbts.2017.08.002%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BUse%252Bof%252BEstrogen%252BReceptor%252B%2525CE%2525B2%252BAgonists%252Bin%252BPrevention%252Band%252BTreatment%252Bof%252BEndocrine%252BTherapy%252BResistant%252BBreast%252BCancers%25253A%252BObservations%252BFrom%252BPreclinical%252BModels%26aulast%3DRamasamy%26aufirst%3DKumaraguruparan%26date%3D2017%26spage%3D177%26epage%3D194%26pub%3DElsevier%26atitle%3DApproaches%252Bto%252BUnderstanding%252BBreast%252BCancer%26date%3D2017%26volume%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koch  Visser</span>, <span class="hlFld-ContribAuthor ">Oliver  Zierau</span>, <span class="hlFld-ContribAuthor ">Dana  Macejová</span>, <span class="hlFld-ContribAuthor ">Florian  Goerl</span>, <span class="hlFld-ContribAuthor ">Michael  Muders</span>, <span class="hlFld-ContribAuthor ">Gustavo B.  Baretton</span>, <span class="hlFld-ContribAuthor ">Günter  Vollmer</span>, <span class="hlFld-ContribAuthor ">Ann  Louw</span>. </span><span class="cited-content_cbyCitation_article-title">The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesis. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2016,</strong> <em>163 </em>, 129-135. <a href="https://doi.org/10.1016/j.jsbmb.2016.04.019" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2016.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2016.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2016.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DThe%252Bphytoestrogenic%252BCyclopia%252Bextract%25252C%252BSM6Met%25252C%252Bincreases%252Bmedian%252Btumor%252Bfree%252Bsurvival%252Band%252Breduces%252Btumor%252Bmass%252Band%252Bvolume%252Bin%252Bchemically%252Binduced%252Brat%252Bmammary%252Bgland%252Bcarcinogenesis%26aulast%3DVisser%26aufirst%3DKoch%26date%3D2016%26volume%3D163%26spage%3D129%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian M.  Bird</span>, <span class="hlFld-ContribAuthor ">David H.  Abbott</span>. </span><span class="cited-content_cbyCitation_article-title">The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2016,</strong> <em>163 </em>, 136-146. <a href="https://doi.org/10.1016/j.jsbmb.2016.04.021" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2016.04.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2016.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2016.04.021%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DThe%252Bhunt%252Bfor%252Ba%252Bselective%252B17%25252C20%252Blyase%252Binhibitor%25253B%252Blearning%252Blessons%252Bfrom%252Bnature%26aulast%3DBird%26aufirst%3DIan%2BM.%26date%3D2016%26volume%3D163%26spage%3D136%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Mikel  Zarate</span>, <span class="hlFld-ContribAuthor ">Francesca  Ricci</span>, <span class="hlFld-ContribAuthor ">Giovanna  Damia</span>, <span class="hlFld-ContribAuthor ">Stefano  Pieraccini</span>, <span class="hlFld-ContribAuthor ">Federico  Dapiaggi</span>, <span class="hlFld-ContribAuthor ">Maurizio  Sironi</span>, <span class="hlFld-ContribAuthor ">Leonardo  Lo Presti</span>, <span class="hlFld-ContribAuthor ">Aída Nelly  García-Argáez</span>, <span class="hlFld-ContribAuthor ">Lisa  Dalla Via</span>, <span class="hlFld-ContribAuthor ">Daniele  Passarella</span>. </span><span class="cited-content_cbyCitation_article-title">4-(1,2-diarylbut-1-en-1-yl)isobutyranilide derivatives as inhibitors of topoisomerase II. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 79-89. <a href="https://doi.org/10.1016/j.ejmech.2016.03.090" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.090%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-%2525281%25252C2-diarylbut-1-en-1-yl%252529isobutyranilide%252Bderivatives%252Bas%252Binhibitors%252Bof%252Btopoisomerase%252BII%26aulast%3DChristodoulou%26aufirst%3DMichael%2BS.%26date%3D2016%26volume%3D118%26spage%3D79%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Conleth G  Murphy</span>, <span class="hlFld-ContribAuthor ">Maura N  Dickler</span>. </span><span class="cited-content_cbyCitation_article-title">Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Endocrine-Related Cancer</span><span> <strong>2016,</strong> <em>23 </em>
                                    (8)
                                     , R337-R352. <a href="https://doi.org/10.1530/ERC-16-0121" title="DOI URL">https://doi.org/10.1530/ERC-16-0121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1530/ERC-16-0121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1530%2FERC-16-0121%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrine-Related%2520Cancer%26atitle%3DEndocrine%252Bresistance%252Bin%252Bhormone-responsive%252Bbreast%252Bcancer%25253A%252Bmechanisms%252Band%252Btherapeutic%252Bstrategies%26aulast%3DMurphy%26aufirst%3DConleth%2BG%26date%3D2016%26volume%3D23%26issue%3D8%26spage%3DR337%26epage%3DR352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuji  Shoda</span>, <span class="hlFld-ContribAuthor ">Masashi  Kato</span>, <span class="hlFld-ContribAuthor ">Takuma  Fujisato</span>, <span class="hlFld-ContribAuthor ">Takashi  Misawa</span>, <span class="hlFld-ContribAuthor ">Yosuke  Demizu</span>, <span class="hlFld-ContribAuthor ">Hideshi  Inoue</span>, <span class="hlFld-ContribAuthor ">Mikihiko  Naito</span>, <span class="hlFld-ContribAuthor ">Masaaki  Kurihara</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of raloxifene derivatives as a selective estrogen receptor down-regulator. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (13)
                                     , 2914-2919. <a href="https://doi.org/10.1016/j.bmc.2016.04.068" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.068%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Braloxifene%252Bderivatives%252Bas%252Ba%252Bselective%252Bestrogen%252Breceptor%252Bdown-regulator%26aulast%3DShoda%26aufirst%3DTakuji%26date%3D2016%26volume%3D24%26issue%3D13%26spage%3D2914%26epage%3D2919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hassan Mubarak  Ishqi</span>, <span class="hlFld-ContribAuthor ">Sayeed  Ur Rehman</span>, <span class="hlFld-ContribAuthor ">Tarique  Sarwar</span>, <span class="hlFld-ContribAuthor ">Mohammed Amir  Husain</span>, <span class="hlFld-ContribAuthor ">Mohammad  Tabish</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of differentially expressed three novel transcript variants of mouse ARNT gene. </span><span class="cited-content_cbyCitation_journal-name">IUBMB Life</span><span> <strong>2016,</strong> <em>68 </em>
                                    (2)
                                     , 122-135. <a href="https://doi.org/10.1002/iub.1464" title="DOI URL">https://doi.org/10.1002/iub.1464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/iub.1464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fiub.1464%26sid%3Dliteratum%253Aachs%26jtitle%3DIUBMB%2520Life%26atitle%3DIdentification%252Bof%252Bdifferentially%252Bexpressed%252Bthree%252Bnovel%252Btranscript%252Bvariants%252Bof%252Bmouse%252BARNT%252Bgene%26aulast%3DIshqi%26aufirst%3DHassan%2BMubarak%26date%3D2016%26date%3D2015%26volume%3D68%26issue%3D2%26spage%3D122%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Thirunavukarasu</span>, <span class="hlFld-ContribAuthor ">Hua  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamer-Enabled Manipulation of the Hsp70 Chaperone System Suggests a Novel Strategy for Targeted Ubiquitination. </span><span class="cited-content_cbyCitation_journal-name">Nucleic Acid Therapeutics</span><span> <strong>2016,</strong> <em>26 </em>
                                    (1)
                                     , 20-28. <a href="https://doi.org/10.1089/nat.2015.0563" title="DOI URL">https://doi.org/10.1089/nat.2015.0563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/nat.2015.0563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fnat.2015.0563%26sid%3Dliteratum%253Aachs%26jtitle%3DNucleic%2520Acid%2520Therapeutics%26atitle%3DAptamer-Enabled%252BManipulation%252Bof%252Bthe%252BHsp70%252BChaperone%252BSystem%252BSuggests%252Ba%252BNovel%252BStrategy%252Bfor%252BTargeted%252BUbiquitination%26aulast%3DThirunavukarasu%26aufirst%3DDeepak%26date%3D2016%26volume%3D26%26issue%3D1%26spage%3D20%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meghan  Karuturi</span>, <span class="hlFld-ContribAuthor ">Balkees  Abderrahman</span>, <span class="hlFld-ContribAuthor ">Gabriel N  Hortobagyi</span>, <span class="hlFld-ContribAuthor ">V Craig  Jordan</span>. </span><span class="cited-content_cbyCitation_article-title">Oral pure antiestrogens as a solution to acquired drug resistance to aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Breast Cancer Management</span><span> <strong>2015,</strong> <em>4 </em>
                                    (6)
                                     , 275-277. <a href="https://doi.org/10.2217/bmt.15.22" title="DOI URL">https://doi.org/10.2217/bmt.15.22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/bmt.15.22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fbmt.15.22%26sid%3Dliteratum%253Aachs%26jtitle%3DBreast%2520Cancer%2520Management%26atitle%3DOral%252Bpure%252Bantiestrogens%252Bas%252Ba%252Bsolution%252Bto%252Bacquired%252Bdrug%252Bresistance%252Bto%252Baromatase%252Binhibitors%26aulast%3DKaruturi%26aufirst%3DMeghan%26date%3D2015%26volume%3D4%26issue%3D6%26spage%3D275%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/medium/jm-2015-00760e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/large/jm-2015-00760e_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Molecular pharmacology of SERDs in the setting of tamoxifen resistance. Upon binding tamoxifen, ERα undergoes a specific conformational change that enables the presentation of protein–protein interaction surfaces for which in tamoxifen sensitive cells there are no compatible coregulators. Thus, tamoxifen binding commits ER down a “nonproductive” pathway, an activity that manifests as antagonism. It is proposed that chronic administration of tamoxifen, however, results in the selection of a subpopulation of cells that express a compatible coactivator (CoA). In this manner the pharmacology of tamoxifen “switches” from that of an antagonist to an agonist. SERDs, like GDC-0810, have activity in the setting of tamoxifen resistance because they (a) function as high affinity competitive antagonists, (b) induce a conformational change that is incompatible with coregulator interactions, and (c) target the receptor for proteasomal degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-12/acs.jmedchem.5b00760/20150619/images/large/jm-2015-00760e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00760&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i4">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Mayer, E. L.</span><span> </span><span class="NLM_article-title">Targeting breast cancer with CDK inhibitors</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1007%2Fs11912-015-0443-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=25716100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A280%3ADC%252BC2MrptVantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=443&author=E.+L.+Mayer&title=Targeting+breast+cancer+with+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting breast cancer with CDK inhibitors</span></div><div class="casAuthors">Mayer Erica L</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">443</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dysregulation of the cell cycle is a classic hallmark of cancer growth and metastatic potential.  Re-establishing cell cycle control through CDK inhibition has emerged as an attractive option in the development of targeted cancer therapy.  Three oral agents selectively targeting CDK4/6 have been developed: palbociclib, abemaciclib, and LEE011.  Preclinical models show optimal activity in hormone receptor positive breast cancer, which may display biologic features suggesting particular dependence on the CDK4/cyclin D1/Rb interaction.  Palbociclib has been studied in a randomized phase 2 clinical trial in metastatic hormone receptor positive breast cancer in which the combination of palbociclib and endocrine therapy significantly prolonged progression-free survival over endocrine therapy alone.  The toxicity profile of palbociclib and the other CDK 4/6 inhibitors in early phase I and II trials has been predominantly hematologic, characterized by limited neutropenia, as well as variable gastrointestinal toxicity.  Multiple phase II and III studies are ongoing with all three agents, and are designed to explore the role of CDK 4/6 inhibition in metastatic hormone receptor positive breast cancer.  The next wave of studies will examine further clinical and scientific topics, including the role of CDK 4/6 inhibition in the neo/adjuvant setting, the combination of CDK 4/6 inhibitors with other targeted therapies, and the activity of CDK 4/6 inhibitors in the HER2 positive subset of breast cancer, as well as in other cancer subtypes.  Should ongoing study confirm benefits and tolerability of CDK 4/6 inhibition, combination therapy with endocrine agents may become a new standard of care for hormone receptor positive breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRBpxScH0UYfUh5eUSa2oe_fW6udTcc2eaCQHfsDXOmyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrptVantw%253D%253D&md5=01eda5d08847dab9cc5386e44daa00a9</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11912-015-0443-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-015-0443-3%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DE.%2BL.%26atitle%3DTargeting%2520breast%2520cancer%2520with%2520CDK%2520inhibitors%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2015%26volume%3D17%26spage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burris, H. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rugo, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahmoud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gnant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebrun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deleu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukhopadhyay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebwohl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hortobagyi, G. N.</span><span> </span><span class="NLM_article-title">Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1056%2FNEJMoa1109653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=22149876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKqsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=520-529&author=J.+Baselgaauthor=M.+Camponeauthor=M.+Piccartauthor=H.+A.+Burrisauthor=H.+S.+Rugoauthor=T.+Sahmoudauthor=S.+Noguchiauthor=M.+Gnantauthor=K.+I.+Pritchardauthor=F.+Lebrunauthor=J.+T.+Beckauthor=Y.+Itoauthor=D.+Yardleyauthor=I.+Deleuauthor=A.+Perezauthor=T.+Bachelotauthor=L.+Vittoriauthor=Z.+Xuauthor=P.+Mukhopadhyayauthor=D.+Lebwohlauthor=G.+N.+Hortobagyi&title=Everolimus+in+postmenopausal+hormone-receptor-positive+advanced+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer</span></div><div class="casAuthors">Baselga, Jose; Campone, Mario; Piccart, Martine; Burris, Howard A., III; Rugo, Hope S.; Sahmoud, Tarek; Noguchi, Shinzaburo; Gnant, Michael; Pritchard, Kathleen I.; Lebrun, Fabienne; Beck, Thaddeus; Ito, Yoshinori; Yardley, Denise; Deleu, Ines; Perez, Alejandra; Bachelot, Thomas; Vittori, Luc; Xu, Zhiying; Mukhopadhyay, Pabak; Lebwohl, David; Hortobagyi, Gabriel N.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-529</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Resistance to endocrine therapy in breast cancer is assocd. with activation of the mammalian target of rapamycin (mTOR) intracellular signaling pathway.  In early studies, the mTOR inhibitor everolimus added to endocrine therapy showed antitumor activity.  METHODS In this phase 3, randomized trial, we compared everolimus and exemestane vs. exemestane and placebo (randomly assigned in a 2:1 ratio) in 724 patients with hormone-receptor-pos. advanced breast cancer who had recurrence or progression while receiving previous therapy with a nonsteroidal aromatase inhibitor in. the adjuvant setting or to treat advanced disease (or both).  The primary end point was progression-free survival.  Secondary end points included survival, response rate, and safety.  A preplanned interim anal. was performed by an independent data and safety monitoring committee after 359 progression-free survival events were obsd.  RESULTS Baseline characteristics were well balanced between the two study groups.  The median age was 62 years, 56% had visceral involvement, and 84% had hormone-sensitive disease.  Previous therapy included letrozole or anastrozole (1000/%), tamoxifen (48%), fulvestrant (16%), and chemotherapy (68%).  The most common grade 3 or 4 adverse events were stomatitis (8% in the everolimus-plus-exemestane group vs. 1% in the placebo-plus-exemestane group), anemia (6% vs. <1%), dyspnea (4% vs. 1%), hyperglycemia (4% vs. <1%), fatigue (4% vs. 1%), and pneumonitis (3% vs. 0%).  At the interim anal., median progression-free survival was 6.9 mo with everolimus plus exemestane and 2.8 mo with placebo plus exemestane, according to assessments by local investigators (hazard ratio for progression or death, 0.43; 95% confidence interval [CI], 0.35 to 0.54; P < 0.001).  Median progression-free survival was 10.6 mo and 4.1 mo, resp., according to central assessment (hazard ratio, 0.36; 95% CI, 0.27 to 0.47; P < 0.001).  CONCLUSIONS Everolimus combined with an aromatase inhibitor improved progression-free survival in patients with hormone-receptor-pos. advanced breast cancer previously treated with nonsteroidal aromatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW3J0igrmzy7Vg90H21EOLACvtfcHk0lgRY_Ft1zHpwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKqsrs%253D&md5=30e70c0893b458334ec553f43737e4f2</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1109653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1109653%26sid%3Dliteratum%253Aachs%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DCampone%26aufirst%3DM.%26aulast%3DPiccart%26aufirst%3DM.%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DRugo%26aufirst%3DH.%2BS.%26aulast%3DSahmoud%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DS.%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DPritchard%26aufirst%3DK.%2BI.%26aulast%3DLebrun%26aufirst%3DF.%26aulast%3DBeck%26aufirst%3DJ.%2BT.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DYardley%26aufirst%3DD.%26aulast%3DDeleu%26aufirst%3DI.%26aulast%3DPerez%26aufirst%3DA.%26aulast%3DBachelot%26aufirst%3DT.%26aulast%3DVittori%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMukhopadhyay%26aufirst%3DP.%26aulast%3DLebwohl%26aufirst%3DD.%26aulast%3DHortobagyi%26aufirst%3DG.%2BN.%26atitle%3DEverolimus%2520in%2520postmenopausal%2520hormone-receptor-positive%2520advanced%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D520%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Johnston, S. R.</span><span> </span><span class="NLM_article-title">Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">4376s</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387s</span><div class="note"><p class="first last">(discussion 4411s–4412s)</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=11916228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD38Xltlyjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=4376s-4387s&author=S.+R.+Johnston&title=Endocrine+manipulation+in+advanced+breast+cancer%3A+recent+advances+with+SERM+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrine manipulation in advanced breast cancer: Recent advances with SERM therapies</span></div><div class="casAuthors">Johnston, Stephen R. D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12, Suppl.</span>),
    <span class="NLM_cas:pages">4376S-4387S</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Tamoxifen is one of the most effective treatments for breast cancer through its ability to antagonize estrogen-dependent growth by binding estrogen receptors (ERs) and inhibiting breast epithelial cell proliferation.  However, tamoxifen has estrogenic agonist effects in other tissues such as bone and endometrium because of liganded ER-activating target genes in these different cell types.  Several novel antiestrogen compds. have been developed that are also selective ER modulators (SERMs) but that have a reduced agonist profile on breast and gynecol. tissues.  These SERMs offer the potential for enhanced efficacy and reduced toxicity compared with tamoxifen.  In advanced breast cancer clin. data exist for three first-generation SERMs (toremifene, droloxifene, idoxifene), which are related to the triphenylethylene structure of tamoxifen.  In Phase II trials in a total of 263 patients resistant to tamoxifen, the median objective response rate to these SERMs way only 5% (range, 0-15%), with stable disease for 6 mo in an addnl. 18% (range, 9-23%).  As first-line therapy for advanced breast cancer, the median response rate was 31% (range, 20-68%) with a median time to progression of 7 mo.  Randomized Phase III trials for toremifene and idoxifene in more than 1500 patients showed no significant difference compared with tamoxifen.  Fewer clin. data exist for the structurally distinct second- and third-generation SERMs (raloxifene, arzoxifene, EM-800, and ERA-923), although a similarly low median response rate of 6% (range, 0-14%) was seen in Phase II trials in tamoxifen-resistant patients.  It remains unclear whether any clin. advantage exists for second- and third-generation SERMs over tamoxifen as first-line therapy.  With the emergence of potent aromatase inhibitors (AIs) that are superior to tamoxifen, the clin. questions in advanced disease have shifted to which antiestrogen (including SERMs) may be effective following failure of AIs, and whether any merit exists for combined AI/SERM therapy.  The main advantage for SERM therapy probably remains in early stage-disease (adjuvant therapy or prevention), in which the estrogenic effects on bone and reduced gynecol. side effects may prove more beneficial than either tamoxifen or AI.  The issue is whether the current clin. data for SERMs in advanced breast cancer are sufficiently strong to encourage that further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpF6hXEfwfYLVg90H21EOLACvtfcHk0liNNNQ1Eozp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xltlyjug%253D%253D&md5=e8213625c91f3c25c9fbdcccab013aa2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DS.%2BR.%26atitle%3DEndocrine%2520manipulation%2520in%2520advanced%2520breast%2520cancer%253A%2520recent%2520advances%2520with%2520SERM%2520therapies%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D4376s%26epage%3D4387s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Deshmane, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melemed, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzdar, A. U.</span><span> </span><span class="NLM_article-title">Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4967</span><span class="NLM_x">–</span> <span class="NLM_lpage">4973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1200%2FJCO.2006.09.5992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=17971595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOhtbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=4967-4973&author=V.+Deshmaneauthor=S.+Krishnamurthyauthor=A.+S.+Melemedauthor=P.+Petersonauthor=A.+U.+Buzdar&title=Phase+III+double-blind+trial+of+arzoxifene+compared+with+tamoxifen+for+locally+advanced+or+metastatic+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer</span></div><div class="casAuthors">Deshmane, VijayaLaxmi; Krishnamurthy, S.; Melemed, Allen S.; Peterson, Patrick; Buzdar, Aman U.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">4967-4973</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: To compare the efficacy of arzoxifene with tamoxifen for the treatment of locally advanced or metastatic breast cancer.  Patients and Methods: Women with estrogen- or progesterone-receptor-pos. breast cancer who had not received prior systemic therapy, or who had relapsed more than 12 mo after stopping adjuvant hormonal therapy, were randomly assigned to receive 20 mg arzoxifene or 20 mg tamoxifen daily.  Each treatment arm was to have 240 patients enrolled.  The primary end point was progression-free survival.  Secondary end points included other measures of tumor response, overall survival, and safety.  Results: Enrollment was stopped when a planned interim anal. of the first 200 patients suggested arzoxifene to be significantly inferior to tamoxifen.  The median progression-free survival for the 352 patients who had been randomly assigned when enrollment was stopped was 4.0 mo (95% CI, 3.4 to 5.6 mo) for the arzoxifene group and 7.5 mo (95% CI, 5.9 to 8.8 mo) for the tamoxifen group.  On-study progression-free survival (P = .011) and time to treatment failure (P = .029) also favored tamoxifen.  Overall tumor response rate and median response duration were comparable between the groups.  Adverse events were similar between the treatments, except for nausea (more frequent with arzoxifene) and vaginal discharge (more frequent with tamoxifen).  Conclusion: Tamoxifen produced significantly longer progression-free survival and time to treatment failure compared with arzoxifene in the treatment of locally advanced and metastatic breast cancer.  There were no significant differences between tumor response rate, clin. benefit rate, or median response duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0TBBdzHZWMbVg90H21EOLACvtfcHk0liNNNQ1Eozp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOhtbfK&md5=464ad5ce1273cc4210417b6e85f763e7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1200%2FJCO.2006.09.5992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2006.09.5992%26sid%3Dliteratum%253Aachs%26aulast%3DDeshmane%26aufirst%3DV.%26aulast%3DKrishnamurthy%26aufirst%3DS.%26aulast%3DMelemed%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DP.%26aulast%3DBuzdar%26aufirst%3DA.%2BU.%26atitle%3DPhase%2520III%2520double-blind%2520trial%2520of%2520arzoxifene%2520compared%2520with%2520tamoxifen%2520for%2520locally%2520advanced%2520or%2520metastatic%2520breast%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D4967%26epage%3D4973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">DeFriend, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blamey, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundred, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeling, A. E.</span><span> </span><span class="NLM_article-title">Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=408-414&author=D.+J.+DeFriendauthor=A.+Howellauthor=R.+I.+Nicholsonauthor=E.+Andersonauthor=M.+Dowsettauthor=R.+E.+Manselauthor=R.+W.+Blameyauthor=N.+J.+Bundredauthor=J.+F.+Robertsonauthor=C.+Saundersauthor=M.+Baumauthor=P.+Waltonauthor=F.+Sutcliffeauthor=A.+E.+Wakeling&title=Investigation+of+a+new+pure+antiestrogen+%28ICI+182780%29+in+women+with+primary+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeFriend%26aufirst%3DD.%2BJ.%26aulast%3DHowell%26aufirst%3DA.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3DBlamey%26aufirst%3DR.%2BW.%26aulast%3DBundred%26aufirst%3DN.%2BJ.%26aulast%3DRobertson%26aufirst%3DJ.%2BF.%26aulast%3DSaunders%26aufirst%3DC.%26aulast%3DBaum%26aufirst%3DM.%26aulast%3DWalton%26aufirst%3DP.%26aulast%3DSutcliffe%26aufirst%3DF.%26aulast%3DWakeling%26aufirst%3DA.%2BE.%26atitle%3DInvestigation%2520of%2520a%2520new%2520pure%2520antiestrogen%2520%2528ICI%2520182780%2529%2520in%2520women%2520with%2520primary%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D408%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Robertson, J. F. R.</span><span> </span><span class="NLM_article-title">Fulvestrant (Faslodex)—how to make a good drug better</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=774-784&author=J.+F.+R.+Robertson&title=Fulvestrant+%28Faslodex%29%E2%80%94how+to+make+a+good+drug+better"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DJ.%2BF.%2BR.%26atitle%3DFulvestrant%2520%2528Faslodex%2529%25E2%2580%2594how%2520to%2520make%2520a%2520good%2520drug%2520better%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D774%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahraman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnefous, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-j.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aparicio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudente, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darimont, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rix, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span> </span><span class="NLM_article-title">Identification of GDC-0810 (ARN-810), an orally bioavailable selective estrogen receptor degrader (SERD) that demonstrates robust activity in tamoxifen-resistant breast cancer xenografts</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Laiauthor=M.+Kahramanauthor=S.+Govekauthor=J.+Nagasawaauthor=C.+Bonnefousauthor=J.+Julienauthor=K.+Douglasauthor=J.+Sensintaffarauthor=N.+Luauthor=K.-j.+Leeauthor=A.+Aparicioauthor=J.+Kaufmanauthor=J.+Qianauthor=G.+Shaoauthor=R.+Prudenteauthor=M.+J.+Moonauthor=J.+D.+Josephauthor=B.+Darimontauthor=D.+Brighamauthor=K.+Grillotauthor=R.+Heymanauthor=P.+J.+Rixauthor=J.+H.+Hagerauthor=N.+D.+Smith&title=Identification+of+GDC-0810+%28ARN-810%29%2C+an+orally+bioavailable+selective+estrogen+receptor+degrader+%28SERD%29+that+demonstrates+robust+activity+in+tamoxifen-resistant+breast+cancer+xenografts&doi=10.1021%2Facs.jmedchem.5b00054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00054%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DA.%26aulast%3DKahraman%26aufirst%3DM.%26aulast%3DGovek%26aufirst%3DS.%26aulast%3DNagasawa%26aufirst%3DJ.%26aulast%3DBonnefous%26aufirst%3DC.%26aulast%3DJulien%26aufirst%3DJ.%26aulast%3DDouglas%26aufirst%3DK.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DK.-j.%26aulast%3DAparicio%26aufirst%3DA.%26aulast%3DKaufman%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DG.%26aulast%3DPrudente%26aufirst%3DR.%26aulast%3DMoon%26aufirst%3DM.%2BJ.%26aulast%3DJoseph%26aufirst%3DJ.%2BD.%26aulast%3DDarimont%26aufirst%3DB.%26aulast%3DBrigham%26aufirst%3DD.%26aulast%3DGrillot%26aufirst%3DK.%26aulast%3DHeyman%26aufirst%3DR.%26aulast%3DRix%26aufirst%3DP.%2BJ.%26aulast%3DHager%26aufirst%3DJ.%2BH.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26atitle%3DIdentification%2520of%2520GDC-0810%2520%2528ARN-810%2529%252C%2520an%2520orally%2520bioavailable%2520selective%2520estrogen%2520receptor%2520degrader%2520%2528SERD%2529%2520that%2520demonstrates%2520robust%2520activity%2520in%2520tamoxifen-resistant%2520breast%2520cancer%2520xenografts%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">McDonnell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardell, S. E.</span><span> </span><span class="NLM_article-title">The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1016%2Fj.coph.2010.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=20926342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVals73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=620-628&author=D.+P.+McDonnellauthor=S.+E.+Wardell&title=The+molecular+mechanisms+underlying+the+pharmacological+actions+of+ER+modulators%3A+implications+for+new+drug+discovery+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer</span></div><div class="casAuthors">McDonnell, Donald P.; Wardell, Suzanne E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">620-628</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Our understanding of the mol. mechanisms underlying the pharmacol. actions of estrogen receptor (ER) ligands has evolved considerably in recent years.  Much of this knowledge has come from a detailed dissection of the mechanism(s) of action of the Selective Estrogen Receptor Modulators (SERMs) tamoxifen and raloxifene, so called for their ability to function as ER agonists or antagonists depending on the tissue in which they operate.  These mechanistic insights have had a significant impact on the discovery of second generation SERMs, some of which are in late stage clin. development for the treatment/prevention of breast cancer as well as other estrogenopathies.  In addn. to the SERMs, however, have emerged the Selective Estrogen Degraders (SERDs), which as their name suggests, interact with and facilitate ER turnover in cells.  One drug of this class, fulvestrant, has been approved as a third line treatment for ER-pos. metastatic breast cancer.  Whereas the first generation SERMs/SERDs were discovered in a serendipitous manner, this review will highlight how our understanding of the mol. pharmacol. of ER ligands has been utilized in the development of the next generation of SERMs/SERDs, some of which are likely to have a major impact on the pharmacotherapy of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b2l5p-n0bbVg90H21EOLACvtfcHk0liJ-wlSTFYlag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVals73P&md5=24d1490ca0b0570c21e9768c9de134d6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2010.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2010.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DWardell%26aufirst%3DS.%2BE.%26atitle%3DThe%2520molecular%2520mechanisms%2520underlying%2520the%2520pharmacological%2520actions%2520of%2520ER%2520modulators%253A%2520implications%2520for%2520new%2520drug%2520discovery%2520in%2520breast%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2010%26volume%3D10%26spage%3D620%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gottardis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyaswaroop, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1988&pages=812-815&author=M.+M.+Gottardisauthor=S.+P.+Robinsonauthor=P.+G.+Satyaswaroopauthor=V.+C.+Jordan&title=Contrasting+actions+of+tamoxifen+on+endometrial+and+breast+tumor+growth+in+the+athymic+mouse"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGottardis%26aufirst%3DM.%2BM.%26aulast%3DRobinson%26aufirst%3DS.%2BP.%26aulast%3DSatyaswaroop%26aufirst%3DP.%2BG.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DContrasting%2520actions%2520of%2520tamoxifen%2520on%2520endometrial%2520and%2520breast%2520tumor%2520growth%2520in%2520the%2520athymic%2520mouse%26jtitle%3DCancer%2520Res.%26date%3D1988%26volume%3D48%26spage%3D812%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Love, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazess, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barden, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carbone, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMets, D. L.</span><span> </span><span class="NLM_article-title">Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1056%2FNEJM199203263261302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1542321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A280%3ADyaK387nvVaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1992&pages=852-856&author=R.+R.+Loveauthor=R.+B.+Mazessauthor=H.+S.+Bardenauthor=S.+Epsteinauthor=P.+A.+Newcombauthor=V.+C.+Jordanauthor=P.+P.+Carboneauthor=D.+L.+DeMets&title=Effects+of+tamoxifen+on+bone+mineral+density+in+postmenopausal+women+with+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer</span></div><div class="casAuthors">Love R R; Mazess R B; Barden H S; Epstein S; Newcomb P A; Jordan V C; Carbone P P; DeMets D L</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">852-6</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND AND METHODS:  Tamoxifen, a synthetic antiestrogen, increases disease-free and overall survival when used as adjuvant therapy for primary breast cancer.  Because it is given for long periods, it is important to know whether tamoxifen affects the skeleton, particularly since it is used extensively in postmenopausal women who are at risk for osteoporosis.  Using photon absorptiometry, we studied the effects of tamoxifen on the bone mineral density of the lumbar spine and radius and on biochemical measures of bone metabolism in 140 postmenopausal women with axillary-node-negative breast cancer, in a two-year randomized, double-blind, placebo-controlled trial.  RESULTS:  In the women given tamoxifen, the mean bone mineral density of the lumbar spine increased by 0.61 percent per year, whereas in those given placebo it decreased by 1.00 percent per year (P less than 0.001).  Radial bone mineral density decreased to the same extent in both groups.  In a subgroup randomly selected from each group, serum osteocalcin and alkaline phosphatase concentrations decreased significantly in women given tamoxifen (P less than 0.001 for each variable), whereas serum parathyroid hormone and 1,25-dihydroxyvitamin D concentrations did not change significantly in either group.  CONCLUSIONS:  In postmenopausal women, treatment with tamoxifen is associated with preservation of the bone mineral density of the lumbar spine.  Whether this favorable effect on bone mineral density is accompanied by a decrease in the risk of fractures remains to be determined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSY_qsjc-vTAUcLvDNbOD4DfW6udTcc2eZyNJmIqpJbWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387nvVaqtA%253D%253D&md5=a39f73f6913dd02f208ae65e5c520dc4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJM199203263261302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199203263261302%26sid%3Dliteratum%253Aachs%26aulast%3DLove%26aufirst%3DR.%2BR.%26aulast%3DMazess%26aufirst%3DR.%2BB.%26aulast%3DBarden%26aufirst%3DH.%2BS.%26aulast%3DEpstein%26aufirst%3DS.%26aulast%3DNewcomb%26aufirst%3DP.%2BA.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26aulast%3DCarbone%26aufirst%3DP.%2BP.%26aulast%3DDeMets%26aufirst%3DD.%2BL.%26atitle%3DEffects%2520of%2520tamoxifen%2520on%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520women%2520with%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1992%26volume%3D326%26spage%3D852%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Musgrove, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, R. L.</span><span> </span><span class="NLM_article-title">Biological determinants of endocrine resistance in breast cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">643</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1038%2Fnrc2713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=19701242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVegtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=631-643&author=E.+A.+Musgroveauthor=R.+L.+Sutherland&title=Biological+determinants+of+endocrine+resistance+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Biological determinants of endocrine resistance in breast cancer</span></div><div class="casAuthors">Musgrove, Elizabeth A.; Sutherland, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">631-643</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Endocrine therapies targeting estrogen action (anti-estrogens, such as tamoxifen, and aromatase inhibitors) decrease mortality from breast cancer, but their efficacy is limited by intrinsic and acquired therapeutic resistance.  Candidate mol. biomarkers and gene expression signatures of tamoxifen response emphasize the importance of deregulation of proliferation and survival signaling in endocrine resistance.  However, definition of the specific genetic lesions and mol. processes that det. clin. endocrine resistance is incomplete.  The development of large-scale computational and genetic approaches offers the promise of identifying the mediators of endocrine resistance that may be exploited as potential therapeutic targets and biomarkers of response in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbi_1MVsJjz7Vg90H21EOLACvtfcHk0lhNNE89WzdC2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVegtrzL&md5=e57a6a082e0f41d26422350657201de5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc2713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2713%26sid%3Dliteratum%253Aachs%26aulast%3DMusgrove%26aufirst%3DE.%2BA.%26aulast%3DSutherland%26aufirst%3DR.%2BL.%26atitle%3DBiological%2520determinants%2520of%2520endocrine%2520resistance%2520in%2520breast%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D631%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huacani, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowlkes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Peptide antagonists of the human estrogen receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=744-746&author=J.+D.+Norrisauthor=L.+A.+Paigeauthor=D.+J.+Christensenauthor=C.-Y.+Changauthor=M.+R.+Huacaniauthor=D.+Fanauthor=P.+T.+Hamiltonauthor=D.+M.+Fowlkesauthor=D.+P.+McDonnell&title=Peptide+antagonists+of+the+human+estrogen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DPaige%26aufirst%3DL.%2BA.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DChang%26aufirst%3DC.-Y.%26aulast%3DHuacani%26aufirst%3DM.%2BR.%26aulast%3DFan%26aufirst%3DD.%26aulast%3DHamilton%26aufirst%3DP.%2BT.%26aulast%3DFowlkes%26aufirst%3DD.%2BM.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DPeptide%2520antagonists%2520of%2520the%2520human%2520estrogen%2520receptor%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D744%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Shiau, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barstad, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loria, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kushner, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agard, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, G. L.</span><span> </span><span class="NLM_article-title">The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1016%2FS0092-8674%2800%2981717-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=9875847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADyaK1MXjslyltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=927-937&author=A.+K.+Shiauauthor=D.+Barstadauthor=P.+M.+Loriaauthor=L.+Chengauthor=P.+J.+Kushnerauthor=D.+A.+Agardauthor=G.+L.+Greene&title=The+structural+basis+of+estrogen+receptor%2Fcoactivator+recognition+and+the+antagonism+of+this+interaction+by+tamoxifen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen</span></div><div class="casAuthors">Shiau, Andrew K.; Barstad, Danielle; Loria, Paula M.; Cheng, Lin; Kushner, Peter J.; Agard, David A.; Greene, Geoffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">927-937</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ligand-dependent activation of transcription by nuclear receptors (NRs) is mediated by interactions with coactivators.  Receptor agonists promote coactivator binding, and antagonists block coactivator binding.  Here we report the crystal structure of the human estrogen receptor α (hERα) ligand-binding domain (LBD) bound to both the agonist diethylstilbestrol (DES) and a peptide derived from the NR box II region of the coactivator GRIP1 and the crystal structure of the hERα LBD bound to the selective antagonist 4-hydroxytamoxifen (OHT).  In the DES-LBD-peptide complex, the peptide binds as a short α helix to a hydrophobic groove on the surface of the LBD.  In the OHT-LBD complex, helix 12 occludes the coactivator recognition groove by mimicking the interactions of the NR box peptide with the LBD.  These structures reveal the two distinct mechanisms by which structural features of OHT promote this "autoinhibitory" helix 12 conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrjqf40oHhE7Vg90H21EOLACvtfcHk0lhNNE89WzdC2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjslyltQ%253D%253D&md5=074d616cf353f0d98cea5b26c4595c10</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981717-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981717-1%26sid%3Dliteratum%253Aachs%26aulast%3DShiau%26aufirst%3DA.%2BK.%26aulast%3DBarstad%26aufirst%3DD.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DKushner%26aufirst%3DP.%2BJ.%26aulast%3DAgard%26aufirst%3DD.%2BA.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26atitle%3DThe%2520structural%2520basis%2520of%2520estrogen%2520receptor%252Fcoactivator%2520recognition%2520and%2520the%2520antagonism%2520of%2520this%2520interaction%2520by%2520tamoxifen%26jtitle%3DCell%26date%3D1998%26volume%3D95%26spage%3D927%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Connor, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadwater, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottardis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewhirst, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">2917</span><span class="NLM_x">–</span> <span class="NLM_lpage">2922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=11306468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFGqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=2917-2922&author=C.+E.+Connorauthor=J.+D.+Norrisauthor=G.+Broadwaterauthor=T.+M.+Willsonauthor=M.+M.+Gottardisauthor=M.+W.+Dewhirstauthor=D.+P.+McDonnell&title=Circumventing+tamoxifen+resistance+in+breast+cancers+using+antiestrogens+that+induce+unique+conformational+changes+in+the+estrogen+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor</span></div><div class="casAuthors">Connor, Caroline E.; Norris, John D.; Broadwater, Gloria; Willson, Timothy M.; Gottardis, Marco M.; Dewhirst, Mark W.; McDonnell, Donald P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2917-2922</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tamoxifen inhibits estrogen receptor (ER) transcriptional activity by competitively inhibiting estradiol binding and inducing conformational changes in the receptor that may prevent its interaction with coactivators.  In bone, the cardiovascular system, and some breast tumors, however, tamoxifen exhibits agonist activity, suggesting that the tamoxifen-ER complex is not recognized identically in all cells.  We used phage display to demonstrate that the antiestrogen GW5638 induces a unique structural change in the ER.  The biol. significance of this conformational change was revealed in studies that demonstrated that tamoxifen-resistant breast tumor explants are not cross-resistant to GW5638.  Because of these properties, this drug is currently being developed as a potential therapeutic for tamoxifen-resistant breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2YSN94iysMbVg90H21EOLACvtfcHk0lgX9KPEeAc9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFGqsrw%253D&md5=d7ecae7d445901e2f2c4f133ebbacdc5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConnor%26aufirst%3DC.%2BE.%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DBroadwater%26aufirst%3DG.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DGottardis%26aufirst%3DM.%2BM.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DCircumventing%2520tamoxifen%2520resistance%2520in%2520breast%2520cancers%2520using%2520antiestrogens%2520that%2520induce%2520unique%2520conformational%2520changes%2520in%2520the%2520estrogen%2520receptor%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D2917%26epage%3D2922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henke, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momtahen, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charifson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubahn, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauls, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triantafillou, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, P. G.</span><span> </span><span class="NLM_article-title">3-[4-(1,2-Diphenylbut-1- enyl)phenyl]acrylic acid: A non-steroidal estrogen with functional selectivity for bone over uterus in rats</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1550</span><span class="NLM_x">–</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00037a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=1550-1552&author=T.+M.+Willsonauthor=B.+R.+Henkeauthor=T.+M.+Momtahenauthor=P.+S.+Charifsonauthor=K.+W.+Batchelorauthor=D.+B.+Lubahnauthor=L.+B.+Mooreauthor=B.+B.+Oliverauthor=H.+R.+Saulsauthor=J.+A.+Triantafillouauthor=S.+G.+Wolfeauthor=P.+G.+Baer&title=3-%5B4-%281%2C2-Diphenylbut-1-+enyl%29phenyl%5Dacrylic+acid%3A+A+non-steroidal+estrogen+with+functional+selectivity+for+bone+over+uterus+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00037a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00037a002%26sid%3Dliteratum%253Aachs%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DHenke%26aufirst%3DB.%2BR.%26aulast%3DMomtahen%26aufirst%3DT.%2BM.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26aulast%3DBatchelor%26aufirst%3DK.%2BW.%26aulast%3DLubahn%26aufirst%3DD.%2BB.%26aulast%3DMoore%26aufirst%3DL.%2BB.%26aulast%3DOliver%26aufirst%3DB.%2BB.%26aulast%3DSauls%26aufirst%3DH.%2BR.%26aulast%3DTriantafillou%26aufirst%3DJ.%2BA.%26aulast%3DWolfe%26aufirst%3DS.%2BG.%26aulast%3DBaer%26aufirst%3DP.%2BG.%26atitle%3D3-%255B4-%25281%252C2-Diphenylbut-1-%2520enyl%2529phenyl%255Dacrylic%2520acid%253A%2520A%2520non-steroidal%2520estrogen%2520with%2520functional%2520selectivity%2520for%2520bone%2520over%2520uterus%2520in%2520rats%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D1550%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wu, Y. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, G. L.</span><span> </span><span class="NLM_article-title">Structural basis for an unexpected mode of SERM-mediated ER antagonism</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=413-424&author=Y.+V.+L.+Wuauthor=X.+Yangauthor=Z.+Renauthor=D.+P.+McDonnellauthor=J.+D.+Norrisauthor=T.+M.+Willsonauthor=G.+L.+Greene&title=Structural+basis+for+an+unexpected+mode+of+SERM-mediated+ER+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%2BV.%2BL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DZ.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DGreene%26aufirst%3DG.%2BL.%26atitle%3DStructural%2520basis%2520for%2520an%2520unexpected%2520mode%2520of%2520SERM-mediated%2520ER%2520antagonism%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D413%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Schafer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dardes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentrem, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Regan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Los Reyes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2505</span><span class="NLM_x">–</span> <span class="NLM_lpage">2512</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=11489833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsVOmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=2505-2512&author=J.+M.+Schaferauthor=E.+S.+Leeauthor=R.+C.+Dardesauthor=D.+Bentremauthor=R.+M.+O%E2%80%99Reganauthor=A.+De+Los+Reyesauthor=V.+C.+Jordan&title=Analysis+of+cross-resistance+of+the+selective+estrogen+receptor+modulators+arzoxifene+%28LY353381%29+and+LY117018+in+tamoxifen-stimulated+breast+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenografts</span></div><div class="casAuthors">Schafer, Jennifer MacGregor; Lee, Eun-Sook; Dardes, Rita C.; Bentrem, David; O'Regan, Ruth M.; De Los Reyes, Alexander; Jordan, V. Craig</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2505-2512</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cross-resistance is the primary issue facing the evaluation of new antiestrogens to treat metastatic breast cancer because they may be tested, initially, in populations of patients that have failed long-term adjuvant tamoxifen (Tam) therapy.  We have tested the benzothiophene derivs., arzoxifene (Arzox; LY353381) and LY117018 in two models of Tam-stimulated tumor growth derived from either MCF-7 or T47D breast cancer cells.  Using the MCF-7:Tam model, we found that both Arzox and LY117018 (1.5 mg/day) resulted in tumor growth and, therefore, were partially cross-resistant with Tam.  Next, using the T47D:17β-estradiol (E2) model, we compared the antiestrogenic/antitumor properties of Arzox and LY117018 and detd. that neither Arzox nor LY117018 caused T47D:E2 tumor growth after 21 wk.  In addn., we detd. that long-term treatment does not result in failure and subsequent development of transplantable Arzox- or LY117018-stimulated tumors.  To establish whether Arzox and LY117018 are cross-resistant in T47D:Tam tumors, mice were treated with Arzox or LY117018 (1.5 mg/day), and, again, we found that neither resulted in the growth of transplantable tumors.  Lastly, we showed that Arzox and LY117018 were only partially able to compete with postmenopausal E2 (0.3 cm silastic capsule) in T47D:Tam tumors.  However, when T47D:E2 tumors were treated for 7 days instead of 5 days, both Arzox and LY117018 were more effective.  Arzox is not cross-resistant with Tam in the T47D athymic mouse model but does exhibit cross-resistance in the MCF-7 model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWskSi8cKWLbVg90H21EOLACvtfcHk0lgX9KPEeAc9sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsVOmtbs%253D&md5=3158525d66e8988ad2e969995537dede</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchafer%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DE.%2BS.%26aulast%3DDardes%26aufirst%3DR.%2BC.%26aulast%3DBentrem%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Regan%26aufirst%3DR.%2BM.%26aulast%3DDe%2BLos%2BReyes%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DAnalysis%2520of%2520cross-resistance%2520of%2520the%2520selective%2520estrogen%2520receptor%2520modulators%2520arzoxifene%2520%2528LY353381%2529%2520and%2520LY117018%2520in%2520tamoxifen-stimulated%2520breast%2520cancer%2520xenografts%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2001%26volume%3D7%26spage%3D2505%26epage%3D2512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Masamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heitjan, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">2918</span><span class="NLM_x">–</span> <span class="NLM_lpage">2925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1210%2Fjc.80.10.2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=7559875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADyaK2MXoslCns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1995&pages=2918-2925&author=S.+Masamuraauthor=S.+J.+Santnerauthor=D.+F.+Heitjanauthor=R.+J.+Santen&title=Estrogen+deprivation+causes+estradiol+hypersensitivity+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells</span></div><div class="casAuthors">Masamura, Shigeru; Santner, Steven J.; Heitjan, Daniel F.; Santen, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2918-25</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Genetic and environmental factors can modulate the level of sensitivity to various hormones, including estrogens.  Enhanced sensitivity to estradiol (E2) has been demonstrated in several biol. conditions, such as in sheep during the nonbreeding season, in untreated patients with Turner's syndrome, and in the prepubertal state in normal girls.  The authors postulated that secondary responses to hormonal therapy in patients with breast cancer could also result from enhanced E2 sensitivity, developing as an adaptive mechanism to E2 deprivation.  The present study used the MCF-7 human breast cancer cell line as a model system to test the concept that enhanced sensitivity to E2 may occur as a result of adaptation to low E2 levels.  After depriving MCF-7 cells of estrogens in tissue culture medium for periods of 1-6 mo, the authors established conditions under which replication could be stimulated maximally by 10-14-10-15M E2.  In contrast, wild-type cells not exposed to estrogen deprivation required 10-10M E2 to grow at the same rate.  Further, the concn. of the antiestrogen, ICI 164384, needed to inhibit growth by 50% in estrogen-deprived cells was much lower than that required in wild-type cells (i.e. 10-15 vs. 10-9M).  Nude mice implanted with these estrogen-deprived cells demonstrated an earlier appearance of palpable tumors in response to E2 than animals bearing wild-type cells.  Reexposure to 10-10-10-9M E2, either in vivo or in vitro, returned these cells to the level of estrogen sensitivity obsd. in wild-type cells.  Apparently, breast cancer cells can adapt to low levels of estrogens by enhancing their sensitivity to E2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcOoAZDaWphbVg90H21EOLACvtfcHk0lj8-5rWdwuScg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslCns7Y%253D&md5=e61b1298d67a65bc5854b1afc3376af3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1210%2Fjc.80.10.2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.80.10.2918%26sid%3Dliteratum%253Aachs%26aulast%3DMasamura%26aufirst%3DS.%26aulast%3DSantner%26aufirst%3DS.%2BJ.%26aulast%3DHeitjan%26aufirst%3DD.%2BF.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DEstrogen%2520deprivation%2520causes%2520estradiol%2520hypersensitivity%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1995%26volume%3D80%26spage%3D2918%26epage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Jeselsohn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yelensky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwalter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frampton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meric-Bernstam, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Angulo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer-Lozano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Fidalgo, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristofanilli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giltnane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balko, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soussan-Gutman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Come, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusztai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span> </span><span class="NLM_article-title">Emergence of constitutively active estrogen receptor-alpha mutations in pretreated advanced estrogen receptor-positive breast cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1158%2F1078-0432.CCR-13-2332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=24398047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1eiu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1757-1767&author=R.+Jeselsohnauthor=R.+Yelenskyauthor=G.+Buchwalterauthor=G.+Framptonauthor=F.+Meric-Bernstamauthor=A.+M.+Gonzalez-Anguloauthor=J.+Ferrer-Lozanoauthor=J.+A.+Perez-Fidalgoauthor=M.+Cristofanilliauthor=H.+Gomezauthor=C.+L.+Arteagaauthor=J.+Giltnaneauthor=J.+M.+Balkoauthor=M.+T.+Croninauthor=M.+Jaroszauthor=J.+Sunauthor=M.+Hawrylukauthor=D.+Lipsonauthor=G.+Ottoauthor=J.+S.+Rossauthor=A.+Dvirauthor=L.+Soussan-Gutmanauthor=I.+Wolfauthor=T.+Rubinekauthor=L.+Gilmoreauthor=S.+Schnittauthor=S.+E.+Comeauthor=L.+Pusztaiauthor=P.+Stephensauthor=M.+Brownauthor=V.+A.+Miller&title=Emergence+of+constitutively+active+estrogen+receptor-alpha+mutations+in+pretreated+advanced+estrogen+receptor-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer</span></div><div class="casAuthors">Jeselsohn, Rinath; Yelensky, Roman; Buchwalter, Gilles; Frampton, Garrett; Meric-Bernstam, Funda; Gonzalez-Angulo, Ana Maria; Ferrer-Lozano, Jaime; Perez-Fidalgo, Jose A.; Cristofanilli, Massimo; Gomez, Henry; Arteaga, Carlos L.; Giltnane, Jennifer; Balko, Justin M.; Cronin, Maureen T.; Jarosz, Mirna; Sun, James; Hawryluk, Matthew; Lipson, Doron; Otto, Geoff; Ross, Jeffrey S.; Dvir, Addie; Soussan-Gutman, Lior; Wolf, Ido; Rubinek, Tamar; Gilmore, Lauren; Schnitt, Stuart; Come, Steven E.; Pusztai, Lajos; Stephens, Philip; Brown, Myles; Miller, Vincent A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1757-1767</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We undertook this study to det. the prevalence of estrogen receptor (ER) α (ESR1) mutations throughout the natural history of hormone-dependent breast cancer and to delineate the functional roles of the most commonly detected alterations.  Exptl. Design: We studied a total of 249 tumor specimens from 208 patients.  The specimens include 134 ER-pos. (ER+/HER2-) and, as controls, 115 ER-neg. (ER-) tumors.  The ER+ samples consist of 58 primary breast cancers and 76 metastatic samples.  All tumors were sequenced to high unique coverage using next-generation sequencing targeting the coding sequence of the estrogen receptor and an addnl. 182 cancer-related genes.  Results: Recurring somatic mutations in codons 537 and 538 within the ligand-binding domain of ER were detected in ER+ metastatic disease.  Overall, the frequency of these mutations was 12% [9/76; 95% confidence interval (CI), 6%-21%] in metastatic tumors and in a subgroup of patients who received an av. of 7 lines of treatment the frequency was 20% (5/25; 95% CI, 7%-41%).  These mutations were not detected in primary or treatment-naive ER+ cancer or in any stage of ER- disease.  Functional studies in cell line models demonstrate that these mutations render estrogen receptor constitutive activity and confer partial resistance to currently available endocrine treatments.  Conclusions: In this study, we show evidence for the temporal selection of functional ESR1 mutations as potential drivers of endocrine resistance during the progression of ER+ breast cancer.  Clin Cancer Res; 20(7); 1757-67. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdteKI6rKn7Vg90H21EOLACvtfcHk0lj8-5rWdwuScg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1eiu74%253D&md5=245ddc458d449b0fd6b1804285fb4ed1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2332%26sid%3Dliteratum%253Aachs%26aulast%3DJeselsohn%26aufirst%3DR.%26aulast%3DYelensky%26aufirst%3DR.%26aulast%3DBuchwalter%26aufirst%3DG.%26aulast%3DFrampton%26aufirst%3DG.%26aulast%3DMeric-Bernstam%26aufirst%3DF.%26aulast%3DGonzalez-Angulo%26aufirst%3DA.%2BM.%26aulast%3DFerrer-Lozano%26aufirst%3DJ.%26aulast%3DPerez-Fidalgo%26aufirst%3DJ.%2BA.%26aulast%3DCristofanilli%26aufirst%3DM.%26aulast%3DGomez%26aufirst%3DH.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26aulast%3DGiltnane%26aufirst%3DJ.%26aulast%3DBalko%26aufirst%3DJ.%2BM.%26aulast%3DCronin%26aufirst%3DM.%2BT.%26aulast%3DJarosz%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DHawryluk%26aufirst%3DM.%26aulast%3DLipson%26aufirst%3DD.%26aulast%3DOtto%26aufirst%3DG.%26aulast%3DRoss%26aufirst%3DJ.%2BS.%26aulast%3DDvir%26aufirst%3DA.%26aulast%3DSoussan-Gutman%26aufirst%3DL.%26aulast%3DWolf%26aufirst%3DI.%26aulast%3DRubinek%26aufirst%3DT.%26aulast%3DGilmore%26aufirst%3DL.%26aulast%3DSchnitt%26aufirst%3DS.%26aulast%3DCome%26aufirst%3DS.%2BE.%26aulast%3DPusztai%26aufirst%3DL.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26atitle%3DEmergence%2520of%2520constitutively%2520active%2520estrogen%2520receptor-alpha%2520mutations%2520in%2520pretreated%2520advanced%2520estrogen%2520receptor-positive%2520breast%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D1757%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Freedman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anders, C. K.</span><span> </span><span class="NLM_article-title">Treatment of breast cancer brain metastases</span> <span class="citation_source-journal">Curr. Breast Cancer Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1007%2Fs12609-011-0061-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=22754605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFaks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1-9&author=R.+A.+Freedmanauthor=C.+K.+Anders&title=Treatment+of+breast+cancer+brain+metastases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of Breast Cancer Brain Metastases</span></div><div class="casAuthors">Freedman, Rachel A.; Anders, Carey K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Breast Cancer Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">CBCRAO</span>;
        ISSN:<span class="NLM_cas:issn">1943-4588</span>.
    
            (<span class="NLM_cas:orgname">Current Medicine Group LLC</span>)
        </div><div class="casAbstract">A review.  Approx. 10% to 15% of women with metastatic breast cancer will develop brain metastases.  Treatment options for these women remain limited, particularly at the time of central nervous system (CNS) relapse following completion of initial CNS-directed therapy.  Historically, prior studies have broadly examd. systemic treatments for breast cancer brain metastases with mixed, but overall disappointing, results.  More recently, studies have increasingly selected patients based on breast cancer subtype and have examd. novel, targeted agents that have preclin. suggestion of blood-brain barrier penetration.  Correlative science objectives, with both tissue-based and novel imaging endpoints, are more frequently incorporated into trials of this nature, with the goal of enhancing our understanding of possible predictors of response.  This review summarizes the current and emerging data on systemic therapy for breast cancer brain metastases and provides a framework for future directions in treating this clin.-challenging entity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsRjOxjP6vGbVg90H21EOLACvtfcHk0lj8-5rWdwuScg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFaks7g%253D&md5=ebf7717cf16d5bd53e68b945e1095413</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs12609-011-0061-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12609-011-0061-5%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DR.%2BA.%26aulast%3DAnders%26aufirst%3DC.%2BK.%26atitle%3DTreatment%2520of%2520breast%2520cancer%2520brain%2520metastases%26jtitle%3DCurr.%2520Breast%2520Cancer%2520Rep.%26date%3D2012%26volume%3D4%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Duchnowska, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dziadziuszko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Och, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czartoryska-Arlukowicz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radecka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszewski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szubstarski, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polish Brain Metastasis Consortium.</span><span> </span><span class="NLM_article-title">Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain</span> <span class="citation_source-journal">Breast Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">R119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=R119&author=R.+Duchnowskaauthor=R.+Dziadziuszkoauthor=T.+Trojanowskiauthor=T.+Mandatauthor=W.+Ochauthor=B.+Czartoryska-Arlukowiczauthor=B.+Radeckaauthor=W.+Olszewskiauthor=F.+Szubstarskiauthor=W.+Kozlowskiauthor=B.+Jaroszauthor=W.+Rogowskiauthor=A.+Kowalczykauthor=J.+Limonauthor=W.+Biernatauthor=J.+Jassemauthor=Polish+Brain+Metastasis+Consortium.&title=Conversion+of+epidermal+growth+factor+receptor+2+and+hormone+receptor+expression+in+breast+cancer+metastases+to+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuchnowska%26aufirst%3DR.%26aulast%3DDziadziuszko%26aufirst%3DR.%26aulast%3DTrojanowski%26aufirst%3DT.%26aulast%3DMandat%26aufirst%3DT.%26aulast%3DOch%26aufirst%3DW.%26aulast%3DCzartoryska-Arlukowicz%26aufirst%3DB.%26aulast%3DRadecka%26aufirst%3DB.%26aulast%3DOlszewski%26aufirst%3DW.%26aulast%3DSzubstarski%26aufirst%3DF.%26aulast%3DKozlowski%26aufirst%3DW.%26aulast%3DJarosz%26aufirst%3DB.%26aulast%3DRogowski%26aufirst%3DW.%26aulast%3DKowalczyk%26aufirst%3DA.%26aulast%3DLimon%26aufirst%3DJ.%26aulast%3DBiernat%26aufirst%3DW.%26aulast%3DJassem%26aufirst%3DJ.%26aulast%3D%26atitle%3DConversion%2520of%2520epidermal%2520growth%2520factor%2520receptor%25202%2520and%2520hormone%2520receptor%2520expression%2520in%2520breast%2520cancer%2520metastases%2520to%2520the%2520brain%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2012%26volume%3D14%26spage%3DR119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Simpson, E. R.</span><span> </span><span class="NLM_article-title">Sources of estrogen and their importance</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1016%2FS0960-0760%2803%2900360-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=14623515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=225-230&author=E.+R.+Simpson&title=Sources+of+estrogen+and+their+importance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sources of estrogen and their importance</span></div><div class="casAuthors">Simpson, E. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3-5</span>),
    <span class="NLM_cas:pages">225-230</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In premenopausal women, the ovaries are the principle source of estradiol, which functions as a circulating hormone to act on distal target tissues.  However, in postmenopausal women when the ovaries cease to produce estrogen, and in men, this is no longer the case, because estradiol is no longer solely an endocrine factor.  Instead, it is produced in a no. of extra-gonadal sites and acts locally at these sites as a paracrine or even intracrine factor.  These sites include the mesenchymal cells of adipose tissue including that of the breast, osteoblasts and chondrocytes of bone, the vascular endothelium and aortic smooth muscle cells, and numerous sites in the brain.  Thus, circulating levels of estrogens in postmenopausal women and in men are not the drivers of estrogen action, they are reactive rather than proactive.  This is because in these cases circulating estrogen originates in the extra-gonadal sites where it acts locally, and if it escapes local metab. then it enters the circulation.  Therefore, circulating levels reflect rather than direct estrogen action in postmenopausal women and in men.  Tissue-specific regulation of CYP19 expression is achieved through the use of distinct promoters, each of which is regulated by different hormonal factors and second messenger signaling pathways.  Thus, in the ovary, CYP19 expression is regulated by FSH which acts through cAMP via the proximal promoter II, whereas in placenta the distal promoter I.1 regulates CYP19 expression in response to retinoids.  In adipose tissue and bone by contrast, another distal promoter-promoter I.4-drives CYP19 expression under the control of glucocorticoids, class 1 cytokines and TNFα.  The importance of this unique aspect of the tissue-specific regulation of aromatase expression lies in the fact that the low circulating levels of estrogens which are obsd. in postmenopausal women have little bearing on the concns. of estrogen in, for example, a breast tumor, which can reach levels at least one order of magnitude greater than those present in the circulation, due to local synthesis within the breast.  Thus, the estrogen which is responsible for breast cancer development, for the maintenance of bone mineralization and for the maintenance of cognitive function is not circulating estrogen but rather that which is produced locally at these specific sites within the breast, bone and brain.  In breast adipose of breast cancer patients, aromatase activity and CYP19 expression are elevated.  This occurs in response to tumor-derived factors such as prostaglandin E2 produced by breast tumor fibroblasts and epithelium as well as infiltrating macrophages.  This increased CYP19 expression is assocd. with a switch in promoter usage from the normal adipose-specific promoter I.4 to the cAMP responsive promoter, promoter II.  Since these two promoters are regulated by different cohorts of transcription factors and coactivators, it follows that the differential regulation of CYP19 expression via alternative promoters in disease-free and cancerous breast adipose tissue may permit the development of selective aromatase modulators (SAMs) that target the aberrant overexpression of aromatase in cancerous breast, while sparing estrogen synthesis in other sites such as normal adipose tissue, bone and brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkuXyHF9aebVg90H21EOLACvtfcHk0lhi_JzCiVx71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D&md5=c1624c91faeee8db6aec04c2be84b3a2</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900360-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900360-1%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26atitle%3DSources%2520of%2520estrogen%2520and%2520their%2520importance%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D86%26spage%3D225%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Creighton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rae, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Ashry, D.</span><span> </span><span class="NLM_article-title">Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">3903</span><span class="NLM_x">–</span> <span class="NLM_lpage">3911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=3903-3911&author=C.+J.+Creightonauthor=A.+M.+Hilgerauthor=S.+Murthyauthor=J.+M.+Raeauthor=A.+M.+Chinnaiyanauthor=D.+El-Ashry&title=Activation+of+mitogen-activated+protein+kinase+in+estrogen+receptor+alpha-positive+breast+cancer+cells+in+vitro+induces+an+in+vivo+molecular+phenotype+of+estrogen+receptor+alpha-negative+human+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCreighton%26aufirst%3DC.%2BJ.%26aulast%3DHilger%26aufirst%3DA.%2BM.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DRae%26aufirst%3DJ.%2BM.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DEl-Ashry%26aufirst%3DD.%26atitle%3DActivation%2520of%2520mitogen-activated%2520protein%2520kinase%2520in%2520estrogen%2520receptor%2520alpha-positive%2520breast%2520cancer%2520cells%2520in%2520vitro%2520induces%2520an%2520in%2520vivo%2520molecular%2520phenotype%2520of%2520estrogen%2520receptor%2520alpha-negative%2520human%2520breast%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D3903%26epage%3D3911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulazzo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyass, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spector, N. L.</span><span> </span><span class="NLM_article-title">A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7795</span><span class="NLM_x">–</span> <span class="NLM_lpage">7800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7795-7800&author=W.+Xiaauthor=S.+Bacusauthor=P.+Hegdeauthor=I.+Husainauthor=J.+Strumauthor=L.+Liuauthor=G.+Paulazzoauthor=L.+Lyassauthor=P.+Truskauthor=J.+Hillauthor=J.+Harrisauthor=N.+L.+Spector&title=A+model+of+acquired+autoresistance+to+a+potent+ErbB2+tyrosine+kinase+inhibitor+and+a+therapeutic+strategy+to+prevent+its+onset+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DW.%26aulast%3DBacus%26aufirst%3DS.%26aulast%3DHegde%26aufirst%3DP.%26aulast%3DHusain%26aufirst%3DI.%26aulast%3DStrum%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DPaulazzo%26aufirst%3DG.%26aulast%3DLyass%26aufirst%3DL.%26aulast%3DTrusk%26aufirst%3DP.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSpector%26aufirst%3DN.%2BL.%26atitle%3DA%2520model%2520of%2520acquired%2520autoresistance%2520to%2520a%2520potent%2520ErbB2%2520tyrosine%2520kinase%2520inhibitor%2520and%2520a%2520therapeutic%2520strategy%2520to%2520prevent%2520its%2520onset%2520in%2520breast%2520cancer%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7795%26epage%3D7800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bosch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamaschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spratt, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viola-Villegas, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minuesa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Garcia, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grueso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandarlapaty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaltriti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">283ra51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=10.1126%2Fscitranslmed.aaa4442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;key=25877889" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=283ra51&author=A.+Boschauthor=Z.+Liauthor=A.+Bergamaschiauthor=H.+Ellisauthor=E.+Toskaauthor=A.+Pratauthor=J.+J.+Taoauthor=D.+E.+Sprattauthor=N.+T.+Viola-Villegasauthor=P.+Castelauthor=G.+Minuesaauthor=N.+Morseauthor=J.+Rodonauthor=Y.+Ibrahimauthor=J.+Cortesauthor=J.+Perez-Garciaauthor=P.+Galvanauthor=J.+Gruesoauthor=M.+Guzmanauthor=J.+A.+Katzenellenbogenauthor=M.+Kharasauthor=J.+S.+Lewisauthor=M.+Dicklerauthor=V.+Serraauthor=N.+Rosenauthor=S.+Chandarlapatyauthor=M.+Scaltritiauthor=J.+Baselga&title=PI3K+inhibition+results+in+enhanced+estrogen+receptor+function+and+dependence+in+hormone+receptor-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaa4442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaa4442%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBergamaschi%26aufirst%3DA.%26aulast%3DEllis%26aufirst%3DH.%26aulast%3DToska%26aufirst%3DE.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DTao%26aufirst%3DJ.%2BJ.%26aulast%3DSpratt%26aufirst%3DD.%2BE.%26aulast%3DViola-Villegas%26aufirst%3DN.%2BT.%26aulast%3DCastel%26aufirst%3DP.%26aulast%3DMinuesa%26aufirst%3DG.%26aulast%3DMorse%26aufirst%3DN.%26aulast%3DRodon%26aufirst%3DJ.%26aulast%3DIbrahim%26aufirst%3DY.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DPerez-Garcia%26aufirst%3DJ.%26aulast%3DGalvan%26aufirst%3DP.%26aulast%3DGrueso%26aufirst%3DJ.%26aulast%3DGuzman%26aufirst%3DM.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DKharas%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DDickler%26aufirst%3DM.%26aulast%3DSerra%26aufirst%3DV.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChandarlapaty%26aufirst%3DS.%26aulast%3DScaltriti%26aufirst%3DM.%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DPI3K%2520inhibition%2520results%2520in%2520enhanced%2520estrogen%2520receptor%2520function%2520and%2520dependence%2520in%2520hormone%2520receptor-positive%2520breast%2520cancer%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D283ra51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Wijayaratne, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowlkes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Comparative analyses of the mechanistic differences among antiestrogens</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">5828</span><span class="NLM_x">–</span> <span class="NLM_lpage">5840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1999&pages=5828-5840&author=A.+L.+Wijayaratneauthor=S.+C.+Nagelauthor=L.+A.+Paigeauthor=D.+J.+Christensenauthor=J.+D.+Norrisauthor=D.+M.+Fowlkesauthor=D.+P.+McDonnell&title=Comparative+analyses+of+the+mechanistic+differences+among+antiestrogens"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWijayaratne%26aufirst%3DA.%2BL.%26aulast%3DNagel%26aufirst%3DS.%2BC.%26aulast%3DPaige%26aufirst%3DL.%2BA.%26aulast%3DChristensen%26aufirst%3DD.%2BJ.%26aulast%3DNorris%26aufirst%3DJ.%2BD.%26aulast%3DFowlkes%26aufirst%3DD.%2BM.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DComparative%2520analyses%2520of%2520the%2520mechanistic%2520differences%2520among%2520antiestrogens%26jtitle%3DEndocrinology%26date%3D1999%26volume%3D140%26spage%3D5828%26epage%3D5840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Wittmann, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, D. P.</span><span> </span><span class="NLM_article-title">Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">9549</span><span class="NLM_x">–</span> <span class="NLM_lpage">9560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=9549-9560&author=B.+M.+Wittmannauthor=A.+Sherkauthor=D.+P.+McDonnell&title=Definition+of+functionally+important+mechanistic+differences+among+selective+estrogen+receptor+down-regulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWittmann%26aufirst%3DB.%2BM.%26aulast%3DSherk%26aufirst%3DA.%26aulast%3DMcDonnell%26aufirst%3DD.%2BP.%26atitle%3DDefinition%2520of%2520functionally%2520important%2520mechanistic%2520differences%2520among%2520selective%2520estrogen%2520receptor%2520down-regulators%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D9549%26epage%3D9560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00760&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00760%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-12%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00760" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                581KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677af2221dd23c70","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
